(dp0
(S'ZEB1'
p1
S'FOXA1'
p2
S'increases'
p3
tp4
(lp5
s(S'FOXJ1'
p6
S'GATA6'
p7
S'increases'
p8
tp9
(lp10
s(S'TFAP4'
p11
S'FOXD3'
p12
S'increases'
p13
tp14
(lp15
s(S'TBP'
p16
S'MEIS1'
p17
S'increases'
p18
tp19
(lp20
s(S'GCM1'
p21
S'GATA6'
p22
S'increases'
p23
tp24
(lp25
s(S'T-DHT'
p26
S'SRC'
p27
S'adds_modification'
p28
tp29
(lp30
s(S'MAZ'
p31
S'GABPB2'
p32
S'increases'
p33
tp34
(lp35
s(S'HMGA1'
p36
S'EN1'
p37
S'increases'
p38
tp39
(lp40
s(S'CYP26A1'
p41
S'NRAS'
p42
S'increases'
p43
tp44
(lp45
s(S'CUX1'
p46
S'MEIS1'
p47
S'increases'
p48
tp49
(lp50
s(S'REPIN1'
p51
S'BACH1'
p52
S'increases'
p53
tp54
(lp55
s(S'TFDP1'
p56
S'HOXA9'
p57
S'increases'
p58
tp59
(lp60
s(S'NFE2L1'
p61
S'CYP26A1'
p62
S'increases'
p63
tp64
(lp65
s(S'MAZ'
p66
S'GATA1'
p67
S'increases'
p68
tp69
(lp70
s(S'TCF12'
p71
S'GABPB2'
p72
S'increases'
p73
tp74
(lp75
s(S'ETS2'
p76
S'FOXO3'
p77
S'increases'
p78
tp79
(lp80
s(S'hsa-let-7c-5p'
p81
S'NRAS'
p82
S'decreases'
p83
tp84
(lp85
s(S'SPI1'
p86
S'CYP26A1'
p87
S'increases'
p88
tp89
(lp90
s(S'RAC1/GTP'
p91
S'MKK4'
p92
S'adds_modification'
p93
tp94
(lp95
s(S'Quercetin'
p96
S'KRAS MRNA'
p97
S'decreases'
p98
tp99
(lp100
s(S'INSULIN RECEPTOR/INSULIN/SHC'
p101
S'GRB2'
p102
S'binds'
p103
tp104
(lp105
s(S'TAp63a (tetramer)'
p106
S'PKC DELTA'
p107
S'increases'
p108
tp109
(lp110
s(S'FOXO1'
p111
S'POU2F1'
p112
S'increases'
p113
tp114
(lp115
s(S'FOXL1'
p116
S'EN1'
p117
S'increases'
p118
tp119
(lp120
s(S'TBP'
p121
S'CYP26A1'
p122
S'increases'
p123
tp124
(lp125
s(S'Heptachlor'
p126
S'HRAS MRNA'
p127
S'decreases'
p128
tp129
(lp130
s(S'PCBP1'
p131
S'CYP26A1'
p132
S'increases'
p133
tp134
(lp135
s(S'ZBTB18'
p136
S'CYP26A1'
p137
S'increases'
p138
tp139
(lp140
s(S'GATA2'
p141
S'CYP26A1'
p142
S'increases'
p143
tp144
(lp145
s(S'Cadmium'
p146
S'KRAS MRNA'
p147
S'increases'
p148
tp149
(lp150
s(S'HNF1A'
p151
S'POU2F1'
p152
S'increases'
p153
tp154
(lp155
s(S'ABT-100'
p156
S'HRAS PROTEIN'
p157
S'inhibits_modification'
p158
tp159
(lp160
s(S'ELF1'
p161
S'CYP26A1'
p162
S'increases'
p163
tp164
(lp165
s(S'LEF1'
p166
S'KRAS'
p167
S'increases'
p168
tp169
(lp170
s(S'NKX2-1'
p171
S'FOXD3'
p172
S'increases'
p173
tp174
(lp175
s(S'PI-3-4-5-P3'
p176
S'BTK-ITK'
p177
S'translocates'
p178
tp179
(lp180
s(S'POU6F1'
p181
S'HOXA9'
p182
S'increases'
p183
tp184
(lp185
s(S'Myb'
p186
S'MYB'
p187
S'increases'
p188
tp189
(lp190
s(S'PAX5'
p191
S'CYP26A1'
p192
S'increases'
p193
tp194
(lp195
s(S'FOXO4'
p196
S'FOXD3'
p197
S'increases'
p198
tp199
(lp200
s(S'CYP26A1'
p201
S'FOXO4'
p202
S'increases'
p203
tp204
(lp205
s(S'cell adhesion'
p206
S'HRAS/GDP'
p207
S'increases_activity'
p208
tp209
(lp210
s(S'IRF7'
p211
S'CYP26A1'
p212
S'increases'
p213
tp214
(lp215
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p216
S'KRAS PROTEIN'
p217
S'increases'
p218
tp219
(lp220
s(S'PITX2'
p221
S'POU2F1'
p222
S'increases'
p223
tp224
(lp225
s(S'E2F1'
p226
S'CYP26A1'
p227
S'increases'
p228
tp229
(lp230
s(S'ATF1'
p231
S'CYP26A1'
p232
S'increases'
p233
tp234
(lp235
s(S'PI3K'
p236
S'PKC DELTA'
p237
S'adds_modification'
p238
tp239
(lp240
s(S'SOX5'
p241
S'HOXA9'
p242
S'increases'
p243
tp244
(lp245
s(S'FOXO4'
p246
S'POU2F1'
p247
S'increases'
p248
tp249
(lp250
s(S'FOXO4'
p251
S'GATA6'
p252
S'increases'
p253
tp254
(lp255
s(S'LEF1'
p256
S'FOXF2'
p257
S'increases'
p258
tp259
(lp260
s(S'Insulin Receptor/Insuli/IRS1/GRB2/SHC/Sos'
p261
S'HRAS/GDP'
p262
S'increases_activity'
p263
tp264
(lp265
s(S'TLX2'
p266
S'RUNX1'
p267
S'increases'
p268
tp269
(lp270
s(S'ALX4'
p271
S'JUN'
p272
S'increases'
p273
tp274
(lp275
s(S'RHOA/GTP'
p276
S'RHOGDI'
p277
S'binds'
p278
tp279
(lp280
s(S'GCM1'
p281
S'CYP26A1'
p282
S'increases'
p283
tp284
(lp285
s(S'RB1'
p286
S'ONECUT1'
p287
S'increases'
p288
tp289
(lp290
s(S'NHLH1'
p291
S'CYP26A1'
p292
S'increases'
p293
tp294
(lp295
s(S'NR3C1'
p296
S'BACH1'
p297
S'increases'
p298
tp299
(lp300
s(S'HNF4A'
p301
S'CYP26A1'
p302
S'increases'
p303
tp304
(lp305
s(S'YY1'
p306
S'FOXO3'
p307
S'increases'
p308
tp309
(lp310
s(S'GRB2:SOS1'
p311
S'P-EGFR MUTANTS DIMER'
p312
S'binds'
p313
tp314
(lp315
s(S'P-Y349,350-SHC1:P-ERBB4'
p316
S'GRB2:SOS1'
p317
S'binds'
p318
tp319
(lp320
s(S'FOXN1'
p321
S'ONECUT1'
p322
S'increases'
p323
tp324
(lp325
s(S'TFAP4'
p326
S'MYC'
p327
S'increases'
p328
tp329
(lp330
s(S'MYC'
p331
S'EN1'
p332
S'increases'
p333
tp334
(lp335
s(S'Antigen/IgE/Fc epsilon R1/LYN/SYK'
p336
S'SHC/GRB2/SOS1'
p337
S'increases_activity'
p338
tp339
(lp340
s(S'14-3-3 BETA, ZETA'
p341
S'GARNL4'
p342
S'binds'
p343
tp344
(lp345
s(S'SMAD1'
p346
S'EN1'
p347
S'increases'
p348
tp349
(lp350
s(S'Raf-1'
p351
S'MEK1-2'
p352
S'adds_modification'
p353
tp354
(lp355
s(S'POU2F1'
p356
S'FOXO3'
p357
S'increases'
p358
tp359
(lp360
s(S'NGF (dimer)/TRKA'
p361
S'RASGRF1'
p362
S'adds_modification'
p363
tp364
(lp365
s(S'TCF4'
p366
S'CYP26A1'
p367
S'increases'
p368
tp369
(lp370
s(S'STAT5B'
p371
S'TLX2'
p372
S'increases'
p373
tp374
(lp375
s(S'CYP26A1'
p376
S'SRF'
p377
S'increases'
p378
tp379
(lp380
s(S'STAT1'
p381
S'NRAS'
p382
S'increases'
p383
tp384
(lp385
s(S'TFDP1'
p386
S'GATA1'
p387
S'increases'
p388
tp389
(lp390
s(S'PI3K'
p391
S'ALPHA6/BETA4 INTEGRIN/LAMININ'
p392
S'binds'
p393
tp394
(lp395
s(S'FOXF2'
p396
S'NRAS'
p397
S'increases'
p398
tp399
(lp400
s(S'CUX1'
p401
S'POU2F1'
p402
S'increases'
p403
tp404
(lp405
s(S'ETS2'
p406
S'STAT4'
p407
S'increases'
p408
tp409
(lp410
s(S'EN1'
p411
S'CYP26A1'
p412
S'increases'
p413
tp414
(lp415
s(S'COMPLEX (RAS/GTP)'
p416
S'RAF'
p417
S'binds'
p418
tp419
(lp420
s(S'LEF1'
p421
S'EN1'
p422
S'increases'
p423
tp424
(lp425
s(S'FOXL1'
p426
S'NRAS'
p427
S'increases'
p428
tp429
(lp430
s(S'ELF2'
p431
S'CYP26A1'
p432
S'increases'
p433
tp434
(lp435
s(S'Src Family Kinases-active'
p436
S'EGF/EGFR'
p437
S'adds_modification'
p438
tp439
(lp440
s(S'RUNX1'
p441
S'POU2F1'
p442
S'increases'
p443
tp444
(lp445
s(S'RHOA/GTP'
p446
S'CITRON-N'
p447
S'increases_activity'
p448
tp449
(lp450
s(S'PAX4'
p451
S'SRF'
p452
S'increases'
p453
tp454
(lp455
s(S'Vitamin E'
p456
S'HRAS MRNA'
p457
S'increases'
p458
tp459
(lp460
s(S'CDX2'
p461
S'FOXD3'
p462
S'increases'
p463
tp464
(lp465
s(S'Plant Extracts'
p466
S'KEAP1 PROTEIN'
p467
S'decreases'
p468
tp469
(lp470
s(S'PAX4'
p471
S'CBFA2T3'
p472
S'increases'
p473
tp474
(lp475
s(S'FOXD1'
p476
S'CYP26A1'
p477
S'increases'
p478
tp479
(lp480
s(S'Antigen/IgE/Fc epsilon R1/LYN/SYK'
p481
S'VAV1'
p482
S'adds_modification'
p483
tp484
(lp485
s(S'PCBP1'
p486
S'MEIS1'
p487
S'increases'
p488
tp489
(lp490
s(S'FOXI1'
p491
S'FOXD3'
p492
S'increases'
p493
tp494
(lp495
s(S'GATA4'
p496
S'MEIS1'
p497
S'increases'
p498
tp499
(lp500
s(S'STAT5B'
p501
S'CEBPG'
p502
S'increases'
p503
tp504
(lp505
s(S'TFDP2'
p506
S'MAZ'
p507
S'increases'
p508
tp509
(lp510
s(S'PI3K'
p511
S'SHP2'
p512
S'binds'
p513
tp514
(lp515
s(S'SPI1'
p516
S'ONECUT1'
p517
S'increases'
p518
tp519
(lp520
s(S'STAT6'
p521
S'EN1'
p522
S'increases'
p523
tp524
(lp525
s(S'TLX2'
p526
S'CYP26A1'
p527
S'increases'
p528
tp529
(lp530
s(S'RAF1'
p531
S'MEK1-2'
p532
S'increases_activity'
p533
tp534
(lp535
s(S'STAT5A'
p536
S'IRF1'
p537
S'increases'
p538
tp539
(lp540
s(S'2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine'
p541
S'HRAS MRNA'
p542
S'increases'
p543
tp544
(lp545
s(S'MAZ'
p546
S'POU2F1'
p547
S'increases'
p548
tp549
(lp550
s(S'MAZ'
p551
S'SRF'
p552
S'increases'
p553
tp554
(lp555
s(S'GATA1'
p556
S'JUN'
p557
S'increases'
p558
tp559
(lp560
s(S'FOXA1'
p561
S'NRAS'
p562
S'increases'
p563
tp564
(lp565
s(S'STAT1'
p566
S'EN1'
p567
S'increases'
p568
tp569
(lp570
s(S'GTF2A2'
p571
S'MAX'
p572
S'increases'
p573
tp574
(lp575
s(S'LMO2'
p576
S'EN1'
p577
S'increases'
p578
tp579
(lp580
s(S'MYOD1'
p581
S'LEF1'
p582
S'increases'
p583
tp584
(lp585
s(S'ATF3'
p586
S'JUN'
p587
S'increases'
p588
tp589
(lp590
s(S'GRB2:SOS1'
p591
S'ACTIVATED FGFR:P-SHC1'
p592
S'binds'
p593
tp594
(lp595
s(S'MAFG'
p596
S'BACH1'
p597
S'increases'
p598
tp599
(lp600
s(S'POU3F2'
p601
S'POU2F1'
p602
S'increases'
p603
tp604
(lp605
s(S'K 7174'
p606
S'KRAS MRNA'
p607
S'increases'
p608
tp609
(lp610
s(S'POU1F1'
p611
S'RUNX1'
p612
S'increases'
p613
tp614
(lp615
s(S'HRAS protein'
p616
S'CCND1 MRNA'
p617
S'increases'
p618
tp619
(lp620
s(S'YY1'
p621
S'EN1'
p622
S'increases'
p623
tp624
(lp625
s(S'resveratrol'
p626
S'HRAS MRNA'
p627
S'increases'
p628
tp629
(lp630
s(S'NKX2-1'
p631
S'HOXA9'
p632
S'increases'
p633
tp634
(lp635
s(S'HSF1'
p636
S'CYP26A1'
p637
S'increases'
p638
tp639
(lp640
s(S'MYC'
p641
S'HOXA9'
p642
S'increases'
p643
tp644
(lp645
s(S'Raf'
p646
S'MEK'
p647
S'adds_modification'
p648
tp649
(lp650
S'Raf, mitogen-activated protein kinase (MEK) and extracellular signal-regulated kinase (ERK1/2) have been thought to be target effectors of PKC.'
p651
aS'On the other hand, the contents of total Raf, MEK and ERK proteins were relatively constant at all times examined.'
p652
aS'Anti-phosphorylated-Raf (p-Raf), MEK, p-MEK, p-ERK and ERK antibodies were purchased from New England Biolabs, Inc. (Beverly, MA).'
p653
aS'Protein quantification, separation by SDS-PAGE, and immunoblotting were performed as described above using primary antibody (anti-Raf, MEK, ERK1/2, pRaf, pMEK and pERK1/2, diluted 1:400) and secondary antibody (horseradish peroxidase-conjugated anti-mouse Ig and anti-rabbit Ig antibodies, diluted 1:5000 with T-PBS).'
p654
aS'Time course of sevoflurane-induced phosphorylation of Raf, MEK and ERK proteins.'
p655
aS'Total cell lysates were assessed by immunoblotting analysis with antibodies against the phosphorylated and unphosphorylated forms of Raf, MEK and ERK1/2.'
p656
aS'pRaf, phosphorylated Raf; tRaf, total Raf protein; pMEK, phosphorylated MEK; tMEK, total MEK protein; pERK1/2, phosphorylated ERK; tERK1/2, total ERK1/2 protein.'
p657
aS'Time course of Raf, MEK and ERK activation by sevoflurane.'
p658
aS'The ALI enhanced the expression of Raf-1, MEK-1 and pERK-1/2 components of the mitogen-activated protein kinase (MAPK) cascade, in cells more than the submerged condition did.'
p659
aS'Growth-, invasion-, and motility-related molecules such as mitogen-activated protein kinase (MAPK) cascade proteins (Raf-1, MEK-1, and pERK-1/2), matrix metalloproteinase-1 and -9 (MMP-1 and -9), laminin 5, and filamin A ['
p660
aS'To characterize the growth of melanoma cells, we examined the expression of molecules in the MAPK cascade (Raf-1, MEK-1, and pERK-1/2) important for cell growth signaling ['
p661
aS'The ALI also enhances the expression of components of the growth-related MAPK signaling pathway (Raf-1/MEK-1/ERK-1, 2) in melanoma cells, but not the expression of the invasion-related molecules MMP-1, MMP-9, laminin 5, and filamin A.'
p662
aS'Expression of MAPK pathway (Raf-1, MEK-1 and ERK-1/2) of melanoma cells with or without ALI.'
p663
aS'Interestingly, his data suggest that Raf/MEK/ERK signaling plays a central role in the pathologic growth of hematopoietic tumors that have inactivated NF1.'
p664
aS'However, he found that there are disease stage-specific effects of treatment with MEK inhibitors in that advanced cancers such as AML initiated by NF1 inactivation are highly dependent on Raf/MEK/ERK signaling and sensitive to MEK inhibitors ['
p665
aS'One important signaling pathway induced by RAS activation is the Raf/MEK/Erk pathway, which leads to the activation of many cyclin/CDK complexes related to the G'
p666
aS'The main activation mechanism of IR is via the RAS/Raf/MEK/MAPK pathway.'
p667
aS'Some major autophagic regulators and related pathways, including Beclin 1 interactome, p53 signaling, PI3K-Akt-mTOR pathways, and Ras-Raf-MEK-ERK pathways, play crucial roles in the regulation of autophagy in cancer.'
p668
aS'Evidence of aberrant activation of mTORC1, PI3K/Akt, and Raf/MEK/ERK pathways in B-cell lymphomas.'
p669
aS'Dysregulated signaling through the Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways is often the result of genetic alterations in critical components in these pathways or upstream activators.'
p670
aS'The Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR signaling pathways have been shown over the past 25 years to play key roles in the transmission of proliferative signals from membrane bound receptors.'
p671
aS'The Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR signaling pathways consist of kinases cascades that are regulated by phosphorylation and de-phosphorylation by specific kinases, phosphatases as well as GTP/GDP exchange proteins, adaptor proteins and scaffolding proteins.'
p672
aS'An introductory overview of the Ras/Raf/MEK/ERK pathway is presented in Figure '
p673
aS'The Ras/Raf/MEK/ERK pathway is regulated by Ras (indicated in green ovals), as well as various upstream growth factor receptors (indicated in purple) and non-receptor kinases.'
p674
aS'The Ras/Raf/MEK/ERK pathway also interacts with key proteins involved in protein translation (indicated in green ovals).'
p675
aS'Activated ERK can also phosphorylate B-Raf, Raf-1 and MEK1 which alter their activity (Figure '
p676
aS'The Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR pathways can affect protein translation by complex interactions regulating the mTORC1 (grouped together in a purple box) and mTORC2 (grouped together in a blue box) complexes.'
p677
aS'GF stimulation results in GFR activation which can activate both the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR pathways.'
p678
aS'The Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR pathways can be activated by mutations/amplifications of upstream growth factor receptors.'
p679
aS'The abnormal production of growth factors can result in receptor activation which in turns mobilizes the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR cascades.'
p680
aS'An illustration of some of the receptors, exchange factors, kinases and phosphatases that are mutated/amplified in human cancer and how they may impact the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR cascades is presented in Figure '
p681
aS'Mutations downstream of Raf in the Ras/Raf/MEK/ERK cascade have not been frequently detected in human cancer although there are some rare germline mutations detected at '
p682
aS'Signaling via the Ras/Raf/MEK/ERK cascade plays a critical role in liver carcinogenesis ['
p683
aS'In addition, activation of Ras/Raf/MEK/ERK pathway in HCC may be due to down-regulation of Ras inhibitors Sprouty and the '
p684
aS'Down-regulation of RKIP expression is a major factor in activation of the Ras/Raf/MEK/ERK pathway during human hepatocarcinogenesis ['
p685
aS'One central molecule involved in cell growth is p70S6K which is regulated by both the Ras/PI3K/PTEN/Akt/mTOR and Ras/Raf/MEK/ERK pathways ['
p686
aS'The progression of prostate cancer from androgen-dependent to androgen-independent tumors involves the alteration of the androgen receptor and/or the activation of pro-survival pathways, namely those of the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR signaling cascades ['
p687
aS'Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR pathways are often regulated by the tumor suppressor p53.'
p688
aS'Furthermore p53 activity is likewise regulated by the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR pathways.'
p689
aS'The Ras/Raf/MEK/ERK pathway can regulate p53 activity and p53 can also induce the activity of key components of this pathway ['
p690
aS'In certain scenarios, increased p53 expression after chemotherapeutic drug treatment may lead to increased Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR pathways activation, resulting in an undesired pro-proliferative effect ['
p691
aS'In the previous sections, we have discussed the mechanisms of activation of the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR pathways in human cancers, predominantly by mutational based mechanisms.'
p692
aS'Recently the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR pathways have been shown to have roles in cancer stem cells, senescence, aging and sensitivity to targeted therapy ['
p693
aS'We have observed that some drug resistant breast cells that express properties similar to CICs display elevated activation of the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR signaling cascades and that CICs can be isolated from these cell populations ['
p694
aS'The Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways play key roles in regulation of diverse processes ranging from: autophagy DNA damage responses, cellular senescence and aging ['
p695
aS'Over the past 25 years, there has been significant progress in elucidating the involvement of the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR cascades in promoting cell growth, regulating apoptosis, chemotherapeutic drug resistance and more recently, cellular senescence and aging.'
p696
aS'For example, cancer researchers predominately consider that Raf, MEK, PI3K, Akt and mTOR inhibitors will suppress the growth of malignant cancer cells.'
p697
aS'Recent reports have also demonstrated that the suppression of the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR pathways may prevent the induction of cellular senescence and aging.'
p698
aS'In conclusion, the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR pathways are prime therapeutic targets for diverse human diseases as well as aging.'
p699
aS"It is possible that activation of the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR survival pathways by additional mutations in upstream oncogenes may replace the tumor's initial oncogene addition."
p700
aS'Although the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR pathways have distinct effects on cell proliferation, they have many common downstream targets that may be able to function in promoting survival in the absence of the corresponding functional pathway.'
p701
aS'The Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR pathways also regulate other pathways which have not been discussed in this manuscript.'
p702
aS'This is believed to activate Ras/Raf/MEK1 signaling to the extracellular-signal regulated kinases 1 and 2 (ERK1/2) through its receptor, FGFR2b, expressed in the airway epithelium ('
p703
aS'PI3K signaling is complex and can be modulated by crosstalk with other kinase cascades, such as the Ras/Raf/MEK pathway.'
p704
aS'Agents targeting mutant B-Raf (RAF265 and PLX4032), MEK (PD0325901, AZD6244), heat-shock protein 90 (tanespimycin), mTOR (everolimus, deforolimus, temsirolimus) and VEGFR (axitinib) showed some promise in earlier stages of clinical development.'
p705
aS'Several reports have suggested that there is cross-talk between Ras/Raf/MAP/MEK/ERK and/or PTEN/PI3K/Akt pathways.'
p706
aS'The activation of EGFR signaling, such as Ras/Raf/MAP/MEK/ERK and/or PTEN/PI3K/Akt pathways, plays an important role in tumorigenesis and the tumor progression of CRC.'
p707
aS'Published studies have indicated that PHB plays an important role in the Ras-mediated activation of the Raf/MEK/ERK pathway ['
p708
aS'To investigate further the contribution of the MEK-1 pathway, we modulated the expression of Ras and Raf-1 proteins, which are known to trigger MEK-1 activation in chondrocytes ['
p709
aS'Taken together, these findings confirmed the linkage between activation of Ras/Raf-1, MEK-1, and ERK pathways ['
p710
aS'Mechanical signals induced activation and subsequent C-Raf-mediated activation of MAP kinases (MEK1/2).'
p711
aS'The cell lysates were subjected to SDS-10%-PAGE, electrotransferred to a nitrocellulose membrane (Bio-Rad Laboratories, Inc., Hercules, CA, USA), and reacted with antibodies to phospho-Thr202/Tyr204 ERK1/2 and total ERK1/2, phospho-Ser 217/221 MEK1/2 and total MEK1/2, phospho-Ser338 cRaf, phospho-Ser445 B-Raf, phospho-Thr423-PAK1, phospho-Thr58/Ser62 Myc, and total c-Myc proteins (Cell Signaling Technology, Inc., Danvers, MA, USA).'
p712
aS'Since phosphorylation of Raf kinases is necessary for MEK1/2 activation, we next determined whether A-Raf, B-Raf, or c-Raf is activated by DS.'
p713
aS'Akt, protein kinase B; Grb-2, growth receptor-bound-2; IRS, insulin receptor substrate; MEK, mitogen-activated protein kinase kinase; PIAS 3, protein inhibitor of activated STAT3; Raf, MEK-kinase; Ras, G-protein; SHP-2, SH2-domain containing protein tyrosine phosphatase; SOCS3, suppressor of cytokine signalling-3.'
p714
aS'Activated MAPKKK and/or Raf subsequently regulate activation of downstream effectors including MAPKK, p38 MAPK, or MEK and ERK, respectively.'
p715
aS'The prototypical MAPK signaling pathway is the Raf/MEK/ERK cascade, which regulates cell growth and embryonic development ('
p716
as(S'TFDP1'
p717
S'MAZ'
p718
S'increases'
p719
tp720
(lp721
s(S'SPRED1'
p722
S'HRAS'
p723
S'binds'
p724
tp725
(lp726
s(S'MYCN'
p727
S'CYP26A1'
p728
S'increases'
p729
tp730
(lp731
s(S'AHR'
p732
S'FOXD3'
p733
S'increases'
p734
tp735
(lp736
s(S'SF1'
p737
S'CYP26A1'
p738
S'increases'
p739
tp740
(lp741
s(S'MEIS1'
p742
S'ETS1'
p743
S'increases'
p744
tp745
(lp746
s(S'Copper Sulfate'
p747
S'HRAS MRNA'
p748
S'decreases'
p749
tp750
(lp751
s(S'MAZ'
p752
S'MYC'
p753
S'increases'
p754
tp755
(lp756
s(S'E4F1'
p757
S'HOXA9'
p758
S'increases'
p759
tp760
(lp761
s(S'GATA1'
p762
S'GATA6'
p763
S'increases'
p764
tp765
(lp766
s(S'RUNX2'
p767
S'POU2F1'
p768
S'increases'
p769
tp770
(lp771
s(S'CYP26A1'
p772
S'GATA6'
p773
S'increases'
p774
tp775
(lp776
s(S'PAX4'
p777
S'GATA1'
p778
S'increases'
p779
tp780
(lp781
s(S'ELF2'
p782
S'STAT5A'
p783
S'increases'
p784
tp785
(lp786
s(S'CART1'
p787
S'NRAS'
p788
S'increases'
p789
tp790
(lp791
s(S'IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc'
p792
S'HRAS/GDP'
p793
S'increases_activity'
p794
tp795
(lp796
s(S'RB1'
p797
S'CYP26A1'
p798
S'increases'
p799
tp800
(lp801
s(S'CEBPG'
p802
S'HOXA9'
p803
S'increases'
p804
tp805
(lp806
s(S'GRB2/SOS1/SHC'
p807
S'IGF-1R HETEROTETRAMER/IGF1'
p808
S'binds'
p809
tp810
(lp811
s(S'PRRX2'
p812
S'CYP26A1'
p813
S'increases'
p814
tp815
(lp816
s(S'TEAD1'
p817
S'CYP26A1'
p818
S'increases'
p819
tp820
(lp821
s(S'STAT5A'
p822
S'FOXA1'
p823
S'increases'
p824
tp825
(lp826
s(S'ATF2'
p827
S'FOXD3'
p828
S'increases'
p829
tp830
(lp831
s(S'REPIN1'
p832
S'FOXO4'
p833
S'increases'
p834
tp835
(lp836
s(S'FOXF2'
p837
S'ETS1'
p838
S'increases'
p839
tp840
(lp841
s(S'ETV7'
p842
S'MEIS1'
p843
S'increases'
p844
tp845
(lp846
s(S'RUNX2'
p847
S'RUNX1'
p848
S'increases'
p849
tp850
(lp851
s(S'OR5I1'
p852
S'GATA1'
p853
S'increases'
p854
tp855
(lp856
s(S'MSX1'
p857
S'EN1'
p858
S'increases'
p859
tp860
(lp861
s(S'GTF3A'
p862
S'IRF1'
p863
S'increases'
p864
tp865
(lp866
s(S'POU2F1'
p867
S'SRF'
p868
S'increases'
p869
tp870
(lp871
s(S'PLC-GAMMA'
p872
S'COMPLEX (GADS/SLP-76)'
p873
S'binds'
p874
tp875
(lp876
s(S'STAT4'
p877
S'STAT5A'
p878
S'increases'
p879
tp880
(lp881
s(S'JUN'
p882
S'BACH1'
p883
S'increases'
p884
tp885
(lp886
s(S'POU1F1'
p887
S'HOXA9'
p888
S'increases'
p889
tp890
(lp891
s(S'docetaxel'
p892
S'HRAS PROTEIN'
p893
S'increases'
p894
tp895
(lp896
s(S'MAX'
p897
S'LEF1'
p898
S'increases'
p899
tp900
(lp901
s(S'FOXA1'
p902
S'CYP26A1'
p903
S'increases'
p904
tp905
(lp906
s(S'GATA4'
p907
S'FOXD3'
p908
S'increases'
p909
tp910
(lp911
s(S'ZBTB18'
p912
S'RUNX1'
p913
S'increases'
p914
tp915
(lp916
s(S'ATF3'
p917
S'RUNX1'
p918
S'increases'
p919
tp920
(lp921
s(S'NKX2-1'
p922
S'CYP26A1'
p923
S'increases'
p924
tp925
(lp926
s(S'NR3C1'
p927
S'FOXA1'
p928
S'increases'
p929
tp930
(lp931
s(S'RAS family/GTP'
p932
S'RIN1'
p933
S'increases_activity'
p934
tp935
(lp936
s(S'COMPLEX (RAS/GTP/ RAF)'
p937
S'MEK'
p938
S'binds'
p939
tp940
(lp941
s(S'CDC5L'
p942
S'NRAS'
p943
S'increases'
p944
tp945
(lp946
s(S'Vitamin E'
p947
S'NRAS MRNA'
p948
S'decreases'
p949
tp950
(lp951
s(S'NF1'
p952
S'LEF1'
p953
S'increases'
p954
tp955
(lp956
s(S'ETS1'
p957
S'EN1'
p958
S'increases'
p959
tp960
(lp961
s(S'CRAF'
p962
S'YWHAB'
p963
S'binds'
p964
tp965
(lp966
s(S'CEBPD'
p967
S'JUN'
p968
S'increases'
p969
tp970
(lp971
s(S'MAX'
p972
S'RUNX2'
p973
S'increases'
p974
tp975
(lp976
s(S'CEBPA'
p977
S'MECOM'
p978
S'increases'
p979
tp980
(lp981
s(S'PAX2'
p982
S'GATA1'
p983
S'increases'
p984
tp985
(lp986
s(S'CYP26A1'
p987
S'TLX2'
p988
S'increases'
p989
tp990
(lp991
s(S'GFI1'
p992
S'ETS1'
p993
S'increases'
p994
tp995
(lp996
s(S'14-3-3:P-S259,Y340,Y341,S621-RAF1:RAS:GTP'
p997
S'MEK'
p998
S'binds'
p999
tp1000
(lp1001
s(S'P-S,T-MEK2'
p1002
S'ERK2'
p1003
S'binds'
p1004
tp1005
(lp1006
s(S'HRAS/GTP'
p1007
S'RIN2'
p1008
S'increases_activity'
p1009
tp1010
(lp1011
s(S'Ras-GTP'
p1012
S'P42/P44MAPKS'
p1013
S'adds_modification'
p1014
tp1015
(lp1016
s(S'SRF'
p1017
S'CYP26A1'
p1018
S'increases'
p1019
tp1020
(lp1021
s(S'FOXL1'
p1022
S'RUNX2'
p1023
S'increases'
p1024
tp1025
(lp1026
s(S'EGR4'
p1027
S'LEF1'
p1028
S'increases'
p1029
tp1030
(lp1031
s(S'P-IRS1,2'
p1032
S'GRB2:SOS1'
p1033
S'binds'
p1034
tp1035
(lp1036
s(S'VEGFR2 (dimer)/VEGFA (dimer)/alphav/beta3 Integrin/Vitronectin'
p1037
S'SRC'
p1038
S'adds_modification'
p1039
tp1040
(lp1041
s(S'BACH2'
p1042
S'BACH1'
p1043
S'increases'
p1044
tp1045
(lp1046
s(S'ONECUT1'
p1047
S'RUNX1'
p1048
S'increases'
p1049
tp1050
(lp1051
s(S'FOXJ2'
p1052
S'RUNX2'
p1053
S'increases'
p1054
tp1055
(lp1056
s(S'PI-3-4-5-P3'
p1057
S'AKT1'
p1058
S'translocates'
p1059
tp1060
(lp1061
s(S'TFAP4'
p1062
S'BACH1'
p1063
S'increases'
p1064
tp1065
(lp1066
s(S'MEKK1/4'
p1067
S'MKK3/6'
p1068
S'adds_modification'
p1069
tp1070
(lp1071
s(S'VSX1'
p1072
S'MECOM'
p1073
S'increases'
p1074
tp1075
(lp1076
s(S'IRF1'
p1077
S'GATA6'
p1078
S'increases'
p1079
tp1080
(lp1081
s(S'MAX'
p1082
S'HOXA9'
p1083
S'increases'
p1084
tp1085
(lp1086
s(S'RB1'
p1087
S'MAZ'
p1088
S'increases'
p1089
tp1090
(lp1091
s(S'GATA1'
p1092
S'EN1'
p1093
S'increases'
p1094
tp1095
(lp1096
s(S'HIF1A'
p1097
S'SRF'
p1098
S'increases'
p1099
tp1100
(lp1101
s(S'IRF8'
p1102
S'CYP26A1'
p1103
S'increases'
p1104
tp1105
(lp1106
s(S'MTF1'
p1107
S'CYP26A1'
p1108
S'increases'
p1109
tp1110
(lp1111
s(S'PI-3-4-5-P3'
p1112
S'GAB1'
p1113
S'translocates'
p1114
tp1115
(lp1116
s(S'PI-3-4-5-P3'
p1117
S'AKT1'
p1118
S'adds_modification'
p1119
tp1120
(lp1121
s(S'RXRA'
p1122
S'HOXA9'
p1123
S'increases'
p1124
tp1125
(lp1126
s(S'AKT1'
p1127
S'RAF1'
p1128
S'binds'
p1129
tp1130
(lp1131
s(S'HSF2'
p1132
S'JUN'
p1133
S'increases'
p1134
tp1135
(lp1136
s(S'PAX2'
p1137
S'CYP26A1'
p1138
S'increases'
p1139
tp1140
(lp1141
s(S'ETV7'
p1142
S'CYP26A1'
p1143
S'increases'
p1144
tp1145
(lp1146
s(S'FOXO3'
p1147
S'NRAS'
p1148
S'increases'
p1149
tp1150
(lp1151
s(S'TP53'
p1152
S'REPIN1'
p1153
S'increases'
p1154
tp1155
(lp1156
s(S'STAT6'
p1157
S'CYP26A1'
p1158
S'increases'
p1159
tp1160
(lp1161
s(S'JUN'
p1162
S'NRAS'
p1163
S'increases'
p1164
tp1165
(lp1166
s(S'MYCN'
p1167
S'NRAS'
p1168
S'increases'
p1169
tp1170
(lp1171
s(S'STAT3'
p1172
S'YY1'
p1173
S'increases'
p1174
tp1175
(lp1176
s(S'Methyl Methanesulfonate'
p1177
S'HRAS MRNA'
p1178
S'increases'
p1179
tp1180
(lp1181
s(S'RHOA/GTP'
p1182
S'PKN'
p1183
S'increases_activity'
p1184
tp1185
(lp1186
s(S'NHLH1'
p1187
S'FOXJ2'
p1188
S'increases'
p1189
tp1190
(lp1191
s(S'RAS family/GTP'
p1192
S'BRAF'
p1193
S'adds_modification'
p1194
tp1195
(lp1196
s(S'RELA'
p1197
S'FOXJ2'
p1198
S'increases'
p1199
tp1200
(lp1201
s(S'TCF3'
p1202
S'RUNX1'
p1203
S'increases'
p1204
tp1205
(lp1206
s(S'FOXF2'
p1207
S'FOXO4'
p1208
S'increases'
p1209
tp1210
(lp1211
s(S'ATF4'
p1212
S'FOXD3'
p1213
S'increases'
p1214
tp1215
(lp1216
s(S'HAND1'
p1217
S'MECOM'
p1218
S'increases'
p1219
tp1220
(lp1221
s(S'RHOA/GTP'
p1222
S'P27KIP1'
p1223
S'adds_modification'
p1224
tp1225
(lp1226
s(S'SRF'
p1227
S'NRAS'
p1228
S'increases'
p1229
tp1230
(lp1231
s(S'ESRRA'
p1232
S'POU3F2'
p1233
S'increases'
p1234
tp1235
(lp1236
s(S'BRAF'
p1237
S'MEK1'
p1238
S'adds_modification'
p1239
tp1240
(lp1241
S'To test whether autoantibodies to BRAF influence BRAF kinase activity, we developed a phosphorylation assay with BRAF, its substrate MEK1 and purified anti-BRAF autoantibodies from RA patients.'
p1242
aS'BRAF dependent phosphotransferase activity was measured in a kinase reaction using inactive recombinant MEK1 as a BRAF substrate (BRAF kinase assay Kit, chemiluminescence detection, Millipore Upstate Temecula, CA, USA).'
p1243
aS'To test whether autoantibodies directed to BRAF interfere with its enzymatic activity, we analyzed the phosphorylation of MEK1 in presence of BRAF and autoantibodies to BRAF purified from 20 RA patients.'
p1244
aS'After quantification of purified autoantibodies to BRAF, we tested the phosphorylation of MEK1 in presence of BRAF and autoantibodies to BRAF purified from 20 RA patients.'
p1245
aS'Phosphorylation of MEK1 by BRAF was detected by Western blotting and quantified.'
p1246
aS'Among 20 purified autoantibodies to BRAF, 1 inhibited and 13 activated MEK1 phosphorylation (Figure '
p1247
aS'Among autoantibodies to BRAF that activated MEK1 phosphorylation, 10/13 were weak activators (1 < ratio < 1.5) and 3/13 were strong activators (ratio > 1.5).'
p1248
aS'No difference was observed in the recognition of BRAF peptides between autoantibodies to BRAF that inhibited or activated MEK1 phosphorylation (data not shown).'
p1249
aS"To test whether autoantibodies to BRAF may influence BRAF activity as a kinase, we developed a phosphorylation assay using BRAF, MEK1 (its major substrate) and autoantibodies to BRAF purified from RA patients' sera."
p1250
aS'We observed that 65% of anti-BRAF autoantibodies activate phosphorylation of MEK1 by BRAF '
p1251
aS'ACPA: anti-citrullinated peptide antibodies; AS: ankylosing spondylitis; BRAF: v raf murine sarcoma viral oncogene homologue B1; CCP: cyclic citrullinated peptides; MAPKs: mitogen-activated protein kinases; MEK1: mitogen extracellular regulated kinase; PAD4: peptidyl arginine deiminase 4; PBS: phosphate buffer saline; PsA: psoriasis arthritis; RA: rheumatoid arthritis; SD: standard deviation.'
p1252
as(S'Cadmium Chloride'
p1253
S'KRAS PROTEIN'
p1254
S'increases'
p1255
tp1256
(lp1257
s(S'PRRX2'
p1258
S'MEIS1'
p1259
S'increases'
p1260
tp1261
(lp1262
s(S'MYC'
p1263
S'NRAS'
p1264
S'increases'
p1265
tp1266
(lp1267
s(S'MAZ'
p1268
S'KRAS'
p1269
S'increases'
p1270
tp1271
(lp1272
s(S'Rho Family GTPase-active'
p1273
S'PI3K'
p1274
S'increases_activity'
p1275
tp1276
(lp1277
s(S'STAT2'
p1278
S'CYP26A1'
p1279
S'increases'
p1280
tp1281
(lp1282
s(S'hsa-let-7a-5p'
p1283
S'KRAS'
p1284
S'decreases'
p1285
tp1286
(lp1287
s(S'POU3F2'
p1288
S'NRAS'
p1289
S'increases'
p1290
tp1291
(lp1292
s(S'SRF'
p1293
S'FOXO4'
p1294
S'increases'
p1295
tp1296
(lp1297
s(S'S1P1/Sphingosine-1-phosphate/PDGF-BB/PDGFRB (dimer)'
p1298
S'SRC FAMILY KINASES'
p1299
S'increases_activity'
p1300
tp1301
(lp1302
s(S'MYC/Max'
p1303
S'ERBB2'
p1304
S'decreases'
p1305
tp1306
(lp1307
s(S'SREBF1'
p1308
S'CBFA2T3'
p1309
S'increases'
p1310
tp1311
(lp1312
s(S'PI3K'
p1313
S'GELSOLIN/PI-3-4-5-P3'
p1314
S'binds'
p1315
tp1316
(lp1317
s(S'NHLH1'
p1318
S'EN1'
p1319
S'increases'
p1320
tp1321
(lp1322
s(S'LMO2'
p1323
S'GATA6'
p1324
S'increases'
p1325
tp1326
(lp1327
s(S'POU1F1'
p1328
S'FOXD3'
p1329
S'increases'
p1330
tp1331
(lp1332
s(S'hsa-miR-148b-3p'
p1333
S'NRAS'
p1334
S'decreases'
p1335
tp1336
(lp1337
s(S'Quercetin'
p1338
S'KRAS PROTEIN'
p1339
S'decreases'
p1340
tp1341
(lp1342
s(S'PAK2'
p1343
S'MEKK1'
p1344
S'adds_modification'
p1345
tp1346
(lp1347
s(S'LMO2'
p1348
S'MAZ'
p1349
S'increases'
p1350
tp1351
(lp1352
s(S'FOXO1'
p1353
S'POU3F2'
p1354
S'increases'
p1355
tp1356
(lp1357
s(S'NKX2-1'
p1358
S'MAZ'
p1359
S'increases'
p1360
tp1361
(lp1362
s(S'GRB2/SOS1'
p1363
S'PDGF-BB/PDGFRB (DIMER)/P52 SHC'
p1364
S'binds'
p1365
tp1366
(lp1367
s(S'PI3K'
p1368
S'CRK/P130 CAS/PAXILLIN'
p1369
S'increases_activity'
p1370
tp1371
(lp1372
s(S'ATF1'
p1373
S'FOXD3'
p1374
S'increases'
p1375
tp1376
(lp1377
s(S'GATA1'
p1378
S'SRF'
p1379
S'increases'
p1380
tp1381
(lp1382
s(S'TFAP2C'
p1383
S'CYP26A1'
p1384
S'increases'
p1385
tp1386
(lp1387
s(S'AHR'
p1388
S'MEIS1'
p1389
S'increases'
p1390
tp1391
(lp1392
s(S'ETS2'
p1393
S'CYP26A1'
p1394
S'increases'
p1395
tp1396
(lp1397
s(S'Estradiol'
p1398
S'NRAS MRNA'
p1399
S'increases'
p1400
tp1401
(lp1402
s(S'E2F1'
p1403
S'HOXA9'
p1404
S'increases'
p1405
tp1406
(lp1407
s(S'PDGF-BB/PDGFRB (DIMER)'
p1408
S'RASGAP'
p1409
S'binds'
p1410
tp1411
(lp1412
s(S'E2F1'
p1413
S'GABPB2'
p1414
S'increases'
p1415
tp1416
(lp1417
s(S'FOXJ1'
p1418
S'POU3F2'
p1419
S'increases'
p1420
tp1421
(lp1422
s(S'VSX1'
p1423
S'CYP26A1'
p1424
S'increases'
p1425
tp1426
(lp1427
s(S'SPI1'
p1428
S'CDC5L'
p1429
S'increases'
p1430
tp1431
(lp1432
s(S'Gi family'
p1433
S'HRAS/GDP'
p1434
S'increases_activity'
p1435
tp1436
(lp1437
s(S'TCF3'
p1438
S'CYP26A1'
p1439
S'increases'
p1440
tp1441
(lp1442
s(S'IGF-1R HETEROTETRAMER/IGF1/IRS1'
p1443
S'GRB2/SOS1'
p1444
S'binds'
p1445
tp1446
(lp1447
s(S'RAS family/GTP'
p1448
S'RALGDS'
p1449
S'translocates'
p1450
tp1451
(lp1452
s(S'PI3K'
p1453
S'RAC1/GDP'
p1454
S'increases_activity'
p1455
tp1456
(lp1457
s(S'Ca2+'
p1458
S'PKC'
p1459
S'increases_activity'
p1460
tp1461
(lp1462
S'In vitro inhibit the activity of PKC of the protein kinase II Ca2+/calmodulina dependent and inhibit the activation, induced by 5HT, of the protein kinase activated by mithogen (MAPK).The proposed mechanism of pure ethyl EPA as the calcium-antagonist, blocking Ca2+ channels, is confirmed in cardiovascular studies.'
p1463
aS'Inhibition of intracellular Ca2+ release by TMB-8 also induced dephosphorylation of the P proteins, which is compatible with the requirement of intracellular Ca2+ for classical PKC isozyme activity.'
p1464
aS'Our results demonstrate that inhibition of Ca2+ dependent PKC activity decreases the phosphorylation of the P protein CK2 sites and protein synthesis.'
p1465
as(S'ZIC1'
p1466
S'CYP26A1'
p1467
S'increases'
p1468
tp1469
(lp1470
s(S'IRF7'
p1471
S'TLX2'
p1472
S'increases'
p1473
tp1474
(lp1475
s(S'SHC/SHIP'
p1476
S'HRAS/GDP'
p1477
S'decreases_activity'
p1478
tp1479
(lp1480
s(S'hsa-let-7a-5p'
p1481
S'HRAS'
p1482
S'decreases'
p1483
tp1484
(lp1485
s(S'GATA4'
p1486
S'MAZ'
p1487
S'increases'
p1488
tp1489
(lp1490
s(S'EN1'
p1491
S'NRAS'
p1492
S'increases'
p1493
tp1494
(lp1495
s(S'PI3K'
p1496
S'BAM32'
p1497
S'adds_modification'
p1498
tp1499
(lp1500
s(S'GABPB1'
p1501
S'CYP26A1'
p1502
S'increases'
p1503
tp1504
(lp1505
s(S'Trifluoroethanol'
p1506
S'HRAS'
p1507
S'increases_activity'
p1508
tp1509
(lp1510
s(S'SOX5'
p1511
S'CYP26A1'
p1512
S'increases'
p1513
tp1514
(lp1515
s(S'GRB2/SOS1'
p1516
S'HGF(DIMER)/MET(DIMER)/P52 SHC'
p1517
S'binds'
p1518
tp1519
(lp1520
s(S'TCF12'
p1521
S'EN1'
p1522
S'increases'
p1523
tp1524
(lp1525
s(S'SOX9'
p1526
S'MEIS1'
p1527
S'increases'
p1528
tp1529
(lp1530
s(S'RB1'
p1531
S'MYC'
p1532
S'increases'
p1533
tp1534
(lp1535
s(S'RXRA'
p1536
S'FOXA1'
p1537
S'increases'
p1538
tp1539
(lp1540
s(S'decitabine'
p1541
S'HRAS MRNA'
p1542
S'decreases'
p1543
tp1544
(lp1545
s(S'VSX1'
p1546
S'EN1'
p1547
S'increases'
p1548
tp1549
(lp1550
s(S'FOXL1'
p1551
S'CYP26A1'
p1552
S'increases'
p1553
tp1554
(lp1555
s(S'PAX2'
p1556
S'RUNX1'
p1557
S'increases'
p1558
tp1559
(lp1560
s(S'MEKK1/4'
p1561
S'MKK4/7'
p1562
S'adds_modification'
p1563
tp1564
(lp1565
s(S'HOXA9'
p1566
S'CYP26A1'
p1567
S'increases'
p1568
tp1569
(lp1570
s(S'TRKC'
p1571
S'NT3 (DIMER)'
p1572
S'binds'
p1573
tp1574
(lp1575
s(S'PTF1A'
p1576
S'REPIN1'
p1577
S'increases'
p1578
tp1579
(lp1580
s(S'TGIF'
p1581
S'CYP26A1'
p1582
S'increases'
p1583
tp1584
(lp1585
s(S'MYOD1'
p1586
S'MYC'
p1587
S'increases'
p1588
tp1589
(lp1590
s(S'PKCT'
p1591
S'KRAS ISO2'
p1592
S'adds_modification'
p1593
tp1594
(lp1595
s(S'RAS family/GTP'
p1596
S'BRAF'
p1597
S'increases_activity'
p1598
tp1599
(lp1600
s(S'SPZ1'
p1601
S'CYP26A1'
p1602
S'increases'
p1603
tp1604
(lp1605
s(S'HRAS/GTP'
p1606
S'GALECTIN-1'
p1607
S'binds'
p1608
tp1609
(lp1610
s(S'DBP'
p1611
S'FOXD3'
p1612
S'increases'
p1613
tp1614
(lp1615
s(S'E2F1'
p1616
S'POU2F1'
p1617
S'increases'
p1618
tp1619
(lp1620
s(S'MEIS1'
p1621
S'CYP26A1'
p1622
S'increases'
p1623
tp1624
(lp1625
s(S'YY1'
p1626
S'NRAS'
p1627
S'increases'
p1628
tp1629
(lp1630
s(S'RAS:RAF'
p1631
S'YWHAB'
p1632
S'binds'
p1633
tp1634
(lp1635
s(S'NFE2L2'
p1636
S'CYP26A1'
p1637
S'increases'
p1638
tp1639
(lp1640
s(S'FARNESYL'
p1641
S'KRAS'
p1642
S'increases_activity'
p1643
tp1644
(lp1645
s(S'MTF1'
p1646
S'MECOM'
p1647
S'increases'
p1648
tp1649
(lp1650
s(S'TLX2'
p1651
S'FOXD3'
p1652
S'increases'
p1653
tp1654
(lp1655
s(S'Insulin Receptor/Insulin/SHC/GRB2/Sos1'
p1656
S'HRAS/GDP'
p1657
S'increases_activity'
p1658
tp1659
(lp1660
s(S'MYC'
p1661
S'ELK1'
p1662
S'increases'
p1663
tp1664
(lp1665
s(S'ONECUT1'
p1666
S'POU2F1'
p1667
S'increases'
p1668
tp1669
(lp1670
s(S'Paraquat'
p1671
S'HRAS MRNA'
p1672
S'translocates'
p1673
tp1674
(lp1675
s(S'GRB2/SOS1'
p1676
S'PDGF-BB/PDGFRB (DIMER)/SHP2'
p1677
S'binds'
p1678
tp1679
(lp1680
s(S'ONECUT1'
p1681
S'CYP26A1'
p1682
S'increases'
p1683
tp1684
(lp1685
s(S'MYC'
p1686
S'FOXO3'
p1687
S'increases'
p1688
tp1689
(lp1690
s(S'PAX3'
p1691
S'ELK1'
p1692
S'increases'
p1693
tp1694
(lp1695
s(S'DOK-R'
p1696
S'RASGAP'
p1697
S'binds'
p1698
tp1699
(lp1700
s(S'HOXA4'
p1701
S'HOXA9'
p1702
S'increases'
p1703
tp1704
(lp1705
s(S'MAX'
p1706
S'POU3F2'
p1707
S'increases'
p1708
tp1709
(lp1710
s(S'Estradiol'
p1711
S'KRAS MRNA'
p1712
S'decreases'
p1713
tp1714
(lp1715
s(S'KRAS ISOFORM 4B/GTP'
p1716
S'CAM/CA2+'
p1717
S'binds'
p1718
tp1719
(lp1720
s(S'MAZ'
p1721
S'FOXO4'
p1722
S'increases'
p1723
tp1724
(lp1725
s(S'hsa-miR-181a-5p'
p1726
S'KRAS'
p1727
S'decreases'
p1728
tp1729
(lp1730
s(S'GATA1'
p1731
S'CYP26A1'
p1732
S'increases'
p1733
tp1734
(lp1735
s(S'PGR'
p1736
S'ETS1'
p1737
S'increases'
p1738
tp1739
(lp1740
s(S'GATA1'
p1741
S'POU2F1'
p1742
S'increases'
p1743
tp1744
(lp1745
s(S'BRAF'
p1746
S'MEK1-2'
p1747
S'increases_activity'
p1748
tp1749
(lp1750
s(S'LEF1'
p1751
S'GABPB2'
p1752
S'increases'
p1753
tp1754
(lp1755
s(S'CYP26A1'
p1756
S'MYC'
p1757
S'increases'
p1758
tp1759
(lp1760
s(S'STAT1'
p1761
S'IRF1'
p1762
S'increases'
p1763
tp1764
(lp1765
S'According to our preliminary experiments, muraglitazar did not affect the activation of STAT1 or IRF1 either.'
p1766
aS'ANOVA: analysis of variance; C3orf1: Chromosome 3 open reading frame 1; C5orf56: Chromosome 5 open reading frame 56; Dapple: Disease Association Protein-Protein Link Evaluator; FDR: false discovery rate; GEO: Gene Expression Omnibus; Grail: Gene Relationships Across Implicated Loci; GWAS: genome-wide association studies; ILAR: International League Against Rheumatism; IPA: Ingenuity pathway analysis; IRF1: Interferon regulatory factor 1; JIA: juvenile idiopathic arthritis; JMJD1C: Jumonji domain containing 1C; KSR1: Kinase suppressor of Ras; MEN: minimal essential network; PBMC: peripheral blood mononuclear cell; PCA: principal components analysis; PTPN2: Protein tyrosine phosphatase, non-receptor type 2; RF: rheumatoid factor; SFM: synovial fluid monocytes; SNP: single nucleotide polymorphism; STAT1: Signal transducer and activator of transcription 1.'
p1767
as(S'SMAD1'
p1768
S'RUNX2'
p1769
S'increases'
p1770
tp1771
(lp1772
s(S'ZEB1'
p1773
S'TLX2'
p1774
S'increases'
p1775
tp1776
(lp1777
s(S'STAT5B'
p1778
S'IRF1'
p1779
S'increases'
p1780
tp1781
(lp1782
s(S'POU6F1'
p1783
S'CYP26A1'
p1784
S'increases'
p1785
tp1786
(lp1787
s(S'Vincristine'
p1788
S'HRAS MRNA'
p1789
S'increases'
p1790
tp1791
(lp1792
s(S'DAG'
p1793
S'RASGRP1'
p1794
S'adds_modification'
p1795
tp1796
(lp1797
s(S'PI3K'
p1798
S'PDK1'
p1799
S'increases_activity'
p1800
tp1801
(lp1802
S'PI3K activates PDK1, which phosphorylates Akt on Thr'
p1803
aS'Pretreatment of the cortical neurons with tricribine, which blocks all Akt isoforms (Akt1, Akt2, and Akt3) without inhibiting known upstream activators PDK1 and PI3K, completely eliminated the effects of atorvastatin on TNBL, terminal branch number, neurite number, and soma size.'
p1804
aS'To further ascertain the requirement for the activation of the PI3K/Akt signaling pathway in the atorvastatin-induced increases in neurite outgrowth, we used phospho-specific antibodies to measure the relative levels of phosphorylated, active forms of the protein kinases phosphoinositide-dependent kinase-1 (PDK1) and Akt after cultured neurons were treated with atorvastatin.'
p1805
aS'The protein serine/threonine kinase 30-phosphoinositide-dependent kinase1 (PDK1) and Akt/PKB are both critical for the transforming effects of deregulated PI3K activity.'
p1806
aS'After insulin binding to IR and subsequent activation of IRS1, activated PI3K catalyzes the production of PI-3,4,5-P3, which results in the phosphorylation of PDK1 and several downstream enzymes, including Akt and PKC.'
p1807
aS'Conversely, Class I PI3Ks inhibit autophagy through a PDK1 and Akt/PKB pathway, which is inappropriate activated in many types of cancers.'
p1808
aS'(a) PI3K/Akt pathway: upon activation PI3K most possibly induces mTORC2 complex stimulation and also promotes the translocation of Akt and PDK1 to the cell membrane, where Akt becomes activated by PDK1 and mTORC2.'
p1809
aS'Akt, serine/threonine kinase PKB; IRS-1, insulin-receptor substrate; INS-RK, insulin receptor tyrosine kinase; PDK1, phosphoinositide-dependent protein kinase-1; PI3K, phosphatidylinositol-3 kinase; PTEN, phosphatase and tensin homolog on chromosome 10; PTP1B, protein tyrosine phosphatase 1B; PI(3,4)P'
p1810
aS'IFNT-activated JAK1/TYK2 may regulate phosphorylation of PI3K, resulting in downstream activation of PDK1 and AKT.'
p1811
aS'Legend: IFNT = Interferon tau; IFNAR = Type I IFN receptor; JAK1 = Janus kinase 1; TYK2 = Tyrosine kinase 2; GAF = Gamma interferon activation factor; GAS = Gamma interferon activation sequence; IRF = Interferon regulatory factor; ISG = Interferon tau-stimulated gene; LGALS15 = Galectin 15; WNT7A = Wingless-type MMTV integration site family, member 7A; CTSL = Cathepsin L; CST3 = Cystatin C; PI3K = Phosphatidylinositol 3-kinase; PDK1 = Phosphoinositide-dependent protein kinase 1; AKT = Proto oncogenic protein kinase Akt; CREB = cAMP-response element binding protein; Mtor = Mechanistic target of rapamycin; 4EBP1 = EIF4-E-binding protein 1; E1F4E = Eukaryotic translation-initiation factor 4 E; p70S = p70 ribosomal protein S6 kinase; RPS6 = Ribosomal protein S6; MAPK3 = Mitogen-activated protein kinase (MAPK) kinase kinase; MAPK'
p1812
as(S'ETS2'
p1813
S'PAX4'
p1814
S'increases'
p1815
tp1816
(lp1817
s(S'NR3C1'
p1818
S'ONECUT1'
p1819
S'increases'
p1820
tp1821
(lp1822
s(S'CUX1'
p1823
S'CYP26A1'
p1824
S'increases'
p1825
tp1826
(lp1827
s(S'ZEB1'
p1828
S'GATA1'
p1829
S'increases'
p1830
tp1831
(lp1832
s(S'NRF1'
p1833
S'POU2F1'
p1834
S'increases'
p1835
tp1836
(lp1837
s(S'FOXJ2'
p1838
S'MECOM'
p1839
S'increases'
p1840
tp1841
(lp1842
s(S'MAZ'
p1843
S'MYCN'
p1844
S'increases'
p1845
tp1846
(lp1847
s(S'Hydrogen Peroxide'
p1848
S'HRAS MRNA'
p1849
S'increases'
p1850
tp1851
(lp1852
s(S'RASA1'
p1853
S'P-EPHBS:EFNBS'
p1854
S'binds'
p1855
tp1856
(lp1857
s(S'SPI1'
p1858
S'CEBPG'
p1859
S'increases'
p1860
tp1861
(lp1862
s(S'EGR1'
p1863
S'LEF1'
p1864
S'increases'
p1865
tp1866
(lp1867
s(S'RET51/GFRALPHA1/GDNF'
p1868
S'P62DOK'
p1869
S'binds'
p1870
tp1871
(lp1872
s(S'TFDP2'
p1873
S'CYP26A1'
p1874
S'increases'
p1875
tp1876
(lp1877
s(S'matrine'
p1878
S'NRAS MRNA'
p1879
S'increases'
p1880
tp1881
(lp1882
s(S'Isotretinoin'
p1883
S'KRAS MRNA'
p1884
S'decreases'
p1885
tp1886
(lp1887
s(S'PITX2'
p1888
S'FOXF2'
p1889
S'increases'
p1890
tp1891
(lp1892
s(S'MYOD1'
p1893
S'POU2F1'
p1894
S'increases'
p1895
tp1896
(lp1897
s(S'sodium arsenite'
p1898
S'KRAS PROTEIN'
p1899
S'increases'
p1900
tp1901
(lp1902
s(S'TCF4'
p1903
S'CBFA2T3'
p1904
S'increases'
p1905
tp1906
(lp1907
s(S'CYP26A1'
p1908
S'FOXA1'
p1909
S'increases'
p1910
tp1911
(lp1912
s(S'TP53'
p1913
S'CYP26A1'
p1914
S'increases'
p1915
tp1916
(lp1917
s(S'ATF3'
p1918
S'FOXD3'
p1919
S'increases'
p1920
tp1921
(lp1922
s(S'POU2F1'
p1923
S'NRAS'
p1924
S'increases'
p1925
tp1926
(lp1927
s(S'NRF1'
p1928
S'GABPB2'
p1929
S'increases'
p1930
tp1931
(lp1932
s(S'PAX4'
p1933
S'TLX2'
p1934
S'increases'
p1935
tp1936
(lp1937
s(S'PITX2'
p1938
S'FOXA1'
p1939
S'increases'
p1940
tp1941
(lp1942
s(S'GTF3A'
p1943
S'POU2F1'
p1944
S'increases'
p1945
tp1946
(lp1947
s(S'HLF'
p1948
S'FOXO3'
p1949
S'increases'
p1950
tp1951
(lp1952
s(S'PAX4'
p1953
S'FOXO4'
p1954
S'increases'
p1955
tp1956
(lp1957
s(S'CEBPA'
p1958
S'FOXD3'
p1959
S'increases'
p1960
tp1961
(lp1962
s(S'NFE2'
p1963
S'CYP26A1'
p1964
S'increases'
p1965
tp1966
(lp1967
s(S'MYB'
p1968
S'GABPB2'
p1969
S'increases'
p1970
tp1971
(lp1972
s(S'MYC'
p1973
S'CEBPA'
p1974
S'increases'
p1975
tp1976
(lp1977
s(S'ELK1'
p1978
S'EN1'
p1979
S'increases'
p1980
tp1981
(lp1982
s(S'E2F1'
p1983
S'CDC5L'
p1984
S'increases'
p1985
tp1986
(lp1987
s(S'YWHAZ (DIMER)'
p1988
S'RAF1'
p1989
S'binds'
p1990
tp1991
(lp1992
s(S'ATF6'
p1993
S'CYP26A1'
p1994
S'increases'
p1995
tp1996
(lp1997
s(S'sodium arsenite'
p1998
S'HRAS MRNA'
p1999
S'increases'
p2000
tp2001
(lp2002
s(S'EGR3'
p2003
S'CYP26A1'
p2004
S'increases'
p2005
tp2006
(lp2007
s(S'lead acetate'
p2008
S'HRAS PROTEIN'
p2009
S'increases_activity'
p2010
tp2011
(lp2012
s(S'REPIN1'
p2013
S'MYC'
p2014
S'increases'
p2015
tp2016
(lp2017
s(S'CEBPA'
p2018
S'NRAS'
p2019
S'increases'
p2020
tp2021
(lp2022
s(S'Quercetin'
p2023
S'NRAS MRNA'
p2024
S'decreases'
p2025
tp2026
(lp2027
s(S'14-3-3 E'
p2028
S'TERT'
p2029
S'binds'
p2030
tp2031
(lp2032
s(S'Antigen/IgE/Fc epsilon R1/LYN/SYK'
p2033
S'BTK'
p2034
S'adds_modification'
p2035
tp2036
(lp2037
s(S'HSF2'
p2038
S'CBFA2T3'
p2039
S'increases'
p2040
tp2041
(lp2042
s(S'Fluorouracil'
p2043
S'HRAS MRNA'
p2044
S'increases'
p2045
tp2046
(lp2047
s(S'STAT4'
p2048
S'MECOM'
p2049
S'increases'
p2050
tp2051
(lp2052
s(S'ETS2'
p2053
S'ETS1'
p2054
S'increases'
p2055
tp2056
(lp2057
S'MAP-kinases can phosphorilate proteins ETS1 and ETS2 after activation by the Epidermal Growth Factor (EGF) and its analogue HER2/Neu.'
p2058
as(S'CEBPG'
p2059
S'CYP26A1'
p2060
S'increases'
p2061
tp2062
(lp2063
s(S'Complex (PDGF receptor A/PDGF receptor B)'
p2064
S'NCK'
p2065
S'adds_modification'
p2066
tp2067
(lp2068
s(S'Fog1'
p2069
S'MYB'
p2070
S'decreases'
p2071
tp2072
(lp2073
s(S'CREB1'
p2074
S'FOXD3'
p2075
S'increases'
p2076
tp2077
(lp2078
s(S'Numb'
p2079
S'NICS'
p2080
S'translocates'
p2081
tp2082
(lp2083
s(S'STAT6'
p2084
S'STAT5A'
p2085
S'increases'
p2086
tp2087
(lp2088
s(S'RAF1/14-3-3'
p2089
S'BRAF/14-3-3'
p2090
S'binds'
p2091
tp2092
(lp2093
s(S'B-cell antigen/BCR complex/LYN/SYK/BLNK'
p2094
S'SHC/GRB2/SOS1'
p2095
S'increases_activity'
p2096
tp2097
(lp2098
s(S'IRF2'
p2099
S'CYP26A1'
p2100
S'increases'
p2101
tp2102
(lp2103
s(S'GATA6'
p2104
S'CYP26A1'
p2105
S'increases'
p2106
tp2107
(lp2108
s(S'HMGA1'
p2109
S'CYP26A1'
p2110
S'increases'
p2111
tp2112
(lp2113
s(S'MTF1'
p2114
S'FOXO4'
p2115
S'increases'
p2116
tp2117
(lp2118
s(S'STAT1'
p2119
S'GABPB2'
p2120
S'increases'
p2121
tp2122
(lp2123
s(S'manumycin'
p2124
S'HRAS PROTEIN'
p2125
S'decreases'
p2126
tp2127
(lp2128
s(S'STAT5A'
p2129
S'ETS1'
p2130
S'increases'
p2131
tp2132
(lp2133
s(S'SPI1'
p2134
S'CBFA2T3'
p2135
S'increases'
p2136
tp2137
(lp2138
s(S'GMCSF/GMR ALPHA/CSF2RB/JAK2 (DODECAMER)/SHC'
p2139
S'GRB2/SOS1'
p2140
S'binds'
p2141
tp2142
(lp2143
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p2144
S'NRAS PROTEIN'
p2145
S'increases'
p2146
tp2147
(lp2148
s(S'CDC5L'
p2149
S'CYP26A1'
p2150
S'increases'
p2151
tp2152
(lp2153
s(S'PAX4'
p2154
S'POU3F2'
p2155
S'increases'
p2156
tp2157
(lp2158
s(S'SPRED2'
p2159
S'HRAS'
p2160
S'binds'
p2161
tp2162
(lp2163
s(S'PITX2'
p2164
S'FOXO4'
p2165
S'increases'
p2166
tp2167
(lp2168
s(S'FOXD3'
p2169
S'CYP26A1'
p2170
S'increases'
p2171
tp2172
(lp2173
s(S'NFIL3'
p2174
S'FOXO3'
p2175
S'increases'
p2176
tp2177
(lp2178
s(S'MTF1'
p2179
S'POU2F1'
p2180
S'increases'
p2181
tp2182
(lp2183
s(S'TFCP2'
p2184
S'BACH1'
p2185
S'increases'
p2186
tp2187
(lp2188
s(S'NF1'
p2189
S'MECOM'
p2190
S'increases'
p2191
tp2192
(lp2193
s(S'FOXO3'
p2194
S'FOXD3'
p2195
S'increases'
p2196
tp2197
(lp2198
s(S'STAT5A'
p2199
S'TLX2'
p2200
S'increases'
p2201
tp2202
(lp2203
s(S'RIN1'
p2204
S'HRAS/GTP'
p2205
S'adds_modification'
p2206
tp2207
(lp2208
s(S'STAT5A'
p2209
S'CEBPG'
p2210
S'increases'
p2211
tp2212
(lp2213
s(S'DAG'
p2214
S'PKC'
p2215
S'increases_activity'
p2216
tp2217
(lp2218
S'Myocardial diacylglycerol (DAG) activates protein kinase C (PKC) signaling pathways.'
p2219
aS'Our results suggest that wogonin inhibits lipotoxicity-induced apoptosis of VSMCs via suppressing the intracellular DAG accumulation and subsequent inhibition of PKC phosphorylation.'
p2220
aS'In this study, our results show that wogonin attenuates lipotoxicity-induced apoptosis and inhibits endoplasmic reticulum (ER) stress by suppressing intracellular DAG accumulation, which perturbs the DAG/PKC pathway in cultured VSMCs.'
p2221
aS'Accumulating evidence suggests that the DAG/PKC pathway contributes to deleterious consequences in cells, including apoptosis in response to FFA administration'
p2222
aS'The administration of wogonin inhibits the DAG/PKC pathway by downregulating intracellular DAG accumulation and attenuating ER stress.'
p2223
aS'Furthermore, we found that palmitate increased the intracellular accumulation of DAG and consequently enhanced PKC phosphorylation ('
p2224
aS'In conclusion, we provide novel evidence that wogonin attenuates lipotoxicity-induced apoptosis by suppressing intracellular DAG accumulation and inhibiting PKC phosphorylation in cultured VSMCs.'
p2225
aS"DAG, diacylglycerol; DMEM, Dulbecco's modified Eagle's medium; ER, endoplasmic reticulum; FBS, fetal bovine serum; FFA, free fatty acid; PKC, protein kinase C; ROS, reactive oxygen species; VSMC, vascular smooth muscle cell; PBS, phosphate-buffered saline."
p2226
aS'Wogonin ameliorated intracellular DAG accumulation and attenuated PKC phosphorylation.'
p2227
aS' DAG, the other by-product of PLC cleavage, can activate PKC in cooperation with calcium ['
p2228
aS' A highly conserved cysteine-rich motif in the regulatory region of most PKC isoforms acts as the specific docking receptor for DAG as well as for phorbol esters like PMA ['
p2229
aS' Of interest is the differential targeting of PKC isoforms by phorbol esters versus certain synthetic or natural DAG analogue lactones.'
p2230
aS'synthesized and tested the activity of several DAG analogues that are agonists of the PKC pathway ['
p2231
aS'PKC modulating agents represent functional analogues of DAG that similarly activate the PKC cascade.'
p2232
aS'These improvements in liver and muscle insulin responsiveness were associated with reductions in liver and muscle TAG and DAG content as well as decreases in PKC activity in liver and skeletal muscle.'
p2233
aS'The G-protein, using guanosine triphosphate (GTP) as an energy source, then activates PKC via the PIP2 intermediate, the diacylglycerol/inositol triphosphate (DAG/IP3) complex ['
p2234
as(S'HNF4A'
p2235
S'FOXA1'
p2236
S'increases'
p2237
tp2238
(lp2239
s(S'LEF1'
p2240
S'MAZ'
p2241
S'increases'
p2242
tp2243
(lp2244
s(S'hsa-miR-124-3p'
p2245
S'NRAS'
p2246
S'decreases'
p2247
tp2248
(lp2249
s(S'RAF1'
p2250
S'14-3-3 E'
p2251
S'binds'
p2252
tp2253
(lp2254
s(S'GATA1'
p2255
S'MYB'
p2256
S'decreases'
p2257
tp2258
(lp2259
s(S'LMO2'
p2260
S'GATA1'
p2261
S'increases'
p2262
tp2263
(lp2264
s(S'HRAS/GTP'
p2265
S'RAF1'
p2266
S'increases_activity'
p2267
tp2268
(lp2269
s(S'MYCN'
p2270
S'RUNX2'
p2271
S'increases'
p2272
tp2273
(lp2274
s(S'STAT5B'
p2275
S'CYP26A1'
p2276
S'increases'
p2277
tp2278
(lp2279
s(S'ZIC2'
p2280
S'MYCN'
p2281
S'increases'
p2282
tp2283
(lp2284
s(S'FOXL1'
p2285
S'FOXD3'
p2286
S'increases'
p2287
tp2288
(lp2289
s(S'ZBTB18'
p2290
S'CBFA2T3'
p2291
S'increases'
p2292
tp2293
(lp2294
s(S'HSF1'
p2295
S'IRF1'
p2296
S'increases'
p2297
tp2298
(lp2299
s(S'SPZ1'
p2300
S'MAZ'
p2301
S'increases'
p2302
tp2303
(lp2304
s(S'SRY'
p2305
S'CYP26A1'
p2306
S'increases'
p2307
tp2308
(lp2309
s(S'FOXO4'
p2310
S'HOXA9'
p2311
S'increases'
p2312
tp2313
(lp2314
s(S'IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos'
p2315
S'HRAS/GDP'
p2316
S'increases_activity'
p2317
tp2318
(lp2319
s(S'hsa-miR-615-3p'
p2320
S'HRAS'
p2321
S'decreases'
p2322
tp2323
(lp2324
s(S'ESRRA'
p2325
S'FOXD3'
p2326
S'increases'
p2327
tp2328
(lp2329
s(S'ELK1'
p2330
S'CYP26A1'
p2331
S'increases'
p2332
tp2333
(lp2334
s(S'Hexane-1,6-Diol'
p2335
S'HRAS'
p2336
S'increases_activity'
p2337
tp2338
(lp2339
s(S'MAZ'
p2340
S'NRAS'
p2341
S'increases'
p2342
tp2343
(lp2344
s(S'MIF'
p2345
S'CYP26A1'
p2346
S'increases'
p2347
tp2348
(lp2349
s(S'AHR'
p2350
S'POU2F1'
p2351
S'increases'
p2352
tp2353
(lp2354
s(S'SMAD3'
p2355
S'CYP26A1'
p2356
S'increases'
p2357
tp2358
(lp2359
s(S'PI-3-4-5-P3'
p2360
S'GELSOLIN'
p2361
S'binds'
p2362
tp2363
(lp2364
s(S'ADP'
p2365
S'P-S724-IRE1 DIMER'
p2366
S'binds'
p2367
tp2368
(lp2369
s(S'testosterone enanthate'
p2370
S'KRAS MRNA'
p2371
S'increases'
p2372
tp2373
(lp2374
s(S'CYP26A1'
p2375
S'ONECUT1'
p2376
S'increases'
p2377
tp2378
(lp2379
s(S'Valproic Acid'
p2380
S'NRAS MRNA'
p2381
S'decreases'
p2382
tp2383
(lp2384
s(S'GTF2A2'
p2385
S'CYP26A1'
p2386
S'increases'
p2387
tp2388
(lp2389
s(S'CEBPA'
p2390
S'FOXO3'
p2391
S'increases'
p2392
tp2393
(lp2394
s(S'GATA3'
p2395
S'POU2F1'
p2396
S'increases'
p2397
tp2398
(lp2399
s(S'PI3K'
p2400
S'RAC1B/GDP'
p2401
S'increases_activity'
p2402
tp2403
(lp2404
s(S'CDC25C'
p2405
S'YWHAB'
p2406
S'binds'
p2407
tp2408
(lp2409
s(S'RAC1/GTP'
p2410
S'PAK1/BETAPIX/PKL/NCK1-2'
p2411
S'increases_activity'
p2412
tp2413
(lp2414
s(S'SMAD1'
p2415
S'CYP26A1'
p2416
S'increases'
p2417
tp2418
(lp2419
s(S'PI3K'
p2420
S'FAK'
p2421
S'adds_modification'
p2422
tp2423
(lp2424
S'It plays a key role in cell proliferation, survival, and malignant transformation by regulating the mitogen-activated protein kinase (MAPK) and the PI3K/Akt and integrin-focal adhesion kinase (FAK) pathways.'
p2425
aS'Upon localization to the integrin cluster, FAK becomes autophosphorylated and activates a number of downstream targets such as Src and PI3K.'
p2426
aS"3D = three-dimensional; DMEM = Dulbecco's modified Eagle's medium; FAK = focal adhesion kinase; FBS = fetal bovine serum; LIPUS = low-intensity pulsed ultrasound; MAPK= mitogen-activated protein kinase; PBS = phosphate-buffered saline; PCNA = proliferating cell nuclear antigen; PI3K= phosphatidylinositol 3-OH kinase."
p2427
as(S'NRF1'
p2428
S'MAX'
p2429
S'increases'
p2430
tp2431
(lp2432
s(S'FOXI1'
p2433
S'RUNX2'
p2434
S'increases'
p2435
tp2436
(lp2437
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p2438
S'HRAS MRNA'
p2439
S'increases'
p2440
tp2441
(lp2442
s(S'ETS1'
p2443
S'CBFA2T3'
p2444
S'increases'
p2445
tp2446
(lp2447
s(S'hsa-miR-98-5p'
p2448
S'NRAS'
p2449
S'decreases'
p2450
tp2451
(lp2452
s(S'PHOSPHORYLATED BRF1 (SER92, SER203):MRNA COMPLEX'
p2453
S'YWHAB'
p2454
S'binds'
p2455
tp2456
(lp2457
s(S'LMO2'
p2458
S'CYP26A1'
p2459
S'increases'
p2460
tp2461
(lp2462
s(S'SOS1'
p2463
S'GRB2:PFAK BOUND TO NCAM1:PFYN'
p2464
S'binds'
p2465
tp2466
(lp2467
s(S'GTF3A'
p2468
S'GATA6'
p2469
S'increases'
p2470
tp2471
(lp2472
s(S'ZIC2'
p2473
S'CYP26A1'
p2474
S'increases'
p2475
tp2476
(lp2477
s(S'PAX2'
p2478
S'POU3F2'
p2479
S'increases'
p2480
tp2481
(lp2482
s(S'CEBPD'
p2483
S'FOXO3'
p2484
S'increases'
p2485
tp2486
(lp2487
s(S'NF1'
p2488
S'CYP26A1'
p2489
S'increases'
p2490
tp2491
(lp2492
s(S'BRAF'
p2493
S'MEK2'
p2494
S'adds_modification'
p2495
tp2496
(lp2497
s(S'TFAP4'
p2498
S'RUNX1'
p2499
S'increases'
p2500
tp2501
(lp2502
s(S'FAK'
p2503
S'SOS'
p2504
S'binds'
p2505
tp2506
(lp2507
s(S'EGR1'
p2508
S'RUNX1'
p2509
S'increases'
p2510
tp2511
(lp2512
S'For example, the upregulated pathway group contains 18 different upregulated components (EGFR, TP73L, CCR5, OR1A1, TCF4, AVPR1B, RELA, GLP1R, GNAO1, SOST, ADRA1A, GNG4, DGKA, PRB4, NRP1, DOK2, SORCS2, PTPRS), the skeletal group 14 components (DLX2, BAPX1, SGCA, LMO2, HOXA2, IBSP, COL9A2, RUNX1, EGR1, ANKH, CSRP3, ANXA13, NPR3, SOX6), and the ion transport group 8 components (SLC34A2, ATP7A, TRPM1, MBP, SLC10A1, VMD2, TRPC5, SLC17A2). '
p2513
aS"Interphase FISH studies were done on the bone marrow aspirates using commercially available probes (BCR/ABL1, RUNX1/RUNX1T1, PML/RARA, CBFB/MYH11, MLL, EGR1/D5S23, D5S721, and CEP7/D7S486; Abbott Laboratories, Abbott Park, IL, USA), according to the manufacturer's instructions."
p2514
as(S'TCF4'
p2515
S'FOXO4'
p2516
S'increases'
p2517
tp2518
(lp2519
s(S'MAZ'
p2520
S'CBFA2T3'
p2521
S'increases'
p2522
tp2523
(lp2524
s(S'MEIS1'
p2525
S'HRAS'
p2526
S'increases'
p2527
tp2528
(lp2529
s(S'RELA'
p2530
S'CYP26A1'
p2531
S'increases'
p2532
tp2533
(lp2534
s(S'hsa-miR-877-3p'
p2535
S'NRAS'
p2536
S'decreases'
p2537
tp2538
(lp2539
s(S'MYC'
p2540
S'LEF1'
p2541
S'increases'
p2542
tp2543
(lp2544
s(S'FOXO4'
p2545
S'RUNX1'
p2546
S'increases'
p2547
tp2548
(lp2549
s(S'LEF1'
p2550
S'RUNX1'
p2551
S'increases'
p2552
tp2553
(lp2554
s(S'TFDP2'
p2555
S'GATA1'
p2556
S'increases'
p2557
tp2558
(lp2559
s(S'AHR'
p2560
S'CYP26A1'
p2561
S'increases'
p2562
tp2563
(lp2564
s(S'4-Nitroquinoline-1-oxide'
p2565
S'PTGS2 MRNA'
p2566
S'increases'
p2567
tp2568
(lp2569
s(S'TGIF'
p2570
S'FOXO3'
p2571
S'increases'
p2572
tp2573
(lp2574
s(S'FOXF2'
p2575
S'CEBPA'
p2576
S'increases'
p2577
tp2578
(lp2579
s(S'NFE2L1'
p2580
S'POU2F1'
p2581
S'increases'
p2582
tp2583
(lp2584
s(S'LHX3'
p2585
S'CYP26A1'
p2586
S'increases'
p2587
tp2588
(lp2589
s(S'HMGA1'
p2590
S'MEIS1'
p2591
S'increases'
p2592
tp2593
(lp2594
s(S'POU2F1'
p2595
S'CYP26A1'
p2596
S'increases'
p2597
tp2598
(lp2599
s(S'PRRX2'
p2600
S'HOXA9'
p2601
S'increases'
p2602
tp2603
(lp2604
s(S'ETS2'
p2605
S'CEBPG'
p2606
S'increases'
p2607
tp2608
(lp2609
s(S'hsa-miR-193b-3p'
p2610
S'KRAS'
p2611
S'decreases'
p2612
tp2613
(lp2614
s(S'RREB1'
p2615
S'RUNX1'
p2616
S'increases'
p2617
tp2618
(lp2619
s(S'IL2/IL2R BETA/GAMMA/JAK1/FYN/JAK3'
p2620
S'PI3K'
p2621
S'binds'
p2622
tp2623
(lp2624
s(S'ELK1'
p2625
S'MEIS1'
p2626
S'increases'
p2627
tp2628
(lp2629
s(S'CYP26A1'
p2630
S'HOXA9'
p2631
S'increases'
p2632
tp2633
(lp2634
s(S'SPZ1'
p2635
S'HOXA9'
p2636
S'increases'
p2637
tp2638
(lp2639
s(S'ERK1'
p2640
S'P-S218,222-MEK1'
p2641
S'binds'
p2642
tp2643
(lp2644
s(S'NHLH1'
p2645
S'MYC'
p2646
S'increases'
p2647
tp2648
(lp2649
s(S'Daunorubicin'
p2650
S'NRAS MRNA'
p2651
S'increases'
p2652
tp2653
(lp2654
s(S'HNF1A'
p2655
S'FOXA1'
p2656
S'increases'
p2657
tp2658
(lp2659
s(S'MYC'
p2660
S'ONECUT1'
p2661
S'increases'
p2662
tp2663
(lp2664
s(S'Vanadates'
p2665
S'HRAS PROTEIN'
p2666
S'increases'
p2667
tp2668
(lp2669
s(S'Purine nucleotide'
p2670
S'H+'
p2671
S'translocates'
p2672
tp2673
(lp2674
s(S'NFE2'
p2675
S'BACH1'
p2676
S'increases'
p2677
tp2678
(lp2679
s(S'EGR4'
p2680
S'CYP26A1'
p2681
S'increases'
p2682
tp2683
(lp2684
s(S'NRF1'
p2685
S'ONECUT1'
p2686
S'increases'
p2687
tp2688
(lp2689
s(S'GFI1'
p2690
S'HOXA9'
p2691
S'increases'
p2692
tp2693
(lp2694
s(S'NR1H4'
p2695
S'FOXD3'
p2696
S'increases'
p2697
tp2698
(lp2699
s(S'STAT6'
p2700
S'FOXA1'
p2701
S'increases'
p2702
tp2703
(lp2704
s(S'INSULIN RECEPTOR/INSULI/IRS1/GRB2/SHC'
p2705
S'SOS1'
p2706
S'binds'
p2707
tp2708
(lp2709
s(S'Tetrachlorodibenzodioxin'
p2710
S'KRAS MRNA'
p2711
S'increases'
p2712
tp2713
(lp2714
s(S'TCF3'
p2715
S'MYC'
p2716
S'increases'
p2717
tp2718
(lp2719
s(S'BACH1'
p2720
S'EN1'
p2721
S'increases'
p2722
tp2723
(lp2724
s(S'RFX1'
p2725
S'CYP26A1'
p2726
S'increases'
p2727
tp2728
(lp2729
s(S'ZEB1'
p2730
S'FOXD3'
p2731
S'increases'
p2732
tp2733
(lp2734
s(S'IRF7'
p2735
S'EN1'
p2736
S'increases'
p2737
tp2738
(lp2739
s(S'GAB2/GRB2/SOS1'
p2740
S'IL2/IL2R ALPHA/BETA/GAMMA/JAK1/LCK/JAK3/SHC'
p2741
S'binds'
p2742
tp2743
(lp2744
s(S'GATA3'
p2745
S'FOXA1'
p2746
S'increases'
p2747
tp2748
(lp2749
s(S'TFAP4'
p2750
S'CYP26A1'
p2751
S'increases'
p2752
tp2753
(lp2754
s(S'FOXF2'
p2755
S'MECOM'
p2756
S'increases'
p2757
tp2758
(lp2759
s(S'NF1'
p2760
S'POU2F1'
p2761
S'increases'
p2762
tp2763
(lp2764
s(S'IRF1'
p2765
S'FOXA1'
p2766
S'increases'
p2767
tp2768
(lp2769
s(S'Rho Family GTPase-active'
p2770
S'PIP5K1A'
p2771
S'increases_activity'
p2772
tp2773
(lp2774
s(S'POU6F1'
p2775
S'EN1'
p2776
S'increases'
p2777
tp2778
(lp2779
s(S'TCF4'
p2780
S'LEF1'
p2781
S'increases'
p2782
tp2783
(lp2784
s(S'MAZ'
p2785
S'FOXO3'
p2786
S'increases'
p2787
tp2788
(lp2789
s(S'POU3F2'
p2790
S'MECOM'
p2791
S'increases'
p2792
tp2793
(lp2794
s(S'GTF3A'
p2795
S'CYP26A1'
p2796
S'increases'
p2797
tp2798
(lp2799
s(S'PI-3-4-5-P3'
p2800
S'AKT2'
p2801
S'adds_modification'
p2802
tp2803
(lp2804
s(S'VSX1'
p2805
S'POU2F1'
p2806
S'increases'
p2807
tp2808
(lp2809
s(S'PHOSPHORYLATED TTP:MRNA COMPLEX'
p2810
S'YWHAB'
p2811
S'binds'
p2812
tp2813
(lp2814
s(S'MEIS1'
p2815
S'MYC'
p2816
S'increases'
p2817
tp2818
(lp2819
s(S'Complex (PDGF receptor A/PDGF receptor B)'
p2820
S'RASGAP'
p2821
S'adds_modification'
p2822
tp2823
(lp2824
s(S'RORA'
p2825
S'CYP26A1'
p2826
S'increases'
p2827
tp2828
(lp2829
s(S'ATF4'
p2830
S'CDC5L'
p2831
S'increases'
p2832
tp2833
(lp2834
s(S'SHC/RasGAP'
p2835
S'RAS FAMILY/GTP'
p2836
S'increases_activity'
p2837
tp2838
(lp2839
s(S'NKX2-1'
p2840
S'MYC'
p2841
S'increases'
p2842
tp2843
(lp2844
s(S'NF1'
p2845
S'SRF'
p2846
S'increases'
p2847
tp2848
(lp2849
s(S'STAT4'
p2850
S'NRAS'
p2851
S'increases'
p2852
tp2853
(lp2854
s(S'POU6F1'
p2855
S'MEIS1'
p2856
S'increases'
p2857
tp2858
(lp2859
s(S'P-KIT COMPLEX'
p2860
S'GRB2:SOS1'
p2861
S'binds'
p2862
tp2863
(lp2864
s(S'MYCN'
p2865
S'MAX'
p2866
S'increases'
p2867
tp2868
(lp2869
s(S'STAT5A'
p2870
S'CYP26A1'
p2871
S'increases'
p2872
tp2873
(lp2874
s(S'GATA3'
p2875
S'EN1'
p2876
S'increases'
p2877
tp2878
(lp2879
s(S'E4F1'
p2880
S'FOXD3'
p2881
S'increases'
p2882
tp2883
(lp2884
s(S'MYB'
p2885
S'ONECUT1'
p2886
S'increases'
p2887
tp2888
(lp2889
s(S'Cadmium Chloride'
p2890
S'NRAS PROTEIN'
p2891
S'increases'
p2892
tp2893
(lp2894
s(S'Deoxycholic Acid'
p2895
S'HRAS PROTEIN'
p2896
S'increases_activity'
p2897
tp2898
(lp2899
s(S'HLF'
p2900
S'CYP26A1'
p2901
S'increases'
p2902
tp2903
(lp2904
s(S'GMCSF/GMR ALPHA/CSF2RB/JAK2 (DIMER)'
p2905
S'YWHAZ'
p2906
S'binds'
p2907
tp2908
(lp2909
s(S'HNF1A'
p2910
S'FOXF2'
p2911
S'increases'
p2912
tp2913
(lp2914
s(S'FOXF2'
p2915
S'GATA6'
p2916
S'increases'
p2917
tp2918
(lp2919
s(S'Arsenic'
p2920
S'GSS PROTEIN'
p2921
S'increases'
p2922
tp2923
(lp2924
s(S'COMPLEX (SOS/GRB2)'
p2925
S'FGFR1-4'
p2926
S'binds'
p2927
tp2928
(lp2929
s(S'MYOD1'
p2930
S'NRAS'
p2931
S'increases'
p2932
tp2933
(lp2934
s(S'MECOM'
p2935
S'CYP26A1'
p2936
S'increases'
p2937
tp2938
(lp2939
s(S'PBX1'
p2940
S'CYP26A1'
p2941
S'increases'
p2942
tp2943
(lp2944
s(S'MAZ'
p2945
S'MEIS1'
p2946
S'increases'
p2947
tp2948
(lp2949
s(S'PAX4'
p2950
S'ELK1'
p2951
S'increases'
p2952
tp2953
(lp2954
s(S'ESRRA'
p2955
S'MECOM'
p2956
S'increases'
p2957
tp2958
(lp2959
s(S'CEBPD'
p2960
S'TLX2'
p2961
S'increases'
p2962
tp2963
(lp2964
s(S'CRX'
p2965
S'FOXA1'
p2966
S'increases'
p2967
tp2968
(lp2969
s(S'GABPB1'
p2970
S'NRAS'
p2971
S'increases'
p2972
tp2973
(lp2974
s(S'CRX'
p2975
S'MEIS1'
p2976
S'increases'
p2977
tp2978
(lp2979
s(S'pirinixic acid/PPARA protein'
p2980
S'KRAS MRNA'
p2981
S'increases'
p2982
tp2983
(lp2984
s(S'BACH2'
p2985
S'FOXA1'
p2986
S'increases'
p2987
tp2988
(lp2989
s(S'JUN'
p2990
S'MECOM'
p2991
S'increases'
p2992
tp2993
(lp2994
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p2995
S'KRAS MRNA'
p2996
S'decreases'
p2997
tp2998
(lp2999
s(S'SRY'
p3000
S'FOXO4'
p3001
S'increases'
p3002
tp3003
(lp3004
s(S'PI3K'
p3005
S'AKT1'
p3006
S'adds_modification'
p3007
tp3008
(lp3009
S'Targeted reduction of AKT1/phosphatidylinositol 3-kinase (PI3K) a ctivation increases the susceptibility of keratinocytes to apoptosis, with selective death of differentiating keratinocytes.'
p3010
aS'MTOR is an\nevolutionarily conserved serine/threonine kinase located downstream of PI3K and\nAKT1, which controls cell growth and proliferation through activation of\nribosomal protein S6 kinase (RPS6K) to phosphorylate RPS6 and, ultimately,\nregulate protein synthesis,'
p3011
as(S'GATA3'
p3012
S'CYP26A1'
p3013
S'increases'
p3014
tp3015
(lp3016
s(S'RAS:GTP'
p3017
S'P-EPHBS:EFNBS:RASA1'
p3018
S'binds'
p3019
tp3020
(lp3021
s(S'STAT5A'
p3022
S'MECOM'
p3023
S'increases'
p3024
tp3025
(lp3026
s(S'RAS family/GTP'
p3027
S'RAF1'
p3028
S'increases_activity'
p3029
tp3030
(lp3031
s(S'RHOA/GTP'
p3032
S'PLD1-2'
p3033
S'increases_activity'
p3034
tp3035
(lp3036
s(S'FOXJ2'
p3037
S'CYP26A1'
p3038
S'increases'
p3039
tp3040
(lp3041
s(S'LEF1'
p3042
S'MECOM'
p3043
S'increases'
p3044
tp3045
(lp3046
s(S'GABPB2'
p3047
S'CDC5L'
p3048
S'increases'
p3049
tp3050
(lp3051
s(S'ESRRA'
p3052
S'CYP26A1'
p3053
S'increases'
p3054
tp3055
(lp3056
s(S'PI-3-4-5-P3'
p3057
S'WAVE2/NAP1/SRA1/ABI1/HSPC300'
p3058
S'translocates'
p3059
tp3060
(lp3061
s(S'CUX1'
p3062
S'MECOM'
p3063
S'increases'
p3064
tp3065
(lp3066
s(S'MAX'
p3067
S'CYP26A1'
p3068
S'increases'
p3069
tp3070
(lp3071
s(S'RXRB'
p3072
S'FOXD3'
p3073
S'increases'
p3074
tp3075
(lp3076
s(S'IRF1'
p3077
S'NRAS'
p3078
S'increases'
p3079
tp3080
(lp3081
s(S'MECOM'
p3082
S'MAX'
p3083
S'increases'
p3084
tp3085
(lp3086
s(S'PAX6'
p3087
S'CYP26A1'
p3088
S'increases'
p3089
tp3090
(lp3091
s(S'GRB2/SOS1'
p3092
S'EGFR/EGFR/EGF/EGF/P46 SHC'
p3093
S'binds'
p3094
tp3095
(lp3096
s(S'POU6F1'
p3097
S'POU2F1'
p3098
S'increases'
p3099
tp3100
(lp3101
s(S'RUNX1'
p3102
S'MYOD1'
p3103
S'increases'
p3104
tp3105
(lp3106
s(S'COMPLEX (GRB2/SOS)'
p3107
S'EGFR'
p3108
S'binds'
p3109
tp3110
(lp3111
s(S'MAZ'
p3112
S'MECOM'
p3113
S'increases'
p3114
tp3115
(lp3116
s(S'REPIN1'
p3117
S'EN1'
p3118
S'increases'
p3119
tp3120
(lp3121
s(S'RAS family/GTP'
p3122
S'RAF1'
p3123
S'adds_modification'
p3124
tp3125
(lp3126
s(S'E4F1'
p3127
S'CYP26A1'
p3128
S'increases'
p3129
tp3130
(lp3131
s(S'Rac'
p3132
S'MEKK1-5'
p3133
S'adds_modification'
p3134
tp3135
(lp3136
s(S'HAND1'
p3137
S'CYP26A1'
p3138
S'increases'
p3139
tp3140
(lp3141
s(S'Quercetin'
p3142
S'NRAS PROTEIN'
p3143
S'decreases'
p3144
tp3145
(lp3146
s(S'HRAS:GTP'
p3147
S'CRAF'
p3148
S'binds'
p3149
tp3150
(lp3151
s(S'REPIN1'
p3152
S'FOXA1'
p3153
S'increases'
p3154
tp3155
(lp3156
s(S'hsa-miR-155-5p'
p3157
S'KRAS'
p3158
S'decreases'
p3159
tp3160
(lp3161
s(S'PAX4'
p3162
S'EN1'
p3163
S'increases'
p3164
tp3165
(lp3166
s(S'FOXN1'
p3167
S'JUN'
p3168
S'increases'
p3169
tp3170
(lp3171
s(S'TFCP2'
p3172
S'GATA1'
p3173
S'increases'
p3174
tp3175
(lp3176
s(S'SHC'
p3177
S'GRAP2'
p3178
S'binds'
p3179
tp3180
(lp3181
s(S'CEBPG'
p3182
S'NRAS'
p3183
S'increases'
p3184
tp3185
(lp3186
s(S'FOXN1'
p3187
S'FOXO4'
p3188
S'increases'
p3189
tp3190
(lp3191
s(S'IL2/IL2R ALPHA/BETA/GAMMA/JAK1/LCK/JAK3/IRS1-2'
p3192
S'PI3K'
p3193
S'binds'
p3194
tp3195
(lp3196
s(S'POU1F1'
p3197
S'EN1'
p3198
S'increases'
p3199
tp3200
(lp3201
s(S'FOXJ1'
p3202
S'POU2F1'
p3203
S'increases'
p3204
tp3205
(lp3206
s(S'YY1'
p3207
S'POU2F1'
p3208
S'increases'
p3209
tp3210
(lp3211
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p3212
S'NRAS MRNA'
p3213
S'increases'
p3214
tp3215
(lp3216
s(S'EGF/EGFR'
p3217
S'HRAS/GDP'
p3218
S'increases_activity'
p3219
tp3220
(lp3221
s(S'TFAP4'
p3222
S'GABPB2'
p3223
S'increases'
p3224
tp3225
(lp3226
s(S'TFAP2A'
p3227
S'POU3F2'
p3228
S'increases'
p3229
tp3230
(lp3231
s(S'TCF12'
p3232
S'CBFA2T3'
p3233
S'increases'
p3234
tp3235
(lp3236
s(S'STAT3'
p3237
S'IRF1'
p3238
S'increases'
p3239
tp3240
(lp3241
s(S'MYOD1'
p3242
S'GATA1'
p3243
S'increases'
p3244
tp3245
(lp3246
s(S'REPIN1'
p3247
S'HRAS'
p3248
S'increases'
p3249
tp3250
(lp3251
s(S'PAX4'
p3252
S'MAX'
p3253
S'increases'
p3254
tp3255
(lp3256
s(S'PAX2'
p3257
S'FOXA1'
p3258
S'increases'
p3259
tp3260
(lp3261
s(S'Lipopolysaccharides'
p3262
S'HRAS PROTEIN'
p3263
S'increases_activity'
p3264
tp3265
(lp3266
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p3267
S'KRAS MRNA'
p3268
S'increases'
p3269
tp3270
(lp3271
s(S'REPIN1'
p3272
S'GATA1'
p3273
S'increases'
p3274
tp3275
(lp3276
s(S'Formaldehyde'
p3277
S'HRAS MRNA'
p3278
S'increases'
p3279
tp3280
(lp3281
s(S'ESRRA'
p3282
S'STAT5A'
p3283
S'increases'
p3284
tp3285
(lp3286
s(S'farnesylthiosalicylic acid'
p3287
S'HRAS PROTEIN'
p3288
S'decreases'
p3289
tp3290
(lp3291
s(S'JUN'
p3292
S'RUNX1'
p3293
S'increases'
p3294
tp3295
(lp3296
s(S'FOXD3'
p3297
S'RUNX1'
p3298
S'increases'
p3299
tp3300
(lp3301
s(S'SOX9'
p3302
S'CYP26A1'
p3303
S'increases'
p3304
tp3305
(lp3306
s(S'hexabromocyclododecane'
p3307
S'HRAS MRNA'
p3308
S'increases'
p3309
tp3310
(lp3311
s(S'RUNX2'
p3312
S'KRAS'
p3313
S'increases'
p3314
tp3315
(lp3316
s(S'PGR'
p3317
S'CYP26A1'
p3318
S'increases'
p3319
tp3320
(lp3321
s(S'CYP26A1'
p3322
S'MAZ'
p3323
S'increases'
p3324
tp3325
(lp3326
s(S'RAC1/GTP'
p3327
S'AKT1'
p3328
S'adds_modification'
p3329
tp3330
(lp3331
s(S'FOXO3'
p3332
S'CYP26A1'
p3333
S'increases'
p3334
tp3335
(lp3336
s(S'MAX'
p3337
S'SRF'
p3338
S'increases'
p3339
tp3340
(lp3341
S'We gratefully acknowledge access to\nsynchrotron radiation\nat the ESRF, Grenoble, France and at MAX IV Laboratory, Lund, Sweden.'
p3342
aS'We acknowledge access to synchrotron radiation at beamlines 9-11 at MAX IV laboratory and ID14-1 and ID29 at the ESRF and thank the beamline staff for support.'
p3343
aS'The synchrotron facilities MAX-lab and ESRF provided excellent facilities for data collection.'
p3344
aS'We acknowledge access to synchrotron radiation at Diamond Light Source, MAX IV Laboratory and the ESRF and thank their staff for excellent support.'
p3345
as(S'RUNX2'
p3346
S'NRAS'
p3347
S'increases'
p3348
tp3349
(lp3350
s(S'HSF2'
p3351
S'CYP26A1'
p3352
S'increases'
p3353
tp3354
(lp3355
s(S'IL2/IL2R ALPHA/BETA/GAMMA/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2/SHP2'
p3356
S'PI3K'
p3357
S'binds'
p3358
tp3359
(lp3360
s(S'SPI1'
p3361
S'STAT5A'
p3362
S'increases'
p3363
tp3364
(lp3365
s(S'ZHX2'
p3366
S'MYC'
p3367
S'increases'
p3368
tp3369
(lp3370
s(S'RAF1-BRAF'
p3371
S'MEK1-2'
p3372
S'increases_activity'
p3373
tp3374
(lp3375
s(S'SHC'
p3376
S'GRB2'
p3377
S'binds'
p3378
tp3379
(lp3380
s(S'RB1'
p3381
S'GATA1'
p3382
S'increases'
p3383
tp3384
(lp3385
s(S'TCF3'
p3386
S'FOXJ2'
p3387
S'increases'
p3388
tp3389
(lp3390
s(S'FOXJ2'
p3391
S'NRAS'
p3392
S'increases'
p3393
tp3394
(lp3395
s(S'REPIN1'
p3396
S'LEF1'
p3397
S'increases'
p3398
tp3399
(lp3400
s(S'Aflatoxin B1'
p3401
S'HRAS MRNA'
p3402
S'increases'
p3403
tp3404
(lp3405
s(S'PAX4'
p3406
S'MEIS1'
p3407
S'increases'
p3408
tp3409
(lp3410
s(S'FOXF2'
p3411
S'FOXD3'
p3412
S'increases'
p3413
tp3414
(lp3415
s(S'CBFA2T3'
p3416
S'RUNX1'
p3417
S'increases'
p3418
tp3419
(lp3420
s(S'FOXC1'
p3421
S'HOXA9'
p3422
S'increases'
p3423
tp3424
(lp3425
s(S'DBP'
p3426
S'CYP26A1'
p3427
S'increases'
p3428
tp3429
(lp3430
s(S'TGIF'
p3431
S'EN1'
p3432
S'increases'
p3433
tp3434
(lp3435
s(S'PI-3-4-5-P3'
p3436
S'P62DOK'
p3437
S'adds_modification'
p3438
tp3439
(lp3440
s(S'JUN'
p3441
S'TLX2'
p3442
S'increases'
p3443
tp3444
(lp3445
s(S'Benzo(a)pyrene'
p3446
S'HRAS MRNA'
p3447
S'increases'
p3448
tp3449
(lp3450
s(S'STAT4'
p3451
S'CYP26A1'
p3452
S'increases'
p3453
tp3454
(lp3455
s(S'EGFR/EGFR/EGF/EGF'
p3456
S'SRC'
p3457
S'adds_modification'
p3458
tp3459
(lp3460
s(S'FOXQ1'
p3461
S'FOXD3'
p3462
S'increases'
p3463
tp3464
(lp3465
s(S'FOXJ1'
p3466
S'NRAS'
p3467
S'increases'
p3468
tp3469
(lp3470
s(S'TCF3'
p3471
S'POU2F1'
p3472
S'increases'
p3473
tp3474
(lp3475
s(S'MYB'
p3476
S'CYP26A1'
p3477
S'increases'
p3478
tp3479
(lp3480
s(S'GATA4'
p3481
S'CYP26A1'
p3482
S'increases'
p3483
tp3484
(lp3485
s(S'ELK1'
p3486
S'STAT4'
p3487
S'increases'
p3488
tp3489
(lp3490
s(S'CYP26A1'
p3491
S'LEF1'
p3492
S'increases'
p3493
tp3494
(lp3495
s(S"Guanosine-5'-Diphosphate"
p3496
S'HRAS'
p3497
S'increases_activity'
p3498
tp3499
(lp3500
s(S'ETV4'
p3501
S'CYP26A1'
p3502
S'increases'
p3503
tp3504
(lp3505
s(S'EPHRIN B/EPHB2'
p3506
S'RASGAP'
p3507
S'binds'
p3508
tp3509
(lp3510
s(S'ESR1'
p3511
S'FOXF2'
p3512
S'increases'
p3513
tp3514
(lp3515
s(S'CDC5L'
p3516
S'FOXA1'
p3517
S'increases'
p3518
tp3519
(lp3520
s(S'MAZ'
p3521
S'HOXA9'
p3522
S'increases'
p3523
tp3524
(lp3525
s(S'HIF1A'
p3526
S'MAX'
p3527
S'increases'
p3528
tp3529
(lp3530
s(S'FOXN1'
p3531
S'HOXA9'
p3532
S'increases'
p3533
tp3534
(lp3535
s(S'LEF1'
p3536
S'BACH1'
p3537
S'increases'
p3538
tp3539
(lp3540
s(S'PDX1'
p3541
S'FOXO3'
p3542
S'increases'
p3543
tp3544
(lp3545
s(S'CBFA2T3'
p3546
S'CYP26A1'
p3547
S'increases'
p3548
tp3549
(lp3550
s(S'Rabex5'
p3551
S'HRAS/GTP'
p3552
S'adds_modification'
p3553
tp3554
(lp3555
s(S'CBFA2T3'
p3556
S'RUNX2'
p3557
S'increases'
p3558
tp3559
(lp3560
s(S'PI-3-4-5-P3'
p3561
S'ARAP3'
p3562
S'translocates'
p3563
tp3564
(lp3565
s(S'CART1'
p3566
S'CYP26A1'
p3567
S'increases'
p3568
tp3569
(lp3570
s(S'Arsenic'
p3571
S'NRAS MRNA'
p3572
S'increases'
p3573
tp3574
(lp3575
s(S'NRF1'
p3576
S'CDC5L'
p3577
S'increases'
p3578
tp3579
(lp3580
s(S'Quercetin'
p3581
S'HRAS PROTEIN'
p3582
S'decreases'
p3583
tp3584
(lp3585
s(S"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE"
p3586
S'HRAS'
p3587
S'increases_activity'
p3588
tp3589
(lp3590
s(S'TFDP1'
p3591
S'FOXD3'
p3592
S'increases'
p3593
tp3594
(lp3595
s(S'AR'
p3596
S'TLX2'
p3597
S'increases'
p3598
tp3599
(lp3600
s(S'hsa-miR-181c-5p'
p3601
S'KRAS'
p3602
S'decreases'
p3603
tp3604
(lp3605
s(S'SMAD3'
p3606
S'CBFA2T3'
p3607
S'increases'
p3608
tp3609
(lp3610
s(S'HOXA9'
p3611
S'NRAS'
p3612
S'increases'
p3613
tp3614
(lp3615
s(S'PITX2'
p3616
S'CYP26A1'
p3617
S'increases'
p3618
tp3619
(lp3620
s(S'ATF3'
p3621
S'CYP26A1'
p3622
S'increases'
p3623
tp3624
(lp3625
s(S'E2F1'
p3626
S'MAZ'
p3627
S'increases'
p3628
tp3629
(lp3630
s(S'Ethyl Methanesulfonate'
p3631
S'HRAS MRNA'
p3632
S'increases'
p3633
tp3634
(lp3635
s(S'LMO2'
p3636
S'FOXA1'
p3637
S'increases'
p3638
tp3639
(lp3640
s(S'FOXC1'
p3641
S'POU2F1'
p3642
S'increases'
p3643
tp3644
(lp3645
s(S'DDIT3'
p3646
S'CYP26A1'
p3647
S'increases'
p3648
tp3649
(lp3650
s(S'PAX8'
p3651
S'CYP26A1'
p3652
S'increases'
p3653
tp3654
(lp3655
s(S'LHX3'
p3656
S'EN1'
p3657
S'increases'
p3658
tp3659
(lp3660
s(S'KAT2B'
p3661
S'CYP26A1'
p3662
S'increases'
p3663
tp3664
(lp3665
s(S'P100'
p3666
S'MYB'
p3667
S'binds'
p3668
tp3669
(lp3670
s(S'SOX9'
p3671
S'FOXA1'
p3672
S'increases'
p3673
tp3674
(lp3675
s(S'HIF1A'
p3676
S'EN1'
p3677
S'increases'
p3678
tp3679
(lp3680
s(S'REPIN1'
p3681
S'RUNX1'
p3682
S'increases'
p3683
tp3684
(lp3685
s(S'MYOD1'
p3686
S'BACH1'
p3687
S'increases'
p3688
tp3689
(lp3690
s(S'EBF2'
p3691
S'REPIN1'
p3692
S'increases'
p3693
tp3694
(lp3695
s(S'bisphenol A'
p3696
S'HRAS MRNA'
p3697
S'increases'
p3698
tp3699
(lp3700
s(S'E2F1'
p3701
S'EN1'
p3702
S'increases'
p3703
tp3704
(lp3705
s(S'MYC/Max/MIZ-1'
p3706
S'GALECTIN-1'
p3707
S'decreases'
p3708
tp3709
(lp3710
s(S'PI-3-4-5-P3'
p3711
S'WAVE2/NAP1/SRA1/ABI1/HSPC300'
p3712
S'adds_modification'
p3713
tp3714
(lp3715
s(S'FOXF2'
p3716
S'FOXO3'
p3717
S'increases'
p3718
tp3719
(lp3720
s(S'REPIN1'
p3721
S'STAT5A'
p3722
S'increases'
p3723
tp3724
(lp3725
s(S'RUNX1'
p3726
S'NRAS'
p3727
S'increases'
p3728
tp3729
(lp3730
s(S'benzo(a)pyrene 7,8-dihydrodiol'
p3731
S'HRAS MRNA'
p3732
S'increases'
p3733
tp3734
(lp3735
s(S'RAC1/GTP'
p3736
S'PAK1 (DIMER)'
p3737
S'adds_modification'
p3738
tp3739
(lp3740
s(S'PAX4'
p3741
S'POU2F1'
p3742
S'increases'
p3743
tp3744
(lp3745
s(S'MYOD1'
p3746
S'CBFA2T3'
p3747
S'increases'
p3748
tp3749
(lp3750
s(S'STAT5A'
p3751
S'RUNX2'
p3752
S'increases'
p3753
tp3754
(lp3755
s(S'EBF2'
p3756
S'FOXJ2'
p3757
S'increases'
p3758
tp3759
(lp3760
s(S'Estradiol'
p3761
S'KRAS MRNA'
p3762
S'increases'
p3763
tp3764
(lp3765
s(S'RXRB'
p3766
S'CYP26A1'
p3767
S'increases'
p3768
tp3769
(lp3770
s(S'bisphenol A'
p3771
S'KRAS MRNA'
p3772
S'decreases'
p3773
tp3774
(lp3775
s(S'COMPLEX (GRB2/SOS)'
p3776
S'FGFR1-4'
p3777
S'binds'
p3778
tp3779
(lp3780
s(S'POU2F1'
p3781
S'RUNX1'
p3782
S'increases'
p3783
tp3784
(lp3785
s(S'TCF3'
p3786
S'TLX2'
p3787
S'increases'
p3788
tp3789
(lp3790
s(S'SPZ1'
p3791
S'POU2F1'
p3792
S'increases'
p3793
tp3794
(lp3795
s(S'TFAP4'
p3796
S'FOXO4'
p3797
S'increases'
p3798
tp3799
(lp3800
s(S'OR5I1'
p3801
S'MECOM'
p3802
S'increases'
p3803
tp3804
(lp3805
s(S'Rho Family GTPase-active'
p3806
S'JNK1'
p3807
S'adds_modification'
p3808
tp3809
(lp3810
s(S'TFDP1'
p3811
S'POU2F1'
p3812
S'increases'
p3813
tp3814
(lp3815
s(S'AHR'
p3816
S'MAX'
p3817
S'increases'
p3818
tp3819
(lp3820
s(S'BACH1'
p3821
S'CYP26A1'
p3822
S'increases'
p3823
tp3824
(lp3825
s(S'ZBTB14'
p3826
S'MAZ'
p3827
S'increases'
p3828
tp3829
(lp3830
s(S'TCF3'
p3831
S'FOXO4'
p3832
S'increases'
p3833
tp3834
(lp3835
s(S'MASTERMIND'
p3836
S'NICS'
p3837
S'binds'
p3838
tp3839
(lp3840
s(S'BPTF'
p3841
S'FOXO4'
p3842
S'increases'
p3843
tp3844
(lp3845
s(S'MYOD1'
p3846
S'RUNX1'
p3847
S'increases'
p3848
tp3849
(lp3850
s(S'JUN'
p3851
S'CYP26A1'
p3852
S'increases'
p3853
tp3854
(lp3855
s(S'BPTF'
p3856
S'CYP26A1'
p3857
S'increases'
p3858
tp3859
(lp3860
s(S'POU3F1'
p3861
S'CYP26A1'
p3862
S'increases'
p3863
tp3864
(lp3865
s(S'NRF1'
p3866
S'CYP26A1'
p3867
S'increases'
p3868
tp3869
(lp3870
s(S'TFAP2C'
p3871
S'POU3F2'
p3872
S'increases'
p3873
tp3874
(lp3875
s(S'NFAT1-C-4-INACTIVE2'
p3876
S'YWHAQ'
p3877
S'binds'
p3878
tp3879
(lp3880
s(S'STAT6'
p3881
S'ONECUT1'
p3882
S'increases'
p3883
tp3884
(lp3885
s(S'RUNX1'
p3886
S'RUNX2'
p3887
S'increases'
p3888
tp3889
(lp3890
s(S'ZIC3'
p3891
S'MYCN'
p3892
S'increases'
p3893
tp3894
(lp3895
s(S'CYP26A1'
p3896
S'MAX'
p3897
S'increases'
p3898
tp3899
(lp3900
s(S'ETS2'
p3901
S'FOXO4'
p3902
S'increases'
p3903
tp3904
(lp3905
s(S'GATA6'
p3906
S'FOXA1'
p3907
S'increases'
p3908
tp3909
(lp3910
s(S'Doxorubicin'
p3911
S'HRAS MRNA'
p3912
S'increases'
p3913
tp3914
(lp3915
s(S'PPARA'
p3916
S'HOXA9'
p3917
S'increases'
p3918
tp3919
(lp3920
s(S'REPIN1'
p3921
S'GABPB2'
p3922
S'increases'
p3923
tp3924
(lp3925
s(S'FOXN1'
p3926
S'FOXA1'
p3927
S'increases'
p3928
tp3929
(lp3930
s(S'Dronabinol'
p3931
S'KRAS MRNA'
p3932
S'increases'
p3933
tp3934
(lp3935
s(S'FOXO1'
p3936
S'RUNX1'
p3937
S'increases'
p3938
tp3939
(lp3940
s(S'SMAD4'
p3941
S'HOXA9'
p3942
S'increases'
p3943
tp3944
(lp3945
s(S'PAX4'
p3946
S'JUN'
p3947
S'increases'
p3948
tp3949
(lp3950
s(S'Raf-1'
p3951
S'MEK'
p3952
S'adds_modification'
p3953
tp3954
(lp3955
g659
ag660
ag661
ag662
ag663
ag676
ag709
ag710
as(S'PIM1'
p3956
S'MYC/MAX'
p3957
S'binds'
p3958
tp3959
(lp3960
s(S'YY1'
p3961
S'MECOM'
p3962
S'increases'
p3963
tp3964
(lp3965
s(S'NRF1'
p3966
S'MAZ'
p3967
S'increases'
p3968
tp3969
(lp3970
s(S'GATA1'
p3971
S'MECOM'
p3972
S'increases'
p3973
tp3974
(lp3975
s(S'PDGF/PDGFRA'
p3976
S'SHC/GRB2/SOS1'
p3977
S'increases_activity'
p3978
tp3979
(lp3980
s(S'GRB2/SOS1'
p3981
S'FAK'
p3982
S'binds'
p3983
tp3984
(lp3985
s(S'HNF4A'
p3986
S'HOXA9'
p3987
S'increases'
p3988
tp3989
(lp3990
s(S'FOXA2'
p3991
S'CYP26A1'
p3992
S'increases'
p3993
tp3994
(lp3995
s(S'FOXI1'
p3996
S'CYP26A1'
p3997
S'increases'
p3998
tp3999
(lp4000
s(S'GRB2 BOUND TO TIE2'
p4001
S'SOS1'
p4002
S'binds'
p4003
tp4004
(lp4005
s(S'PHOSPHORYLATED BRF1 (SER54, SER92, SER203):MRNA COMPLEX'
p4006
S'YWHAB'
p4007
S'binds'
p4008
tp4009
(lp4010
s(S'COMPLEX (GRB2/SOS)'
p4011
S'GAB'
p4012
S'binds'
p4013
tp4014
(lp4015
s(S'NFE2'
p4016
S'TLX2'
p4017
S'increases'
p4018
tp4019
(lp4020
s(S'MAX'
p4021
S'FOXF2'
p4022
S'increases'
p4023
tp4024
(lp4025
s(S'GRB2:SOS1'
p4026
S'ACTIVATED FGFR:P-FRS2'
p4027
S'binds'
p4028
tp4029
(lp4030
s(S'FOXO4'
p4031
S'MECOM'
p4032
S'increases'
p4033
tp4034
(lp4035
s(S'TCF3'
p4036
S'LEF1'
p4037
S'increases'
p4038
tp4039
(lp4040
s(S'ZIC1'
p4041
S'LEF1'
p4042
S'increases'
p4043
tp4044
(lp4045
s(S'NFIL3'
p4046
S'CYP26A1'
p4047
S'increases'
p4048
tp4049
(lp4050
s(S'RAF1'
p4051
S'MEK1'
p4052
S'increases_activity'
p4053
tp4054
(lp4055
s(S'AR'
p4056
S'FOXA1'
p4057
S'increases'
p4058
tp4059
(lp4060
S'H3K4 mono- and dimethylation (H3K4me1, H3K4me2) have been thought of as markers for enhancer sites in directing the androgen receptor (AR) transcriptional program, by facilitating AR binding directly or indirectly through the recruitment of coactivators, such as FOXA1, GATA2, and MED1.'
p4061
aS'The fact that FOXA1 is overexpressed and mutated in hormone-dependent cancers, prostate cancer, and breast cancer, is in concordance with its predominant role in directing AR/ER signaling to drive cancer development.'
p4062
as(S'POU2F1'
p4063
S'POU3F2'
p4064
S'increases'
p4065
tp4066
(lp4067
s(S'PCBP1'
p4068
S'MAZ'
p4069
S'increases'
p4070
tp4071
(lp4072
s(S'LEF1'
p4073
S'HOXA9'
p4074
S'increases'
p4075
tp4076
(lp4077
s(S'NR6A1'
p4078
S'CYP26A1'
p4079
S'increases'
p4080
tp4081
(lp4082
s(S'PI3K'
p4083
S'BTK'
p4084
S'translocates'
p4085
tp4086
(lp4087
s(S'AHR'
p4088
S'RUNX1'
p4089
S'increases'
p4090
tp4091
(lp4092
s(S'NR1H4'
p4093
S'CYP26A1'
p4094
S'increases'
p4095
tp4096
(lp4097
s(S'NR2F2'
p4098
S'CYP26A1'
p4099
S'increases'
p4100
tp4101
(lp4102
s(S'GNB1/GNG2'
p4103
S'PI3K'
p4104
S'binds'
p4105
tp4106
(lp4107
s(S'RHOA/GTP'
p4108
S'PKN2'
p4109
S'increases_activity'
p4110
tp4111
(lp4112
s(S'MAZ'
p4113
S'LEF1'
p4114
S'increases'
p4115
tp4116
(lp4117
s(S'RFX1'
p4118
S'MECOM'
p4119
S'increases'
p4120
tp4121
(lp4122
s(S'RUNX1'
p4123
S'HOXA9'
p4124
S'increases'
p4125
tp4126
(lp4127
S'AC9: adenylate cyclase 9; AID:  Activation-Induced Cytidine Deaminase; BACH1:  BTB and CNC homology 1, basic leucine zipper transcription factor 1; BCL2:  B-cell lymphoma 2; BIM:  BCL2-like 11; CEBPB:  CCAAT/enhancer-binding protein beta; CSFR:  Colony stimulating factor  receptor; c-MAF:  musculoaponeurotic fibrosarcoma oncogene homolog; DC: dendritic cell; DUSP5: Dual specificity protein phosphatase 5; DUSP6: Dual specificity protein phosphatase 6; ETS1:  v-ets erythroblastosis virus E26 oncogene homolog 1; FADD:  Fas-Associated protein with Death Domain; HSC: haematopoetic stem cell; HOX:  Homeobox protein; HOXA9:  Homeobox protein Hox-A9; FOXP1:  Forkhead box P1; IKK:  inhibitor of NF-kappaB kinase; IL12a: Interleukin-12 subunit alpha; IRAK-1:  Interleukin-1 receptor-associated kinase 1; IRAK-2:  Interleukin-1 receptor-associated kinase 2;  JAG1: jagged 1; JARID2:  Jumonji; Myb:  Myb oncogene-like; MEF2C: Myocyte-specific enhancer factor 2C; NFIA:  Nuclear factor 1 A-type; PDCD4:  Programmed cell death protein 4;  PTEN:  phosphatase and tensin homolog; PLK2:  pololike kinase 2; PTPN22: Tyrosine-protein phosphatase non-receptor type 22; PU.1:  spleen focus forming virus (SFFV) proviral integration oncogene spi1; Ripk1:  Receptor-interacting serine/threonine-protein kinase 1;  RUNX1: Runt-related transcription factor; SHP2:  SH2 domain containing protein thyrosine phosphatase; SOCS:  Suppressor of cytokine signaling; TAB2:  TAK1-associated binding protein 2 TRAF6:  TNF receptor associated factor-6; TLR:  Toll-like receptor; WNT1:  wingless-related MMTV integration site 1.'
p4128
as(S'FOXL1'
p4129
S'POU2F1'
p4130
S'increases'
p4131
tp4132
(lp4133
s(S'GRB2:SOS1'
p4134
S'PHOSPHORYLATED ERBB2:EGFR HETERODIMERS'
p4135
S'binds'
p4136
tp4137
(lp4138
s(S'TFAP4'
p4139
S'MYCN'
p4140
S'increases'
p4141
tp4142
(lp4143
s(S'E2F1'
p4144
S'GATA1'
p4145
S'increases'
p4146
tp4147
(lp4148
s(S'PTF1A'
p4149
S'GATA6'
p4150
S'increases'
p4151
tp4152
(lp4153
s(S'REL'
p4154
S'CYP26A1'
p4155
S'increases'
p4156
tp4157
(lp4158
s(S'MTF1'
p4159
S'JUN'
p4160
S'increases'
p4161
tp4162
(lp4163
s(S'ZEB1'
p4164
S'REPIN1'
p4165
S'increases'
p4166
tp4167
(lp4168
s(S'IRF8'
p4169
S'GATA6'
p4170
S'increases'
p4171
tp4172
(lp4173
s(S'P-Y349,350-SHC1:PHOSPHORYLATED ERBB2 HETERODIMERS'
p4174
S'GRB2:SOS1'
p4175
S'binds'
p4176
tp4177
(lp4178
s(S'BACH2'
p4179
S'EN1'
p4180
S'increases'
p4181
tp4182
(lp4183
s(S'GFI1'
p4184
S'MEIS1'
p4185
S'increases'
p4186
tp4187
(lp4188
s(S'FOXN1'
p4189
S'LEF1'
p4190
S'increases'
p4191
tp4192
(lp4193
s(S'CYP26A1'
p4194
S'JUN'
p4195
S'increases'
p4196
tp4197
(lp4198
s(S'TCF3'
p4199
S'ONECUT1'
p4200
S'increases'
p4201
tp4202
(lp4203
s(S'FOXF2'
p4204
S'POU2F1'
p4205
S'increases'
p4206
tp4207
(lp4208
s(S'MAZ'
p4209
S'MAX'
p4210
S'increases'
p4211
tp4212
(lp4213
s(S'FOXN1'
p4214
S'CYP26A1'
p4215
S'increases'
p4216
tp4217
(lp4218
s(S'HNF1A'
p4219
S'FOXD3'
p4220
S'increases'
p4221
tp4222
(lp4223
s(S'EGR2'
p4224
S'RUNX1'
p4225
S'increases'
p4226
tp4227
(lp4228
s(S'MYC'
p4229
S'RUNX2'
p4230
S'increases'
p4231
tp4232
(lp4233
s(S'TFAP2A'
p4234
S'IRF1'
p4235
S'increases'
p4236
tp4237
(lp4238
s(S'FOXO4'
p4239
S'YY1'
p4240
S'increases'
p4241
tp4242
(lp4243
s(S'VEGFR2 (dimer)/VEGFA (dimer)'
p4244
S'SRC'
p4245
S'adds_modification'
p4246
tp4247
(lp4248
s(S'resveratrol'
p4249
S'KRAS MRNA'
p4250
S'decreases'
p4251
tp4252
(lp4253
s(S'FOXO4'
p4254
S'CYP26A1'
p4255
S'increases'
p4256
tp4257
(lp4258
s(S'STAT3'
p4259
S'FOXO4'
p4260
S'increases'
p4261
tp4262
(lp4263
s(S'GRB2/SOS1'
p4264
S'FRS2 FAMILY/SHP2'
p4265
S'binds'
p4266
tp4267
(lp4268
s(S'LEF1'
p4269
S'CYP26A1'
p4270
S'increases'
p4271
tp4272
(lp4273
s(S'GTF2A2'
p4274
S'SRF'
p4275
S'increases'
p4276
tp4277
(lp4278
s(S'PPARA'
p4279
S'STAT5A'
p4280
S'increases'
p4281
tp4282
(lp4283
s(S'hsa-miR-143-3p'
p4284
S'KRAS'
p4285
S'decreases'
p4286
tp4287
(lp4288
s(S'GFI1'
p4289
S'CYP26A1'
p4290
S'increases'
p4291
tp4292
(lp4293
s(S'RAC1/GTP'
p4294
S'MKK4-MKK7'
p4295
S'increases_activity'
p4296
tp4297
(lp4298
s(S'REPIN1'
p4299
S'ETS1'
p4300
S'increases'
p4301
tp4302
(lp4303
s(S'ZIC1'
p4304
S'GATA6'
p4305
S'increases'
p4306
tp4307
(lp4308
s(S'INTERLEUKIN RECEPTOR COMPLEXES WITH ACTIVATED SHC1'
p4309
S'GRB2:SOS1'
p4310
S'binds'
p4311
tp4312
(lp4313
s(S'Selenium'
p4314
S'HRAS MRNA'
p4315
S'increases'
p4316
tp4317
(lp4318
s(S'HOXA4'
p4319
S'CYP26A1'
p4320
S'increases'
p4321
tp4322
(lp4323
s(S'NKX2-1'
p4324
S'POU2F1'
p4325
S'increases'
p4326
tp4327
(lp4328
s(S'VSX1'
p4329
S'MAX'
p4330
S'increases'
p4331
tp4332
(lp4333
s(S'FOXD1'
p4334
S'FOXD3'
p4335
S'increases'
p4336
tp4337
(lp4338
s(S'MAX'
p4339
S'NRAS'
p4340
S'increases'
p4341
tp4342
(lp4343
s(S'HOXA9'
p4344
S'TCF3'
p4345
S'increases'
p4346
tp4347
(lp4348
s(S'IRF1'
p4349
S'CYP26A1'
p4350
S'increases'
p4351
tp4352
(lp4353
s(S'HRAS'
p4354
S'RAF1'
p4355
S'adds_modification'
p4356
tp4357
(lp4358
S'AKT: v-akt murine thymoma viral oncogene homolog; BSA: Bovine serum albumin; CA: Constitutively active; CDC42: Cell division cycle 42; DN: Dominantly negative; ERK: Elk-related tyrosine kinase; GST: glutathione S-transferase; HRAS: v-Ha-ras Harvey rat sarcoma viral oncogene homolog; mAb: Monoclonal antibody; MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; PBS: Phosphate-buffered saline; PCR: Polymerase chain reaction; RAF1: v-raf-1 murine leukemia viral oncogene homolog 1; RNAi: Interfering RNA; RRAS: related RAS viral (r-ras) oncogene homolog; siRNA: Small interfering RNA.'
p4359
as(S'CUX1'
p4360
S'HOXA9'
p4361
S'increases'
p4362
tp4363
(lp4364
s(S'ZHX2'
p4365
S'FOXA1'
p4366
S'increases'
p4367
tp4368
(lp4369
s(S'TFDP1'
p4370
S'MYC'
p4371
S'increases'
p4372
tp4373
(lp4374
s(S'RAC1/GTP'
p4375
S'PAK1'
p4376
S'increases_activity'
p4377
tp4378
(lp4379
s(S'AHR'
p4380
S'MAZ'
p4381
S'increases'
p4382
tp4383
(lp4384
s(S'BRAF/14-3-3'
p4385
S'KSR/14-3-3 /MEK1-2'
p4386
S'increases_activity'
p4387
tp4388
(lp4389
s(S'PPARA'
p4390
S'CYP26A1'
p4391
S'increases'
p4392
tp4393
(lp4394
s(S'REPIN1'
p4395
S'SRF'
p4396
S'increases'
p4397
tp4398
(lp4399
s(S'PAX5'
p4400
S'SRF'
p4401
S'increases'
p4402
tp4403
(lp4404
s(S'PAX4'
p4405
S'FOXJ2'
p4406
S'increases'
p4407
tp4408
(lp4409
s(S'REPIN1'
p4410
S'MYCN'
p4411
S'increases'
p4412
tp4413
(lp4414
s(S'RALA/GTP'
p4415
S'SRC'
p4416
S'adds_modification'
p4417
tp4418
(lp4419
s(S'FOXO4'
p4420
S'ETS1'
p4421
S'increases'
p4422
tp4423
(lp4424
s(S'TFDP1'
p4425
S'CDC5L'
p4426
S'increases'
p4427
tp4428
(lp4429
s(S'TFDP1'
p4430
S'CYP26A1'
p4431
S'increases'
p4432
tp4433
(lp4434
s(S'GATA6'
p4435
S'RUNX2'
p4436
S'increases'
p4437
tp4438
(lp4439
s(S'FOXM1'
p4440
S'CYP26A1'
p4441
S'increases'
p4442
tp4443
(lp4444
s(S'sodium arsenite'
p4445
S'HRAS PROTEIN'
p4446
S'increases'
p4447
tp4448
(lp4449
s(S'STAT5A'
p4450
S'RUNX1'
p4451
S'increases'
p4452
tp4453
(lp4454
s(S'CEBPA'
p4455
S'EN1'
p4456
S'increases'
p4457
tp4458
(lp4459
s(S'MSX1'
p4460
S'POU2F1'
p4461
S'increases'
p4462
tp4463
(lp4464
s(S'NHLH1'
p4465
S'CBFA2T3'
p4466
S'increases'
p4467
tp4468
(lp4469
s(S'Parathion'
p4470
S'HRAS PROTEIN'
p4471
S'increases'
p4472
tp4473
(lp4474
s(S'SMAD4'
p4475
S'CYP26A1'
p4476
S'increases'
p4477
tp4478
(lp4479
s(S'E2F1'
p4480
S'MYC'
p4481
S'increases'
p4482
tp4483
(lp4484
S'An interesting target of hsa-miR-9* is E2F1, which is essential for the G1-S1 phase passage, which expression is known to be induced by c-MYC, and in turn controls c-MYC expression ['
p4485
as(S'CYP26A1'
p4486
S'FOXO3'
p4487
S'increases'
p4488
tp4489
(lp4490
s(S'TCF3'
p4491
S'CBFA2T3'
p4492
S'increases'
p4493
tp4494
(lp4495
s(S'ZHX2'
p4496
S'FOXF2'
p4497
S'increases'
p4498
tp4499
(lp4500
s(S'POU2F1'
p4501
S'MECOM'
p4502
S'increases'
p4503
tp4504
(lp4505
s(S'CYP26A1'
p4506
S'POU2F1'
p4507
S'increases'
p4508
tp4509
(lp4510
s(S'MYOD1'
p4511
S'CYP26A1'
p4512
S'increases'
p4513
tp4514
(lp4515
s(S'RAF'
p4516
S'COMPLEX (RAS/GTP)'
p4517
S'binds'
p4518
tp4519
(lp4520
s(S'RET51/GFRalpha1/GDNF/DOK1'
p4521
S'HRAS/GDP'
p4522
S'increases_activity'
p4523
tp4524
(lp4525
s(S'MAFG'
p4526
S'CYP26A1'
p4527
S'increases'
p4528
tp4529
(lp4530
s(S'CRX'
p4531
S'CYP26A1'
p4532
S'increases'
p4533
tp4534
(lp4535
s(S'hsa-miR-126-3p'
p4536
S'KRAS'
p4537
S'decreases'
p4538
tp4539
(lp4540
s(S'EBF2'
p4541
S'CYP26A1'
p4542
S'increases'
p4543
tp4544
(lp4545
s(S'RUNX1'
p4546
S'CYP26A1'
p4547
S'increases'
p4548
tp4549
(lp4550
s(S'HOXA5'
p4551
S'FOXA1'
p4552
S'increases'
p4553
tp4554
(lp4555
s(S'benzo(a)pyrene-3,6-quinone'
p4556
S'HRAS MRNA'
p4557
S'increases'
p4558
tp4559
(lp4560
s(S'K 7174'
p4561
S'HRAS MRNA'
p4562
S'decreases'
p4563
tp4564
(lp4565
s(S'LEF1'
p4566
S'NRAS'
p4567
S'increases'
p4568
tp4569
(lp4570
s(S'SPI1'
p4571
S'FOXA1'
p4572
S'increases'
p4573
tp4574
(lp4575
s(S'hsa-let-7b-5p'
p4576
S'NRAS'
p4577
S'decreases'
p4578
tp4579
(lp4580
s(S'CEBPA'
p4581
S'JUN'
p4582
S'increases'
p4583
tp4584
(lp4585
s(S'GABPB2'
p4586
S'CYP26A1'
p4587
S'increases'
p4588
tp4589
(lp4590
s(S'PI-3-4-5-P3'
p4591
S'MTOR'
p4592
S'increases_activity'
p4593
tp4594
(lp4595
s(S'GRB2:SOS1'
p4596
S'EGF:P-6Y-EGFR'
p4597
S'binds'
p4598
tp4599
(lp4600
s(S'HNF1A'
p4601
S'CYP26A1'
p4602
S'increases'
p4603
tp4604
(lp4605
s(S'HIF1A'
p4606
S'FOXO4'
p4607
S'increases'
p4608
tp4609
(lp4610
s(S'FOXJ1'
p4611
S'HOXA9'
p4612
S'increases'
p4613
tp4614
(lp4615
s(S'hsa-miR-96-5p'
p4616
S'KRAS'
p4617
S'decreases'
p4618
tp4619
(lp4620
s(S'SRC'
p4621
S'SYNDECAN-2/RASGAP'
p4622
S'binds'
p4623
tp4624
(lp4625
s(S'FOXA1'
p4626
S'MEIS1'
p4627
S'increases'
p4628
tp4629
(lp4630
s(S'LEF1'
p4631
S'MEIS1'
p4632
S'increases'
p4633
tp4634
(lp4635
s(S'PAX3'
p4636
S'CYP26A1'
p4637
S'increases'
p4638
tp4639
(lp4640
s(S'PAX4'
p4641
S'HOXA9'
p4642
S'increases'
p4643
tp4644
(lp4645
s(S'hsa-miR-18a-3p'
p4646
S'KRAS'
p4647
S'decreases'
p4648
tp4649
(lp4650
s(S'FOXF2'
p4651
S'EN1'
p4652
S'increases'
p4653
tp4654
(lp4655
s(S'Pyk2'
p4656
S'SRC FAMILY KINASES'
p4657
S'increases_activity'
p4658
tp4659
(lp4660
s(S'TP53'
p4661
S'HOXA9'
p4662
S'increases'
p4663
tp4664
(lp4665
s(S'Genistein'
p4666
S'KRAS MRNA'
p4667
S'decreases'
p4668
tp4669
(lp4670
s(S'POU1F1'
p4671
S'CYP26A1'
p4672
S'increases'
p4673
tp4674
(lp4675
s(S'manumycin'
p4676
S'KRAS PROTEIN'
p4677
S'decreases_activity'
p4678
tp4679
(lp4680
s(S'Ginkgo biloba extract 761'
p4681
S'GCLC PROTEIN'
p4682
S'increases'
p4683
tp4684
(lp4685
s(S'GATA1'
p4686
S'NRAS'
p4687
S'increases'
p4688
tp4689
(lp4690
s(S'CBFA2T3'
p4691
S'FOXF2'
p4692
S'increases'
p4693
tp4694
(lp4695
s(S'PCBP1'
p4696
S'ELK1'
p4697
S'increases'
p4698
tp4699
(lp4700
s(S'MYC'
p4701
S'FOXF2'
p4702
S'increases'
p4703
tp4704
(lp4705
s(S'hsa-mir-622'
p4706
S'KRAS'
p4707
S'decreases'
p4708
tp4709
(lp4710
s(S'TCF3'
p4711
S'MAZ'
p4712
S'increases'
p4713
tp4714
(lp4715
s(S'STAT2'
p4716
S'MEIS1'
p4717
S'increases'
p4718
tp4719
(lp4720
s(S'CYP26A1'
p4721
S'YY1'
p4722
S'increases'
p4723
tp4724
(lp4725
s(S'CYP26A1'
p4726
S'EN1'
p4727
S'increases'
p4728
tp4729
(lp4730
s(S'GRB2/SOS1'
p4731
S'SHC'
p4732
S'binds'
p4733
tp4734
(lp4735
s(S'BAD'
p4736
S'YWHAZ'
p4737
S'binds'
p4738
tp4739
(lp4740
s(S'SPI1'
p4741
S'MAX'
p4742
S'increases'
p4743
tp4744
(lp4745
s(S'PI-3-4-5-P3'
p4746
S'CENTA1'
p4747
S'translocates'
p4748
tp4749
(lp4750
s(S'XBP1'
p4751
S'CYP26A1'
p4752
S'increases'
p4753
tp4754
(lp4755
s(S'PAX4'
p4756
S'NRAS'
p4757
S'increases'
p4758
tp4759
(lp4760
s(S'PI3K'
p4761
S'EPHRIN A1/EPHA2'
p4762
S'binds'
p4763
tp4764
(lp4765
s(S'POU1F1'
p4766
S'MEIS1'
p4767
S'increases'
p4768
tp4769
(lp4770
s(S'NR3C1'
p4771
S'ETS1'
p4772
S'increases'
p4773
tp4774
(lp4775
s(S'MAZ'
p4776
S'POU3F2'
p4777
S'increases'
p4778
tp4779
(lp4780
s(S'Estradiol'
p4781
S'HRAS MRNA'
p4782
S'increases'
p4783
tp4784
(lp4785
s(S'Aflatoxin B1'
p4786
S'HRAS PROTEIN'
p4787
S'increases'
p4788
tp4789
(lp4790
s(S'ETV7'
p4791
S'STAT4'
p4792
S'increases'
p4793
tp4794
(lp4795
s(S'PBX1'
p4796
S'LEF1'
p4797
S'increases'
p4798
tp4799
(lp4800
s(S'CEBPB'
p4801
S'CYP26A1'
p4802
S'increases'
p4803
tp4804
(lp4805
s(S'MAZ'
p4806
S'JUN'
p4807
S'increases'
p4808
tp4809
(lp4810
s(S'FOXF2'
p4811
S'MYC'
p4812
S'increases'
p4813
tp4814
(lp4815
s(S'FOXJ2'
p4816
S'HOXA9'
p4817
S'increases'
p4818
tp4819
(lp4820
s(S'Capsaicin'
p4821
S'HRAS MRNA'
p4822
S'increases'
p4823
tp4824
(lp4825
s(S'POU3F1'
p4826
S'GATA6'
p4827
S'increases'
p4828
tp4829
(lp4830
s(S'EIF2A'
p4831
S'14-3-3 E'
p4832
S'binds'
p4833
tp4834
(lp4835
s(S'RAS family/GTP'
p4836
S'RAF1-BRAF'
p4837
S'increases_activity'
p4838
tp4839
(lp4840
s(S'GATA6'
p4841
S'GATA1'
p4842
S'increases'
p4843
tp4844
(lp4845
s(S'RASA1'
p4846
S'PHOSPHO PDGF BETA RECEPTOR: PDGF CHAIN B HOMODIMER'
p4847
S'binds'
p4848
tp4849
(lp4850
s(S'CART1'
p4851
S'POU2F1'
p4852
S'increases'
p4853
tp4854
(lp4855
s(S'ZIC3'
p4856
S'POU2F1'
p4857
S'increases'
p4858
tp4859
(lp4860
s(S'TCF4'
p4861
S'FOXA1'
p4862
S'increases'
p4863
tp4864
(lp4865
s(S'PKC theta'
p4866
S'RASGRP1'
p4867
S'adds_modification'
p4868
tp4869
(lp4870
s(S'PTF1A'
p4871
S'STAT5A'
p4872
S'increases'
p4873
tp4874
(lp4875
s(S'SPI1'
p4876
S'FOXO4'
p4877
S'increases'
p4878
tp4879
(lp4880
s(S'HNF1A'
p4881
S'GATA6'
p4882
S'increases'
p4883
tp4884
(lp4885
s(S'FOXJ1'
p4886
S'RUNX1'
p4887
S'increases'
p4888
tp4889
(lp4890
s(S'STAT2'
p4891
S'GATA6'
p4892
S'increases'
p4893
tp4894
(lp4895
s(S'RAS FAMILY/GTP'
p4896
S'PI3K'
p4897
S'binds'
p4898
tp4899
(lp4900
s(S'PAX4'
p4901
S'IRF1'
p4902
S'increases'
p4903
tp4904
(lp4905
s(S'PAX3'
p4906
S'HOXA9'
p4907
S'increases'
p4908
tp4909
(lp4910
s(S'MYB'
p4911
S'MAZ'
p4912
S'increases'
p4913
tp4914
(lp4915
s(S"Guanosine-5'-Triphosphate"
p4916
S'HRAS'
p4917
S'increases_activity'
p4918
tp4919
(lp4920
s(S'alpha9/beta1 Integrin/Tenascin C'
p4921
S'SRC'
p4922
S'adds_modification'
p4923
tp4924
(lp4925
s(S'RAF1'
p4926
S'MEK1'
p4927
S'adds_modification'
p4928
tp4929
(lp4930
s(S'JUN'
p4931
S'FOXA1'
p4932
S'increases'
p4933
tp4934
(lp4935
s(S'NFE2L2'
p4936
S'BACH1'
p4937
S'increases'
p4938
tp4939
(lp4940
s(S'CUX1'
p4941
S'FOXD3'
p4942
S'increases'
p4943
tp4944
(lp4945
s(S'JUN'
p4946
S'EN1'
p4947
S'increases'
p4948
tp4949
(lp4950
s(S'ESR1'
p4951
S'CYP26A1'
p4952
S'increases'
p4953
tp4954
(lp4955
s(S'ESRRA'
p4956
S'FOXA1'
p4957
S'increases'
p4958
tp4959
(lp4960
s(S'POU2F1'
p4961
S'MEIS1'
p4962
S'increases'
p4963
tp4964
(lp4965
s(S'TFCP2'
p4966
S'FOXA1'
p4967
S'increases'
p4968
tp4969
(lp4970
s(S'PI-3-4-5-P3'
p4971
S'PDK1'
p4972
S'increases_activity'
p4973
tp4974
(lp4975
s(S'TCF3'
p4976
S'FOXA1'
p4977
S'increases'
p4978
tp4979
(lp4980
s(S'STAT3'
p4981
S'CYP26A1'
p4982
S'increases'
p4983
tp4984
(lp4985
s(S'CYP26A1'
p4986
S'POU3F2'
p4987
S'increases'
p4988
tp4989
(lp4990
s(S'Curcumin'
p4991
S'KRAS MRNA'
p4992
S'decreases'
p4993
tp4994
(lp4995
s(S'STAT1'
p4996
S'CYP26A1'
p4997
S'increases'
p4998
tp4999
(lp5000
s(S'GFI1'
p5001
S'POU2F1'
p5002
S'increases'
p5003
tp5004
(lp5005
s(S'ZIC1'
p5006
S'POU2F1'
p5007
S'increases'
p5008
tp5009
(lp5010
s(S'PI-3-4-5-P3'
p5011
S'AKT3'
p5012
S'adds_modification'
p5013
tp5014
(lp5015
s(S'BACH1'
p5016
S'NRAS'
p5017
S'increases'
p5018
tp5019
(lp5020
s(S'SCF/KIT'
p5021
S'SHC/GRB2/SOS1'
p5022
S'increases_activity'
p5023
tp5024
(lp5025
s(S'CDX2'
p5026
S'CYP26A1'
p5027
S'increases'
p5028
tp5029
(lp5030
s(S'RET51/GFRalpha1/GDNF/DOK/RasGAP/NCK'
p5031
S'HRAS/GDP'
p5032
S'decreases_activity'
p5033
tp5034
(lp5035
s(S'BETAPIX'
p5036
S'RAC1/GTP'
p5037
S'binds'
p5038
tp5039
(lp5040
s(S'RHOA/GTP'
p5041
S'CITRON'
p5042
S'increases_activity'
p5043
tp5044
(lp5045
s(S'P-SHC1:GRB2:SOS'
p5046
S'P-5Y-LAT-2'
p5047
S'binds'
p5048
tp5049
(lp5050
s(S'PAX4'
p5051
S'CYP26A1'
p5052
S'increases'
p5053
tp5054
(lp5055
s(S'TCF3'
p5056
S'KRAS'
p5057
S'increases'
p5058
tp5059
(lp5060
s(S'GRB2:SOS1'
p5061
S'PHOSPHORYLATED ERBB2:ERBB4 HETERODIMERS'
p5062
S'binds'
p5063
tp5064
(lp5065
s(S'CDX2'
p5066
S'MEIS1'
p5067
S'increases'
p5068
tp5069
(lp5070
s(S'SP3'
p5071
S'RUNX1'
p5072
S'increases'
p5073
tp5074
(lp5075
s(S'REST'
p5076
S'CYP26A1'
p5077
S'increases'
p5078
tp5079
(lp5080
s(S'PTF1A'
p5081
S'CYP26A1'
p5082
S'increases'
p5083
tp5084
(lp5085
s(S'PI-3-4-5-P3'
p5086
S'PI3K/GAB1'
p5087
S'translocates'
p5088
tp5089
(lp5090
s(S'LMO2'
p5091
S'FOXO4'
p5092
S'increases'
p5093
tp5094
(lp5095
s(S'STAT4'
p5096
S'ETS1'
p5097
S'increases'
p5098
tp5099
(lp5100
s(S'GTF2A2'
p5101
S'HOXA9'
p5102
S'increases'
p5103
tp5104
(lp5105
s(S'FOXF2'
p5106
S'POU3F2'
p5107
S'increases'
p5108
tp5109
(lp5110
s(S'GATA1'
p5111
S'GABPB2'
p5112
S'increases'
p5113
tp5114
(lp5115
s(S'Polychlorinated Biphenyls'
p5116
S'KRAS MRNA'
p5117
S'decreases'
p5118
tp5119
(lp5120
s(S'GRB2/SOS1'
p5121
S'EGF/EGFR DIMER/SHC'
p5122
S'binds'
p5123
tp5124
(lp5125
s(S'CYP26A1'
p5126
S'FOXF2'
p5127
S'increases'
p5128
tp5129
(lp5130
s(S'EGR1'
p5131
S'CYP26A1'
p5132
S'increases'
p5133
tp5134
(lp5135
s(S'MAX'
p5136
S'FOXO3'
p5137
S'increases'
p5138
tp5139
(lp5140
s(S'T-DHT/AR/PELP1'
p5141
S'SRC'
p5142
S'binds'
p5143
tp5144
(lp5145
s(S'CUX1'
p5146
S'FOXF2'
p5147
S'increases'
p5148
tp5149
(lp5150
s(S'CEBPD'
p5151
S'CYP26A1'
p5152
S'increases'
p5153
tp5154
(lp5155
s(S'CBFA2T3'
p5156
S'NRAS'
p5157
S'increases'
p5158
tp5159
(lp5160
s(S'Cisplatin'
p5161
S'HRAS MRNA'
p5162
S'translocates'
p5163
tp5164
(lp5165
s(S'BAD/BCL-X(L)'
p5166
S'YWHAZ'
p5167
S'binds'
p5168
tp5169
(lp5170
s(S'GATA1'
p5171
S'FOXA1'
p5172
S'increases'
p5173
tp5174
(lp5175
s(S'RREB1'
p5176
S'CYP26A1'
p5177
S'increases'
p5178
tp5179
(lp5180
s(S'STAT4'
p5181
S'RUNX2'
p5182
S'increases'
p5183
tp5184
(lp5185
s(S'FOXD3'
p5186
S'NRAS'
p5187
S'increases'
p5188
tp5189
(lp5190
s(S'NDEL1'
p5191
S'14-3-3 E'
p5192
S'binds'
p5193
tp5194
(lp5195
s(S'CYP26A1'
p5196
S'REPIN1'
p5197
S'increases'
p5198
tp5199
(lp5200
s(S'MAF'
p5201
S'CDC5L'
p5202
S'increases'
p5203
tp5204
(lp5205
s(S'CYP26A1'
p5206
S'ELK1'
p5207
S'increases'
p5208
tp5209
(lp5210
s(S'MYC'
p5211
S'FOXD3'
p5212
S'increases'
p5213
tp5214
(lp5215
s(S'MAX'
p5216
S'FOXD3'
p5217
S'increases'
p5218
tp5219
(lp5220
s(S'POU1F1'
p5221
S'GATA6'
p5222
S'increases'
p5223
tp5224
(lp5225
s(S'POU2F1'
p5226
S'STAT4'
p5227
S'increases'
p5228
tp5229
(lp5230
s(S'GTF3A'
p5231
S'FOXO3'
p5232
S'increases'
p5233
tp5234
(lp5235
s(S'MYB'
p5236
S'FOXF2'
p5237
S'increases'
p5238
tp5239
(lp5240
s(S'ZIC3'
p5241
S'CYP26A1'
p5242
S'increases'
p5243
tp5244
(lp5245
s(S'POU2F1'
p5246
S'EN1'
p5247
S'increases'
p5248
tp5249
(lp5250
s(S'JUN'
p5251
S'STAT1'
p5252
S'increases'
p5253
tp5254
(lp5255
s(S'TEF'
p5256
S'CYP26A1'
p5257
S'increases'
p5258
tp5259
(lp5260
s(S'MAF'
p5261
S'CYP26A1'
p5262
S'increases'
p5263
tp5264
(lp5265
s(S'PAX4'
p5266
S'GATA6'
p5267
S'increases'
p5268
tp5269
(lp5270
s(S'ZIC2'
p5271
S'GATA6'
p5272
S'increases'
p5273
tp5274
(lp5275
s(S'hsa-miR-181d-5p'
p5276
S'HRAS'
p5277
S'decreases'
p5278
tp5279
(lp5280
s(S'BACH2'
p5281
S'CYP26A1'
p5282
S'increases'
p5283
tp5284
(lp5285
s(S'TCF12'
p5286
S'CYP26A1'
p5287
S'increases'
p5288
tp5289
(lp5290
s(S'GATA1'
p5291
S'FOXO4'
p5292
S'increases'
p5293
tp5294
(lp5295
s(S'RFX1'
p5296
S'FOXD3'
p5297
S'increases'
p5298
tp5299
(lp5300
s(S'FOXJ1'
p5301
S'CYP26A1'
p5302
S'increases'
p5303
tp5304
(lp5305
s(S'GTF2A2'
p5306
S'POU2F1'
p5307
S'increases'
p5308
tp5309
(lp5310
s(S'YY1'
p5311
S'SRF'
p5312
S'increases'
p5313
tp5314
(lp5315
s(S'AHR'
p5316
S'REPIN1'
p5317
S'increases'
p5318
tp5319
(lp5320
s(S'MAZ'
p5321
S'CYP26A1'
p5322
S'increases'
p5323
tp5324
(lp5325
s(S'Quercetin'
p5326
S'HRAS MRNA'
p5327
S'increases'
p5328
tp5329
(lp5330
s(S'ELK1'
p5331
S'NRAS'
p5332
S'increases'
p5333
tp5334
(lp5335
s(S'HIF1A'
p5336
S'ONECUT1'
p5337
S'increases'
p5338
tp5339
(lp5340
s(S'FOXF2'
p5341
S'CYP26A1'
p5342
S'increases'
p5343
tp5344
(lp5345
s(S'SOX9'
p5346
S'ETS1'
p5347
S'increases'
p5348
tp5349
(lp5350
s(S'HSF1'
p5351
S'JUN'
p5352
S'increases'
p5353
tp5354
(lp5355
s(S'CEBPA'
p5356
S'CYP26A1'
p5357
S'increases'
p5358
tp5359
(lp5360
s(S'NR1H4'
p5361
S'MEIS1'
p5362
S'increases'
p5363
tp5364
(lp5365
s(S'SMAD1'
p5366
S'GATA1'
p5367
S'increases'
p5368
tp5369
(lp5370
s(S'Quercetin'
p5371
S'HRAS MRNA'
p5372
S'decreases'
p5373
tp5374
(lp5375
s(S'Glycyrrhetinic Acid'
p5376
S'HRAS PROTEIN'
p5377
S'decreases'
p5378
tp5379
(lp5380
s(S'HOXA4'
p5381
S'POU2F1'
p5382
S'increases'
p5383
tp5384
(lp5385
s(S'FOXQ1'
p5386
S'CYP26A1'
p5387
S'increases'
p5388
tp5389
(lp5390
s(S'FOXI1'
p5391
S'CEBPA'
p5392
S'increases'
p5393
tp5394
(lp5395
s(S'GTF3A'
p5396
S'MYCN'
p5397
S'increases'
p5398
tp5399
(lp5400
s(S'LMO2'
p5401
S'IRF1'
p5402
S'increases'
p5403
tp5404
(lp5405
s(S'FOXO1'
p5406
S'CYP26A1'
p5407
S'increases'
p5408
tp5409
(lp5410
s(S'Copper Sulfate'
p5411
S'NRAS MRNA'
p5412
S'increases'
p5413
tp5414
(lp5415
s(S'TFAP2A'
p5416
S'CYP26A1'
p5417
S'increases'
p5418
tp5419
(lp5420
s(S'FOXJ1'
p5421
S'EN1'
p5422
S'increases'
p5423
tp5424
(lp5425
s(S'MEIS1'
p5426
S'RUNX1'
p5427
S'increases'
p5428
tp5429
(lp5430
s(S'MAZ'
p5431
S'FOXA1'
p5432
S'increases'
p5433
tp5434
(lp5435
s(S'ETS1'
p5436
S'FOXO4'
p5437
S'increases'
p5438
tp5439
(lp5440
s(S'ZBTB14'
p5441
S'FOXD3'
p5442
S'increases'
p5443
tp5444
(lp5445
s(S'FOXC1'
p5446
S'LEF1'
p5447
S'increases'
p5448
tp5449
(lp5450
s(S'IRF1'
p5451
S'EN1'
p5452
S'increases'
p5453
tp5454
(lp5455
s(S'NR3C1'
p5456
S'CYP26A1'
p5457
S'increases'
p5458
tp5459
(lp5460
s(S'VSX1'
p5461
S'BACH1'
p5462
S'increases'
p5463
tp5464
(lp5465
s(S'CYP26A1'
p5466
S'ETS1'
p5467
S'increases'
p5468
tp5469
(lp5470
s(S'CEBPA'
p5471
S'MEIS1'
p5472
S'increases'
p5473
tp5474
(lp5475
s(S'ELF1'
p5476
S'FOXO4'
p5477
S'increases'
p5478
tp5479
(lp5480
s(S'RXRA'
p5481
S'CYP26A1'
p5482
S'increases'
p5483
tp5484
(lp5485
s(S'CREB1'
p5486
S'CYP26A1'
p5487
S'increases'
p5488
tp5489
(lp5490
s(S'IRF7'
p5491
S'GATA6'
p5492
S'increases'
p5493
tp5494
(lp5495
s(S'ZEB1'
p5496
S'CYP26A1'
p5497
S'increases'
p5498
tp5499
(lp5500
s(S'AR'
p5501
S'CYP26A1'
p5502
S'increases'
p5503
tp5504
(lp5505
s(S'TFDP2'
p5506
S'MYC'
p5507
S'increases'
p5508
tp5509
(lp5510
s(S'hsa-mir-217'
p5511
S'KRAS'
p5512
S'decreases'
p5513
tp5514
(lp5515
s(S'MEK'
p5516
S'ERK'
p5517
S'adds_modification'
p5518
tp5519
(lp5520
S'The inhibitor of MEK [MAPK (mitogen-activated protein kinase)/ERK (extracellular-signal-regulated kinase) kinase] U0126 was obtained from Calbiochem.'
p5521
aS'Role of Ras and MEK in carbachol-stimulated ERK1/2 activation. '
p5522
ag651
aS'Moreover, the phosphorylation of ERK induced by sevoflurane was significantly decreased by the treatment of PKC inhibitor (staurosporine) and MEK inhibitor (PD98059).'
p5523
ag652
ag653
ag654
ag655
ag656
ag657
ag658
aS'The PKC inhibitor, staurosporine and MEK inhibitor, PD98059, significantly decreased sevoflurane-induced ERK phosphorylation.'
p5524
ag659
aS'The increases in BrdU uptake and pERK-1/2 expression promoted by ALI was abolished by the MEK inhibitor, PD-98059.'
p5525
ag660
ag661
aS'PD-98059, a MEK inhibitor that leads to the inactivation of ERK-1/2 (MAPK) ['
p5526
ag662
aS'As described in this study, ALI-promoted growth of melanoma cells is clearly inhibited by PD-98059, the MEK inhibitor that leads to the inactivation of ERK-1/2 (MAPK) ['
p5527
ag663
aS'Effects of the MEK inhibitor PD-98059 on the morphology, BrdU uptake and MAPK (ERK-1/2) expression of melanoma cells with ALI.'
p5528
aS'Inhibition of ERK1/2 activation 2 hr after AA injection by subcutaneous (sc) injection of the mitogen-activating extracellular kinase (MEK) inhibitor, SL327, had no effect on the nocifensive responses, but did attenuate anxiety-like behavior, as determined by elevated plus-maze and open-field testing results.'
p5529
ag664
ag665
aS'Inhibition of ERK expression and enhanced growth inhibition by MEK inhibitor PD98059.'
p5530
aS'To further investigate the mechanism involved in FLZ-mediated neuroprotection, the activation/phosphorylation of the PI3K/Akt and MAPK (MEK/ERK) pathways were studied.'
p5531
aS'Of tested proteins, the levels of phospho-ERK1/2 and phospho-MEK1/2 were increased in a time-dependent manner, while phospho-AKT1 appeared at 1 h and was maintained at similar levels for up to 6 h. Additionally, the levels of phospho-GSK3 decreased in a time-dependent manner ('
p5532
aS'To determine whether the PKC and ERK1/2 MAPK signaling pathways are involved in the high glucose-induced proliferation and migration of VSMCs, we examined the effect of a PKC inhibitor and a MEK1/2 inhibitor on the proliferation and migration of VSMCs cultured in high glucose medium.'
p5533
aS'These results indicate that luteolin has beneficial effects against LPS-induced ALI in mice, and the attenuation of neutrophil chemotaxis and respiratory burst by luteolin involves the blockade of MEK-, ERK-, and Akt-related signaling cascades.'
p5534
aS'Mouse polyclonal antibodies against Akt, p38 MAPK, ERK, and MEK were obtained from Santa Cruz Biotechnology.'
p5535
aS'Rabbit polyclonal antibodies against phospho-MEK, ERK, p38 MAPK, and Akt were purchased from Cell Signaling Technology.'
p5536
aS'Effect of luteolin on MEK, ERK, and Akt activation in LPS-stimulated neutrophils.'
p5537
aS'E-cadherin may function as a tumor proliferation enhancer via activating the MEK/ERK pathway in development of ovarian epithelial cancers.'
p5538
aS'Meanwhile, our results convincingly indicate that in SKOV-3 cells the activation of MEK/ERK triggered by cell-cell adhesion is E-cadherin-dependent, evidenced by the fact that both siRNA targeting E-cadherin and its specific neutralizing antibody are able to markedly prevent the phosphorylation of MEK or ERK.'
p5539
aS'Previously E-cadherin has been reported to activate MEK/ERK in squamous cell carcinoma via physically interacting with and activating EGFR'
p5540
aS'MEK, mitogen-activated protein kinase kinase; ERK, extracellular signal-related kinase; EGFR, epidermal growth factor receptor; PKA, cAMP-dependent protein kinase A; PI3K, phosphoinositide-3 kinase; OSE, ovarian surface epithelium.'
p5541
aS'Cell-adhesion-mediated MEK/ERK activation is E-cadherin dependent in SKOV-3 cells.'
p5542
aS'(B) E-cadherin is required for cell-cell adhesion mediated MEK-ERK activation.'
p5543
aS'(C, D) After E-cadherin expression was inhibited by siRNA, MEK/ERK failed to be activated after calcium restoration in SKOV-3 cells, for neither ERK (C) nor MEK (D, lane 4) was observed to be phosphorylated.'
p5544
aS'However, the MEK/ERK inhibitor PD98509 had no effect on ADM induction of OPN mRNA expression.'
p5545
ag668
aS'Besides the JNK pathway, the MKK3/6-p38 and MEK1/2-ERK pathways are also associated with several key proteins within the insulin receptor signaling pathway ('
p5546
aS'The MAPK signaling pathways MKK4/7-SAPK/JNK, MKK3/6-p38, and MEK1/2-ERK have been reported to play key roles in insulin resistance induced by excessive ER stress'
p5547
aS'U0126 is a specific membrane-permeable inhibitor of MAPK kinase (MAPKK, also known as MEK), which phosphorylates and activates ERK1/2'
p5548
aS'Effects of MEK inhibitor U0126 on striatal LTD induction and on ERK phosphorylation.'
p5549
aS'MEK inhibitor U0126 enhanced the effects of CEI10 on both phospho-ERK levels and striatal LTD induction.'
p5550
aS'Effects of one-day withdrawal (WD1) and MEK inhibitor U0126 on both phospho-ERK levels and striatal LTD induction.'
p5551
aS'It has been reported that many anti-pigmentation agents regulate tyrosinase and/or MITF expression through regulation of the MEK/ERK or the PI3K/Akt pathway'
p5552
aS'Therefore, we pretreated B16 cells with DMSO or PD98059, a selective inhibitor of MEK (the upstream activator of ERK), for 1 h and then treated the cells with [6]-shogaol.'
p5553
aS'To elucidate the roles of receptor tyrosine kinases RET and VEGFR2 and the RAF/MEK/ERK signaling cascade in cancer treatment with sorafenib.'
p5554
aS'The MEK/ERK pathway is also called the RAF/MEK/ERK serine/threonine kinase cascade, as its upstream molecules belong to the RAF kinase family of serine/threonine kinases'
p5555
aS'Specifically, one serine/threonine kinase, cRAF, and two tyrosine kinases, VEGFR2 and RET, and their potential downstream MEK/ERK pathway targets were examined.'
p5556
aS'To investigate the effect of sorafenib on the post-transcriptional events in cells, the expression and phosphorylation level of the following four proteins were detected by Western blot assays: VEGFR2, RET, MEK, and ERK.'
p5557
aS'At the transcriptional level, we found that sorafenib could briefly activate RET expression and inhibit VEGFR2 expression independent of the RAF/MEK/ERK pathway in A549 cells; at the post-transcriptional level, sorafenib directly inhibited the phosphorylation of RET and VEGFR2 and blocked the downstream factors of the MEK/ERK pathway.'
p5558
aS'The two kinases RET and VEGFR2 could be the targets of sorafenib treatment, but they may not be the upstream messengers of the MEK/ERK kinases pathway.'
p5559
aS'The downstream signaling molecules of the MEK/ERK kinase pathway are also potential candidates for the sorafenib treatment of lung cancer.'
p5560
aS'According to the results for HeLa cells, we found that sorafenib could inhibit VEGFR2 expression but had no effect on the RAF/MEK/ERK pathway at the transcriptional level.'
p5561
aS'At the post-transcriptional level, sorafenib directly inhibited RET and VEGFR2 phosphorylation and blocked the downstream factors of the MEK/ERK pathway.'
p5562
aS'RET, VEGFR2 and the downstream signaling molecules of the MEK/ERK kinase pathway are also important potential targets for sorafenib in the treatment of cervical cancer.'
p5563
aS'In contrast to the results in the above cell lines, sorafenib inhibited RET expression and activated VEGFR2 expression in the HepG2 cells, with little effect on the RAF/MEK/ERK pathway at the transcriptional level.'
p5564
aS'Moreover, sorafenib targeted the downstream molecules of RET and VEGFR2 and blocked the MEK/ERK pathway by inhibiting ERK phosphorylation at the post-transcriptional level.'
p5565
aS'In addition, based on the present results, the MEK/ERK kinase signaling cascade is clearly an important effective target pathway for cancer treatment.'
p5566
aS'The receptor tyrosine kinases RET and VEGFR2 and the MEK/ERK kinase signaling cascade are important targets for cancer treatment with sorafenib, even though these factors participate in different pharmacological mechanisms in different cell lines.'
p5567
aS'Therefore, the present study was consistent with previous results and provided more evidence for kinases as the targets in cancer therapy and partially revealed the pharmacological mechanism, including molecules downstream of the MEK/ERK kinase pathway and the pathways initiated by RET or VEGFR2, of sorafenib in cancer treatment.'
p5568
aS'In future studies, we will perform kinase spectrum screening to identify additional protein kinases involved in the mechanisms of cancer treatment, such as the downstream molecules of the MEK/ERK kinase pathway and the pathways in which RET and VEGFR2 are involved.'
p5569
aS'Sorafenib affected the phosphorylation of receptor tyrosine kinase RET and VEGFR2, as well as MEK/ERK kinases signaling cascades in three cell lines.'
p5570
aS'(A) Sorafenib inhibited RET and VEGFR2 phosphorylation dose-dependently while activated MEK and ERK phosphorylation in A549 cells.'
p5571
aS'(B) Sorafenib also inhibited RET and VEGFR2 phosphorylation, and slightly activated MEK and ERK phosphorylation in HeLa cells.'
p5572
aS'(C) Sorafenib activated the phosphorylation of RET, VEGFR2, and MEK, but inhibited ERK phosphorylation in HepG2 cells.'
p5573
aS'Given several studies revealed that the effects of LTB4 were mediated through MEK/ERK pathway'
p5574
aS'The RAF/MEK/ERK pathway also directly activates mTORC1 through excitatory phosphorylation of raptor, a component of the mTORC1 complex, by RSK.'
p5575
ag669
aS'[CDK: cyclin-dependant kinase; CLL: chronic lymphocytic leukemia; CR: complete response; DLBCL: diffuse large B-cell lymphoma; ERK: extracellular signal regulated kinase; FFP: freedom from progression; FL: follicular lymphoma; HL: Hodgkin lymphoma; JAK: Janus kinase; MCL: mantle cell lymphoma; mPFS: median progression-free survival; NHL: non-Hodgkin lymphoma; MEK: mitogen-activated protein kinase kinase; MM: multiple myeloma; mTOR: mammalian target of rapamycin; ORR: overall response rate; OS: overall survival; PDGF: platelet-derived growth factor; PDGFR: platelet-derived growth factor receptor; PFS: progression-free survival; PR: partial response; R/R: relapsed or refractory; RTK: receptor tyrosine kinase; SD: stable disease; SLL: small lymphocytic lymphoma; TKI: tyrosine kinase inhibitor; VEGFR: vascular endothelial growth factor receptor.]'
p5576
ag670
ag671
ag672
ag673
ag674
ag675
aS'Thus suppression of MEK and ERK activities will have profound effects on cell growth and aging.'
p5577
ag676
ag677
ag678
ag679
ag680
ag681
ag682
ag683
ag684
ag685
ag686
ag687
ag688
ag689
ag690
ag691
ag692
ag693
ag694
ag695
ag696
ag698
ag699
ag700
ag701
ag702
aS'Furthermore, we tested whether activation of stress response MEK1/ERK1/2 pathway contribute to the pathogenesis of apoptosis induced by electrical stimulation in LMNA-related DCM.'
p5578
aS'Notably, ERK1/2, the downstream kinase of MEK1, is a member of the mitogen-activated protein kinases super family mediating cell proliferation and apoptosis depending on the stimuli and cell types.'
p5579
aS'After a vitamin D response element (VDRE) was discovered in the cathelicidin gene it was shown conclusively that vitamin D enhances the expression of the AMP cathelicidin in keratinocytes with epigenetic changes and activation of the Act1 and MEK-ERK pathway as co-regulators.'
p5580
ag703
aS'RAS: protein encoded by genes; TKR: tyrosine\nkinase receptor; MEK: mitogen-activated by protein kinase; ERK: protein kinase\nregulated by extracellular signals'
p5581
aS'In addition to the calcineurin/NFAT pathway, recent studies indicated that CsA also block the activation of BRAF/MEK/ERK signaling, so inhibited Cox-2 promoter activation and protein induction in metastatic melanoma cells ('
p5582
aS'MAPK/ERK kinase 5 (MEK5) phosphorylates the TEY motif and activates ERK5 kinase activity.'
p5583
aS'As a member of the RAF family of serine/threonine kinases, BRAF is a key mediator of the mitogen-activated protein kinase (MAPK) signaling pathway (also known as the RAF-MEK-ERK pathway).'
p5584
aS'In the majority of melanomas, the RAS/RAF/MEK/ERK signaling pathway is constitutively activated, due to oncogenic mutations in the '
p5585
aS'Several genes and signaling cascades, including the RAS/RAF/MEK/ERK signaling pathway, have been implicated in the pathogenesis of cutaneous melanoma.'
p5586
aS'No mutations were observed in RAS, MEK or ERK, but all five tumours harboured an A>C, p.Q209P mutation in '
p5587
aS'(D) Involvement of mitogen-activated protein kinase kinase (MEK) in ADAMTS4 expression and phosphorylation of ERK1/2.'
p5588
ag706
ag707
aS'To assess whether p38 and ERK1/2 activation is causal to the actions of our chemotherapeutics we used specific pharmacological inhibitors of p38 and MEK.'
p5589
aS'Ras controls several effector proteins, including PI3K/Akt and MEK/ERK, that regulate signaling involved in cell survival and CREB phosphorylation.'
p5590
aS'We further analyzed whether mitochondrial PHB coordinates the signaling between MEK1 and ERK1/2 by affecting MEK1 activation in response to STS treatment in primary GCs and whether it affects Bcl family members.'
p5591
aS'STS mediated phosphorylation of ERK1/2 is dependent on PHB protein expression and PHB is also required for MEK1 activity, suggesting that a possible novel regulatory loop affecting this pathway is mediated by PHB.'
p5592
ag708
aS'When isolating liver cells, some pathways are activated, e.g., the RAS/MEK/ERK pathway, whereas others are silenced (e.g.'
p5593
aS'The inhibitor of the MEK/ERK pathway U-0126 strongly inhibited IL-8 mRNA induced by both Th1 and Th2 cells (Figure '
p5594
aS'As far as MCP-1 mRNA levels are concerned, a significant decrease was observed exclusively when Th2 cells were used to activate fibroblasts, whether in the presence of MEK/ERK, proteasome, or by JNK inhibitors.'
p5595
aS'Finally, proteasome and JNK inhibition resulted in a significant reduction in IP-10 mRNA levels induced by Th1 cells, whereas inhibition of MEK/ERK had only a marginal effect.'
p5596
aS'Finally, we demonstrated that the MEK1 (mitogen-activated protein extracellularly regulated kinase kinase 1) inhibitor PD-98059 reproduced the ability of ATRA to reduce the IL-1-induced phosphorylation of extracellularly regulated kinase 1/2 (ERK'
p5597
ag710
aS"APase = alkaline phosphatase; CPPD = calcium pyrophosphate dihydrate; Ct = threshold cycle; DMEM = Dulbecco's modified Eagle's medium; ePPi = extracellular inorganic pyrophosphate; ERK = extracellular signal-regulated kinase; FCS = fetal calf serum; iPPi = intracellular inorganic pyrophosphate; MAPK = mitogen-activated protein kinase; MEK-1 = mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1; NPPase = nucleotide pyrophosphatase phosphodiesterase; PBS = phosphate-buffered saline; PCR = polymerase chain reaction; PKA = protein kinase A; PKC = protein kinase C; "
p5598
ag712
aS'We determined that specific matrix metalloproteinases and cartilage-selective ECM transcript levels were regulated by MEK/ERK, while transcripts of the inflammatory gene macrophage colony stimulating factor 1 (Csf-1), were regulated in a MEK1/2-independent manner.'
p5599
aS'To determine additional, candidate transcription factors that may regulated by MEK/ERK, we considered that Egr-1 is a known early target of MEK/ERK signalling and that IL-1 induction of Egr-1 inhibits the activity of the human type II collagen proximal promoter ['
p5600
aS'APRIL, a proliferation-inducing ligand; BAFF, B-cell activation factor of the tumor necrosis factor family; BLyS, B-lymphocyte stimulator; ERK, extracellular regulating kinase; GPCR, G-protein coupled receptor; IL, interleukin; JAK, Janus kinase; LIGHT, lymphotoxin-related inducible ligand that competes for glycoprotein D binding to herpes virus entry mediator on T cells; LT, lymphotoxin; mAb, monoclonal (therapeutic) antibody; MEK, mitogen-activated protein kinase; P13K, phosphatidylinositol 3-kinase; PDGF-R, platelet-derived growth factor receptor; RA, rheumatoid arthritis; RANKL, receptor activator of nuclear factor-kappa B ligand; sJIA, systemic juvenile idiopathic arthritis; SLE, systemic lupus erythematosus; SMIP, small modular immunopharmaceutical; Syk, spleen tyrosine kinase.'
p5601
aS'In order to test whether MEK-1 (the mitogen-activated protein kinase [MAPK] kinase involved in extracellular signal-regulated kinase [ERK]-1 and ERK-2 phosphorylation/activation) participates in NOS type II induction via leptin/IL-1 co-stimulation, we used the specific MEK-1 inhibitor PD98059.'
p5602
aS'The p38 MAPK inhibitor SB203580 and the ERK1/2-MAPK kinase (MEK)-1 inhibitor PD98059 were from Omnilabo (Breda, The Netherlands), dissolved in dimethylsulfoxide or methanol and used as controls.'
p5603
aS'Using inhibitors of the mitogen-activated protein kinase (MAPK) kinase (MEK)1/extracellular signal (mitogenic)-regulated kinase (ERK)1/2 pathway (i.e.'
p5604
aS'PD98059 (MEK, upstream of ERK1/2, inhibitor ['
p5605
aS'These results suggest the involvement of both the MAPK (including MEK-ERK1/2 and p38MAPK) and PI3K-Akt pathways in chemerin-induced IL-6 production by RA FLSs.'
p5606
aS'Mice that express a dominant-negative form of the ERK pathway component MEK show reduced ERK pathway signaling and reduced expression of DNMT1.'
p5607
aS"DMEM: Dulbecco's modified Eagle's medium; ELISA: enzyme-linked immunosorbent assay; eNAMPT: extracellular nicotinamide phosphoribosyltransferase; ERK: extracellular signal-regulated kinase; IGF-1: insulin-like growth factor-1; IL: interleukin; IRS-1: insulin receptor substrate-1; MAPK: mitogen-activated protein kinase; MEK: mitogen-activated protein kinase kinase; NAMPT: nicotinamide phosphoribosyltransferase; OA: osteoarthritis; PBEF: pre-B-cell colony-enhancing factor; PBS: phosphate-buffered saline; PCR: polymerase chain reaction; PG: proteoglycan."
p5608
aS'The importance of decreased ERK pathway signaling was confirmed by generating a transgenic mouse with an inducible dominant negative MEK.'
p5609
aS'This specific defect is linked to the activation of the MEK/ERK pathwayTLR4 is expressed not only in joint-infiltrating immune cells, but also in non-hematopoietic joint tissues, and regulates joint inflammation by mediating the production of various cytokines ['
p5610
aS'In this study, we evaluated in detail the role of selective ERK activation, through the use of lentivectors for the expression of constitutively active or dominant-negative mutants of MEK-1, the upstream ERK kinase, as a strategy for the treatment of inflammatory arthritis.'
p5611
aS'We have demonstrated that the ERK pathway is suppressive, by using a specific endogenous activator rather than MEK chemical inhibitors.'
p5612
ag715
ag716
aS'Cdc42: cell division control protein 42, ERK: extracellular signal-regulated kinase, mTOR: mammalian target of rapamycin, PI3K: phosphatidylinositol 3-kinase, EGF(R): epidermal growth factor (receptor), Grb2: growth factor receptor-bound protein 2, JNK: c-Jun N-terminal kinase, MEK/MKK: mitogen-activated protein kinase kinases, PDGF(R): platelet derived growth factor (receptor), SOS: son of sevenless, TAK: TGF'
p5613
as(S'ZBTB18'
p5614
S'ONECUT1'
p5615
S'increases'
p5616
tp5617
(lp5618
s(S'TGIF'
p5619
S'MAX'
p5620
S'increases'
p5621
tp5622
(lp5623
s(S'ETS1'
p5624
S'NRAS'
p5625
S'increases'
p5626
tp5627
(lp5628
s(S'KLF12'
p5629
S'GATA1'
p5630
S'increases'
p5631
tp5632
(lp5633
s(S'HRAS/GTP'
p5634
S'PAK2'
p5635
S'increases_activity'
p5636
tp5637
(lp5638
s(S'CYP26A1'
p5639
S'FOXD3'
p5640
S'increases'
p5641
tp5642
(lp5643
s(S'LMO2'
p5644
S'RUNX1'
p5645
S'increases'
p5646
tp5647
(lp5648
g2513
as(S'MLK3'
p5649
S'MKK3/6'
p5650
S'adds_modification'
p5651
tp5652
(lp5653
s(S'TAK'
p5654
S'MKK3/6'
p5655
S'adds_modification'
p5656
tp5657
(lp5658
s(S'GRB2:SOS1'
p5659
S'HB-EGF:P-6Y-EGFR DIMER'
p5660
S'binds'
p5661
tp5662
(lp5663
s(S'FOXO4'
p5664
S'NRAS'
p5665
S'increases'
p5666
tp5667
(lp5668
s(S'MECOM'
p5669
S'NRAS'
p5670
S'increases'
p5671
tp5672
(lp5673
s(S'KLF12'
p5674
S'CYP26A1'
p5675
S'increases'
p5676
tp5677
(lp5678
s(S'RAS family/GTP/PI3K'
p5679
S'TRPV1'
p5680
S'adds_modification'
p5681
tp5682
(lp5683
s(S'hsa-let-7a-5p'
p5684
S'NRAS'
p5685
S'decreases'
p5686
tp5687
(lp5688
s(S'NF1'
p5689
S'HOXA9'
p5690
S'increases'
p5691
tp5692
(lp5693
S'In that study, a four-marker panel (ZNF154, HOXA9, POU4F2, and EOMES) achieved a sensitivity of 84% and a specificity of 96% ('
p5694
as(S'REPIN1'
p5695
S'FOXD3'
p5696
S'increases'
p5697
tp5698
(lp5699
s(S'CYP26A1'
p5700
S'FOXJ2'
p5701
S'increases'
p5702
tp5703
(lp5704
s(S'FOXO4'
p5705
S'MEIS1'
p5706
S'increases'
p5707
tp5708
(lp5709
s(S'EBF2'
p5710
S'MECOM'
p5711
S'increases'
p5712
tp5713
(lp5714
s(S'ETS1'
p5715
S'FOXO3'
p5716
S'increases'
p5717
tp5718
(lp5719
s(S'SP3'
p5720
S'CYP26A1'
p5721
S'increases'
p5722
tp5723
(lp5724
s(S'LNXp80'
p5725
S'NUMB'
p5726
S'decreases'
p5727
tp5728
(lp5729
s(S'RUNX2'
p5730
S'CYP26A1'
p5731
S'increases'
p5732
tp5733
(lp5734
s(S'AHR'
p5735
S'FOXO3'
p5736
S'increases'
p5737
tp5738
(lp5739
s(S'VSX1'
p5740
S'FOXF2'
p5741
S'increases'
p5742
tp5743
(lp5744
s(S'BPTF'
p5745
S'RUNX1'
p5746
S'increases'
p5747
tp5748
(lp5749
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p5750
S'HRAS PROTEIN'
p5751
S'increases'
p5752
tp5753
(lp5754
s(S'TCF3'
p5755
S'POU3F2'
p5756
S'increases'
p5757
tp5758
(lp5759
s(S'TCF3'
p5760
S'IRF1'
p5761
S'increases'
p5762
tp5763
(lp5764
s(S'SREBF1'
p5765
S'EN1'
p5766
S'increases'
p5767
tp5768
(lp5769
s(S'FOXO4'
p5770
S'RUNX2'
p5771
S'increases'
p5772
tp5773
(lp5774
s(S'hsa-miR-181a-5p'
p5775
S'HRAS'
p5776
S'decreases'
p5777
tp5778
(lp5779
s(S'Myb'
p5780
S'NRAS'
p5781
S'decreases'
p5782
tp5783
(lp5784
s(S'HSPA8'
p5785
S'ADP'
p5786
S'binds'
p5787
tp5788
(lp5789
s(S'SOCS3'
p5790
S'RASGAP'
p5791
S'binds'
p5792
tp5793
(lp5794
s(S'ONECUT1'
p5795
S'NRAS'
p5796
S'increases'
p5797
tp5798
(lp5799
s(S'PITX2'
p5800
S'EN1'
p5801
S'increases'
p5802
tp5803
(lp5804
s(S'HGF(dimer)/MET(dimer)'
p5805
S'SRC'
p5806
S'adds_modification'
p5807
tp5808
(lp5809
s(S'2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine'
p5810
S'HRAS PROTEIN'
p5811
S'increases'
p5812
tp5813
(lp5814
s(S'GFI1'
p5815
S'POU3F2'
p5816
S'increases'
p5817
tp5818
(lp5819
s(S'FARNESYL DIPHOSPHATE'
p5820
S'KRAS'
p5821
S'increases_activity'
p5822
tp5823
(lp5824
s(S'IL2/IL2R BETA/GAMMA/JAK1/LCK/JAK3'
p5825
S'PI3K'
p5826
S'binds'
p5827
tp5828
(lp5829
s(S'GTF3A'
p5830
S'MECOM'
p5831
S'increases'
p5832
tp5833
(lp5834
s(S'EGR2'
p5835
S'CYP26A1'
p5836
S'increases'
p5837
tp5838
(lp5839
s(S'RUNX1'
p5840
S'FOXF2'
p5841
S'increases'
p5842
tp5843
(lp5844
s(S'IL3/IL3RA/CSF2RB (DODECAMER)'
p5845
S'YWHAZ'
p5846
S'binds'
p5847
tp5848
(lp5849
s(S'RAF1'
p5850
S'BRAF'
p5851
S'binds'
p5852
tp5853
(lp5854
S'BRAF, a member of the RAF family including ARAF, BRAF and RAF1, is a serine/threonine protein kinase encoded by '
p5855
aS'It was also reported that rearrangements in the rapidly accelerated fibrosarcoma (RAF) pathway also occur in advanced prostate cancer (SLC45A3-BRAF, ESRP1-RAF1), which can be targeted by RAF kinase inhibitors.'
p5856
as(S'MYC'
p5857
S'CYP26A1'
p5858
S'increases'
p5859
tp5860
(lp5861
s(S'UBP1'
p5862
S'CYP26A1'
p5863
S'increases'
p5864
tp5865
(lp5866
s(S'MTF1'
p5867
S'REPIN1'
p5868
S'increases'
p5869
tp5870
(lp5871
s(S'HNF1A'
p5872
S'RUNX1'
p5873
S'increases'
p5874
tp5875
(lp5876
s(S'NHLH1'
p5877
S'FOXA1'
p5878
S'increases'
p5879
tp5880
(lp5881
s(S'HLF'
p5882
S'FOXA1'
p5883
S'increases'
p5884
tp5885
(lp5886
s(S'MEIS1'
p5887
S'GATA6'
p5888
S'increases'
p5889
tp5890
(lp5891
s(S'PDGF-BB/PDGFRB (DIMER)/SHP2'
p5892
S'GRB2/SOS1'
p5893
S'binds'
p5894
tp5895
(lp5896
s(S'ZBTB14'
p5897
S'EN1'
p5898
S'increases'
p5899
tp5900
(lp5901
s(S'alpha6/beta4 Integrin'
p5902
S'HRAS/GDP'
p5903
S'increases_activity'
p5904
tp5905
(lp5906
s(S'ErbB2'
p5907
S'HRAS/GDP'
p5908
S'increases_activity'
p5909
tp5910
(lp5911
s(S'MEIS1'
p5912
S'FOXO3'
p5913
S'increases'
p5914
tp5915
(lp5916
s(S'RELA'
p5917
S'IRF1'
p5918
S'increases'
p5919
tp5920
(lp5921
s(S'MYCN'
p5922
S'FOXO3'
p5923
S'increases'
p5924
tp5925
(lp5926
s(S'RHOA/GTP'
p5927
S'DIA'
p5928
S'increases_activity'
p5929
tp5930
(lp5931
s(S'Fluorouracil'
p5932
S'KRAS PROTEIN'
p5933
S'decreases'
p5934
tp5935
(lp5936
s(S'ATF2'
p5937
S'CYP26A1'
p5938
S'increases'
p5939
tp5940
(lp5941
s(S'GNAI2/GTP'
p5942
S'SRC FAMILY KINASES'
p5943
S'increases_activity'
p5944
tp5945
(lp5946
s(S'HAND1'
p5947
S'POU2F1'
p5948
S'increases'
p5949
tp5950
(lp5951
s(S'PI5K Type 1 family'
p5952
S'PI-4-P'
p5953
S'translocates'
p5954
tp5955
(lp5956
s(S'HSF1'
p5957
S'CBFA2T3'
p5958
S'increases'
p5959
tp5960
(lp5961
s(S'BACH1'
p5962
S'FOXA1'
p5963
S'increases'
p5964
tp5965
(lp5966
s(S'PI-3-4-5-P3'
p5967
S'SGK1'
p5968
S'adds_modification'
p5969
tp5970
(lp5971
s(S'hsa-miR-20a-5p'
p5972
S'NRAS'
p5973
S'decreases'
p5974
tp5975
(lp5976
s(S'CYP26A1'
p5977
S'MECOM'
p5978
S'increases'
p5979
tp5980
(lp5981
s(S'FOXF2'
p5982
S'RUNX1'
p5983
S'increases'
p5984
tp5985
(lp5986
s(S'EGR2'
p5987
S'SRF'
p5988
S'increases'
p5989
tp5990
(lp5991
s(S'LEF1'
p5992
S'FOXD3'
p5993
S'increases'
p5994
tp5995
(lp5996
s(S'TFAP2C'
p5997
S'MECOM'
p5998
S'increases'
p5999
tp6000
(lp6001
s(S'SHC'
p6002
S'GRB2/SOS1'
p6003
S'binds'
p6004
tp6005
(lp6006
s(S'CA2+'
p6007
S'CAM'
p6008
S'binds'
p6009
tp6010
(lp6011
s(S'MYC'
p6012
S'POU3F2'
p6013
S'increases'
p6014
tp6015
(lp6016
s(S'PAX8'
p6017
S'HOXA9'
p6018
S'increases'
p6019
tp6020
(lp6021
s(S'TFDP2'
p6022
S'CDC5L'
p6023
S'increases'
p6024
tp6025
(lp6026
s(S'RAF1/14-3-3'
p6027
S'KSR/14-3-3 /MEK1-2'
p6028
S'increases_activity'
p6029
tp6030
(lp6031
s(S'DDIT3'
p6032
S'MEIS1'
p6033
S'increases'
p6034
tp6035
(lp6036
s(S'GNB1/GNG2'
p6037
S'HRAS/GDP'
p6038
S'increases_activity'
p6039
tp6040
(lp6041
s(S'ACTIVATED FGFR MUTANTS:P-FRS2ALPHA'
p6042
S'GRB2:SOS1'
p6043
S'binds'
p6044
tp6045
(lp6046
s(S'HIF1A'
p6047
S'CYP26A1'
p6048
S'increases'
p6049
tp6050
(lp6051
s(S'RAF1-BRAF'
p6052
S'ERK1-2'
p6053
S'increases_activity'
p6054
tp6055
(lp6056
s(S'SMAD4'
p6057
S'CBFA2T3'
p6058
S'increases'
p6059
tp6060
(lp6061
s(S'resveratrol'
p6062
S'HRAS PROTEIN'
p6063
S'increases'
p6064
tp6065
(lp6066
s(S'Malathion'
p6067
S'HRAS MRNA'
p6068
S'increases'
p6069
tp6070
(lp6071
s(S'NRF1'
p6072
S'FOXO4'
p6073
S'increases'
p6074
tp6075
(lp6076
s(S'CREB1'
p6077
S'JUN'
p6078
S'increases'
p6079
tp6080
(lp6081
s(S'CDC5L'
p6082
S'HOXA9'
p6083
S'increases'
p6084
tp6085
(lp6086
s(S'CDX2'
p6087
S'HOXA9'
p6088
S'increases'
p6089
tp6090
(lp6091
s(S'HMGA1'
p6092
S'POU2F1'
p6093
S'increases'
p6094
tp6095
(lp6096
s(S'Coumestrol'
p6097
S'KRAS MRNA'
p6098
S'decreases'
p6099
tp6100
(lp6101
s(S'LEF1'
p6102
S'FOXO3'
p6103
S'increases'
p6104
tp6105
(lp6106
s(S'CYP26A1'
p6107
S'MEIS1'
p6108
S'increases'
p6109
tp6110
(lp6111
s(S'GTF2A2'
p6112
S'MEIS1'
p6113
S'increases'
p6114
tp6115
(lp6116
s(S'REPIN1'
p6117
S'CBFA2T3'
p6118
S'increases'
p6119
tp6120
(lp6121
s(S'hsa-miR-143-3p'
p6122
S'HRAS'
p6123
S'decreases'
p6124
tp6125
(lp6126
s(S'[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID'
p6127
S'KRAS'
p6128
S'increases_activity'
p6129
tp6130
(lp6131
s(S'TFDP1'
p6132
S'ONECUT1'
p6133
S'increases'
p6134
tp6135
(lp6136
s(S'YY1'
p6137
S'CYP26A1'
p6138
S'increases'
p6139
tp6140
(lp6141
s(S'PITX2'
p6142
S'RUNX1'
p6143
S'increases'
p6144
tp6145
(lp6146
s(S'STAT5A'
p6147
S'NRAS'
p6148
S'increases'
p6149
tp6150
(lp6151
s(S'Valproic Acid'
p6152
S'HRAS MRNA'
p6153
S'increases'
p6154
tp6155
(lp6156
s(S'Malathion'
p6157
S'HRAS PROTEIN'
p6158
S'increases'
p6159
tp6160
(lp6161
s(S'TFAP4'
p6162
S'CBFA2T3'
p6163
S'increases'
p6164
tp6165
(lp6166
s(S'TFAP4'
p6167
S'EN1'
p6168
S'increases'
p6169
tp6170
(lp6171
s(S'POU3F2'
p6172
S'CYP26A1'
p6173
S'increases'
p6174
tp6175
(lp6176
s(S'PAX3'
p6177
S'FOXD3'
p6178
S'increases'
p6179
tp6180
(lp6181
s(S'FOXA2'
p6182
S'RUNX2'
p6183
S'increases'
p6184
tp6185
(lp6186
s(S'MAX'
p6187
S'BACH1'
p6188
S'increases'
p6189
tp6190
(lp6191
s(S'PDX1'
p6192
S'CYP26A1'
p6193
S'increases'
p6194
tp6195
(lp6196
s(S'EPO/EPOR (dimer)/JAK2'
p6197
S'SHC/GRB2/SOS1'
p6198
S'increases_activity'
p6199
tp6200
(lp6201
s(S'E2F1'
p6202
S'MEIS1'
p6203
S'increases'
p6204
tp6205
(lp6206
s(S'FOXF2'
p6207
S'MEIS1'
p6208
S'increases'
p6209
tp6210
(lp6211
s(S'SPZ1'
p6212
S'FOXJ2'
p6213
S'increases'
p6214
tp6215
(lp6216
s(S'SRY'
p6217
S'NRAS'
p6218
S'increases'
p6219
tp6220
(lp6221
s(S'REPIN1'
p6222
S'CYP26A1'
p6223
S'increases'
p6224
tp6225
(lp6226
s(S'VEGFR3/VEGFC-D'
p6227
S'PKC'
p6228
S'increases_activity'
p6229
tp6230
(lp6231
s(S'MEIS1'
p6232
S'EN1'
p6233
S'increases'
p6234
tp6235
(lp6236
s(S'FOXJ1'
p6237
S'FOXD3'
p6238
S'increases'
p6239
tp6240
(lp6241
s(S'SPZ1'
p6242
S'FOXO4'
p6243
S'increases'
p6244
tp6245
(lp6246
s(S'RHOA/GTP'
p6247
S'ROCK1-ROCK2'
p6248
S'increases_activity'
p6249
tp6250
(lp6251
s(S'HMGA1'
p6252
S'ONECUT1'
p6253
S'increases'
p6254
tp6255
(lp6256
s(S'uPA/uPAR/alphav/beta3 Integrin/Vitronectin'
p6257
S'SRC'
p6258
S'adds_modification'
p6259
tp6260
(lp6261
s(S'ETS1'
p6262
S'CYP26A1'
p6263
S'increases'
p6264
tp6265
(lp6266
s(S'ESRRA'
p6267
S'TLX2'
p6268
S'increases'
p6269
tp6270
(lp6271
s(S'ROCK2'
p6272
S'RHO FAMILY GTPASE-ACTIVE'
p6273
S'binds'
p6274
tp6275
(lp6276
s(S'ATF4'
p6277
S'CYP26A1'
p6278
S'increases'
p6279
tp6280
(lp6281
s(S'OR5I1'
p6282
S'CYP26A1'
p6283
S'increases'
p6284
tp6285
(lp6286
s(S'PITX2'
p6287
S'GATA1'
p6288
S'increases'
p6289
tp6290
(lp6291
s(S'AHR'
p6292
S'ONECUT1'
p6293
S'increases'
p6294
tp6295
(lp6296
s(S'PTF1A'
p6297
S'MECOM'
p6298
S'increases'
p6299
tp6300
(lp6301
s(S'arsenic trioxide'
p6302
S'HRAS MRNA'
p6303
S'increases'
p6304
tp6305
(lp6306
s(S'TCF3'
p6307
S'REPIN1'
p6308
S'increases'
p6309
tp6310
(lp6311
s(S'STAT6'
p6312
S'FOXO3'
p6313
S'increases'
p6314
tp6315
(lp6316
s(S'POU1F1'
p6317
S'POU2F1'
p6318
S'increases'
p6319
tp6320
(lp6321
s(S'RHOA/GTP'
p6322
S'ROCK'
p6323
S'increases_activity'
p6324
tp6325
(lp6326
s(S'PITPNA'
p6327
S'PI-4-5-P2'
p6328
S'translocates'
p6329
tp6330
(lp6331
s(S'MDM-2'
p6332
S'P14/19 ARF'
p6333
S'binds'
p6334
tp6335
(lp6336
s(S'TEAD1'
p6337
S'FOXO3'
p6338
S'increases'
p6339
tp6340
(lp6341
s(S'MYC'
p6342
S'MAX'
p6343
S'increases'
p6344
tp6345
(lp6346
s(S'GRB2:SOS1'
p6347
S'EGF:PHOSPHO-EGFR:PHOSPHO-SHC'
p6348
S'binds'
p6349
tp6350
(lp6351
s(S'NF1'
p6352
S'RUNX1'
p6353
S'increases'
p6354
tp6355
(lp6356
s(S'ZEB1'
p6357
S'GATA6'
p6358
S'increases'
p6359
tp6360
(lp6361
s(S'TBP'
p6362
S'EN1'
p6363
S'increases'
p6364
tp6365
(lp6366
s(S'FOXA1'
p6367
S'FOXD3'
p6368
S'increases'
p6369
tp6370
(lp6371
s(S'CART1'
p6372
S'EN1'
p6373
S'increases'
p6374
tp6375
(lp6376
s(S'MAX'
p6377
S'CEBPA'
p6378
S'increases'
p6379
tp6380
(lp6381
s(S'GATA6'
p6382
S'NRAS'
p6383
S'increases'
p6384
tp6385
(lp6386
s(S'PTF1A'
p6387
S'FOXO3'
p6388
S'increases'
p6389
tp6390
(lp6391
s(S'LEF1'
p6392
S'FOXA1'
p6393
S'increases'
p6394
tp6395
(lp6396
s(S'hsa-let-7g-5p'
p6397
S'KRAS'
p6398
S'decreases'
p6399
tp6400
(lp6401
s(S'ZBTB14'
p6402
S'CYP26A1'
p6403
S'increases'
p6404
tp6405
(lp6406
s(S'POU1F1'
p6407
S'FOXO4'
p6408
S'increases'
p6409
tp6410
(lp6411
s(S'PI3K'
p6412
S'PI-4-5-P2'
p6413
S'translocates'
p6414
tp6415
(lp6416
s(S'GABPB2'
p6417
S'NRAS'
p6418
S'increases'
p6419
tp6420
(lp6421
s(S'ELK1'
p6422
S'LEF1'
p6423
S'increases'
p6424
tp6425
(lp6426
s(S'Estrogens'
p6427
S'HRAS MRNA'
p6428
S'increases'
p6429
tp6430
(lp6431
s(S'CYP26A1'
p6432
S'CEBPA'
p6433
S'increases'
p6434
tp6435
(lp6436
s(S'SPI1'
p6437
S'POU2F1'
p6438
S'increases'
p6439
tp6440
(lp6441
s(S'PPARG'
p6442
S'CYP26A1'
p6443
S'increases'
p6444
tp6445
(lp6446
s(S'Asbestos, Serpentine'
p6447
S'HRAS PROTEIN'
p6448
S'increases'
p6449
tp6450
(lp6451
s(S'RET51/GFRALPHA1/GDNF/DOK1'
p6452
S'RASGAP'
p6453
S'binds'
p6454
tp6455
(lp6456
s(S'FOXO1'
p6457
S'GATA6'
p6458
S'increases'
p6459
tp6460
(lp6461
s(S'Cadmium'
p6462
S'KRAS PROTEIN'
p6463
S'increases'
p6464
tp6465
(lp6466
s(S'MAX'
p6467
S'EN1'
p6468
S'increases'
p6469
tp6470
(lp6471
s(S'TLX2'
p6472
S'NRAS'
p6473
S'increases'
p6474
tp6475
(lp6476
s(S'SREBF1'
p6477
S'CYP26A1'
p6478
S'increases'
p6479
tp6480
(lp6481
s(S'SMAD3'
p6482
S'MEIS1'
p6483
S'increases'
p6484
tp6485
(lp6486
s(S'Acetaminophen'
p6487
S'NRAS MRNA'
p6488
S'decreases'
p6489
tp6490
(lp6491
s(S'LEF1'
p6492
S'ETS1'
p6493
S'increases'
p6494
tp6495
(lp6496
s(S'SRF'
p6497
S'MEIS1'
p6498
S'increases'
p6499
tp6500
(lp6501
s(S'BRAF'
p6502
S'MKK3-MKK6'
p6503
S'increases_activity'
p6504
tp6505
(lp6506
s(S'HRAS/GTP'
p6507
S'RAF1'
p6508
S'adds_modification'
p6509
tp6510
(lp6511
s(S'MSX1'
p6512
S'CYP26A1'
p6513
S'increases'
p6514
tp6515
(lp6516
s(S'GATA4'
p6517
S'ETS1'
p6518
S'increases'
p6519
tp6520
(lp6521
s(S'E4F1'
p6522
S'FOXA1'
p6523
S'increases'
p6524
tp6525
(lp6526
s(S'FOXD1'
p6527
S'LEF1'
p6528
S'increases'
p6529
tp6530
(lp6531
s(S'CUX1'
p6532
S'MAX'
p6533
S'increases'
p6534
tp6535
(lp6536
s(S'CYP26A1'
p6537
S'CBFA2T3'
p6538
S'increases'
p6539
tp6540
(lp6541
s(S'CAM/CA2+'
p6542
S'KRAS ISOFORM 4B/GTP'
p6543
S'binds'
p6544
tp6545
(lp6546
s(S'MYOG'
p6547
S'STAT5A'
p6548
S'increases'
p6549
tp6550
(lp6551
s(S'MYOD1'
p6552
S'STAT5A'
p6553
S'increases'
p6554
tp6555
(lp6556
s(S'HNF1A'
p6557
S'POU3F2'
p6558
S'increases'
p6559
tp6560
(lp6561
s(S'EPH'
p6562
S'EPHR'
p6563
S'binds'
p6564
tp6565
(lp6566
s(S'PDGF:PHOSPHO-PDGF RECEPTOR DIMER'
p6567
S'GRB2:SOS1'
p6568
S'binds'
p6569
tp6570
(lp6571
s(S'HRAS/GTP'
p6572
S'PI3K'
p6573
S'increases_activity'
p6574
tp6575
(lp6576
s(S'RUNX1'
p6577
S'TLX2'
p6578
S'increases'
p6579
tp6580
(lp6581
s(S'MYOG'
p6582
S'CYP26A1'
p6583
S'increases'
p6584
tp6585
(lp6586
s(S'PAX2'
p6587
S'EN1'
p6588
S'increases'
p6589
tp6590
(lp6591
s(S'TFCP2'
p6592
S'CYP26A1'
p6593
S'increases'
p6594
tp6595
(lp6596
s(S'hsa-miR-145-5p'
p6597
S'NRAS'
p6598
S'decreases'
p6599
tp6600
(lp6601
s(S'KAT2B'
p6602
S'GATA1'
p6603
S'increases'
p6604
tp6605
(lp6606
s(S'P-EGFR MUTANTS:P-Y349,350-SHC1'
p6607
S'GRB2:SOS1'
p6608
S'binds'
p6609
tp6610
(lp6611
s(S'E2F1'
p6612
S'MECOM'
p6613
S'increases'
p6614
tp6615
(lp6616
s(S'GNB1/GNG2'
p6617
S'SRC'
p6618
S'adds_modification'
p6619
tp6620
(lp6621
s(S'ZBTB14'
p6622
S'MAX'
p6623
S'increases'
p6624
tp6625
(lp6626
s(S'RALGDS'
p6627
S'P21 RAS:GTP'
p6628
S'binds'
p6629
tp6630
(lp6631
s(S'RHOA/GTP'
p6632
S'ROCK2'
p6633
S'increases_activity'
p6634
tp6635
(lp6636
s(S'NR1H3'
p6637
S'FOXD3'
p6638
S'increases'
p6639
tp6640
(lp6641
s(S'TFAP4'
p6642
S'GATA1'
p6643
S'increases'
p6644
tp6645
(lp6646
s(S'FOXA1'
p6647
S'GATA6'
p6648
S'increases'
p6649
tp6650
(lp6651
s(S'GRB2:SOS1'
p6652
S'P-SHC'
p6653
S'binds'
p6654
tp6655
(lp6656
s(S'E2F1'
p6657
S'FOXO3'
p6658
S'increases'
p6659
tp6660
(lp6661
S'Tight regulation of SIRT1 expression and\n                        activity is achieved through regulation of transcription by p53, FOXO3a, and\n                        E2F1 ['
p6662
as.